[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

US20170065339A1 - Methods and apparatus for selective tissue ablation - Google Patents

Methods and apparatus for selective tissue ablation Download PDF

Info

Publication number
US20170065339A1
US20170065339A1 US15/341,512 US201615341512A US2017065339A1 US 20170065339 A1 US20170065339 A1 US 20170065339A1 US 201615341512 A US201615341512 A US 201615341512A US 2017065339 A1 US2017065339 A1 US 2017065339A1
Authority
US
United States
Prior art keywords
electrode
electrodes
anode
cathode
catheter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US15/341,512
Inventor
Steven R. MICKELSEN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Scientific Scimed Inc
Original Assignee
Farapulse Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US15/341,512 priority Critical patent/US20170065339A1/en
Application filed by Farapulse Inc filed Critical Farapulse Inc
Assigned to IOWA APPROACH INC. reassignment IOWA APPROACH INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MICKELSEN, Steven R.
Publication of US20170065339A1 publication Critical patent/US20170065339A1/en
Priority to US15/795,062 priority patent/US11259869B2/en
Assigned to FARAPULSE, INC. reassignment FARAPULSE, INC. CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: IOWA APPROACH, INC.
Assigned to IOWA APPROACH, INC. reassignment IOWA APPROACH, INC. CORRECTIVE ASSIGNMENT TO CORRECT THE PERIOD AFTER APPROACH IN RECEIVING PARTY NAME. PREVIOUSLY RECORDED AT REEL: 041155 FRAME: 0525. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Assignors: MICKELSEN, Steven R.
Assigned to BOSTON SCIENTIFIC SCIMED, INC. reassignment BOSTON SCIENTIFIC SCIMED, INC. SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: FARAPULSE, INC.
Priority to US17/349,299 priority patent/US20220000548A1/en
Assigned to BOSTON SCIENTIFIC SCIMED, INC. reassignment BOSTON SCIENTIFIC SCIMED, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: FARAPULSE, INC.
Priority to US18/664,140 priority patent/US20240299088A1/en
Priority to US18/664,163 priority patent/US20240299089A1/en
Priority to US18/674,565 priority patent/US20240307115A1/en
Priority to US18/674,511 priority patent/US20240307114A1/en
Priority to US18/674,492 priority patent/US20240315769A1/en
Priority to US18/674,533 priority patent/US20240315770A1/en
Priority to US18/674,613 priority patent/US20240307117A1/en
Priority to US18/674,607 priority patent/US20240307116A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • A61B18/1492Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/05Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves 
    • A61B5/053Measuring electrical impedance or conductance of a portion of the body
    • A61B5/0538Measuring electrical impedance or conductance of a portion of the body invasively, e.g. using a catheter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/327Applying electric currents by contact electrodes alternating or intermittent currents for enhancing the absorption properties of tissue, e.g. by electroporation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N7/00Ultrasound therapy
    • A61N7/02Localised ultrasound hyperthermia
    • A61N7/022Localised ultrasound hyperthermia intracavitary
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/1815Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using microwaves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00017Electrical control of surgical instruments
    • A61B2017/00022Sensing or detecting at the treatment site
    • A61B2017/00026Conductivity or impedance, e.g. of tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00017Electrical control of surgical instruments
    • A61B2017/00137Details of operation mode
    • A61B2017/00154Details of operation mode pulsed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053Mechanical features of the instrument of device
    • A61B2018/00214Expandable means emitting energy, e.g. by elements carried thereon
    • A61B2018/0022Balloons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053Mechanical features of the instrument of device
    • A61B2018/00214Expandable means emitting energy, e.g. by elements carried thereon
    • A61B2018/00267Expandable means emitting energy, e.g. by elements carried thereon having a basket shaped structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00345Vascular system
    • A61B2018/00351Heart
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00345Vascular system
    • A61B2018/00404Blood vessels other than those in or around the heart
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00571Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
    • A61B2018/00577Ablation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00571Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
    • A61B2018/00613Irreversible electroporation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00642Sensing and controlling the application of energy with feedback, i.e. closed loop control
    • A61B2018/00654Sensing and controlling the application of energy with feedback, i.e. closed loop control with individual control of each of a plurality of energy emitting elements
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00773Sensed parameters
    • A61B2018/00827Current
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00773Sensed parameters
    • A61B2018/00839Bioelectrical parameters, e.g. ECG, EEG
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00773Sensed parameters
    • A61B2018/00875Resistance or impedance
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00773Sensed parameters
    • A61B2018/00892Voltage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00994Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body combining two or more different kinds of non-mechanical energy or combining one or more non-mechanical energies with ultrasound
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/1206Generators therefor
    • A61B2018/124Generators therefor switching the output to different electrodes, e.g. sequentially
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • A61B2018/1467Probes or electrodes therefor using more than two electrodes on a single probe
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2218/00Details of surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2218/001Details of surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body having means for irrigation and/or aspiration of substances to and/or from the surgical site
    • A61B2218/002Irrigation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2576/00Medical imaging apparatus involving image processing or analysis
    • A61B2576/02Medical imaging apparatus involving image processing or analysis specially adapted for a particular organ or body part
    • A61B2576/023Medical imaging apparatus involving image processing or analysis specially adapted for a particular organ or body part for the heart
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316Modalities, i.e. specific diagnostic methods
    • A61B5/318Heart-related electrical modalities, e.g. electrocardiography [ECG]
    • A61B5/339Displays specially adapted therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/0404Electrodes for external use
    • A61N1/0408Use-related aspects
    • A61N1/0412Specially adapted for transcutaneous electroporation, e.g. including drug reservoirs
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H30/00ICT specially adapted for the handling or processing of medical images
    • G16H30/40ICT specially adapted for the handling or processing of medical images for processing medical images, e.g. editing

Definitions

  • the embodiments described herein relate generally to medical devices for therapeutic electrical energy delivery, and more particularly to systems and methods for delivering electrical energy in the context of ablating tissue rapidly and selectively by the application of suitably timed pulsed voltages that generate irreversible electroporation of cell membranes.
  • the applied electric field at the membrane exceeds a threshold value, typically dependent on cell size, the electroporation is irreversible and the pores remain open, permitting exchange of material across the membrane and leading to apoptosis or cell death. Subsequently, the surrounding tissue heals in a natural process.
  • an apparatus includes a voltage pulse generator and an electrode controller.
  • the voltage pulse generator is configured to produce a pulsed voltage waveform.
  • the electrode controller is configured to be operably coupled to the voltage pulse generator and a medical device including a series of electrodes.
  • the electrode controller includes a selection module and a pulse delivery module.
  • the selection module is configured to select a subset of electrodes from the series of electrodes.
  • the selection module is configured identify at least one electrode as an anode and at least one electrode as a cathode.
  • the pulse delivery module is configured to deliver an output signal associated with the pulsed voltage waveform to the subset of electrodes.
  • FIG. 1 is a perspective view of a portion of a catheter with multiple electrodes disposed along its shaft and wrapped around the pulmonary veins of the heart such that the portion of the catheter is placed in the epicardial space of the heart.
  • FIG. 2A is a schematic illustration of an irreversible electroporation system that includes a DC voltage/signal generator, a controller capable of being configured to apply voltages to selected subsets of electrodes with independent subset selections for anode and cathode.
  • FIG. 2B is a schematic illustration of an irreversible electroporation system that includes a DC voltage/signal generator and a controller according to an embodiment.
  • FIG. 3 is an illustration of an ECG waveform showing the refractory periods during atrial and ventricular pacing, and the time windows for irreversible electroporation ablation.
  • FIG. 4 is a schematic illustration of a user interface according to an embodiment showing various configurations for subsets of electrodes on the catheter to be identified as anodes or cathodes, and the ablation vectors therebetween.
  • FIG. 5 is a schematic illustration of a user interface according to an embodiment, indicating the electrodes that are active and wrapped around the pulmonary veins of a patient anatomy, and that can be actively available for selection in bipolar ablation.
  • FIG. 6 is a schematic illustration of a user interface according to an embodiment that illustrates a method of ablating along a cardiac isthmus line using two catheters, one of which is wrapped around the pulmonary veins.
  • FIG. 7 is a schematic illustration of a user interface according to an embodiment that illustrates a method of focal ablation, wherein nearby electrodes on the same catheter are used for bipolar ablation with irreversible electroporation to ablate a region of contacting tissue at the distal catheter end, and showing a depth selection button that can be used to selectively adjust an ablation parameter.
  • FIG. 8 is a schematic illustration according to an embodiment, showing a graphic window for selection of type of pacing to be used for electroporation therapy delivery.
  • FIG. 9 is a schematic illustration of a user interface according to an embodiment, showing a graphic window with parameters associated with a selected pacing type.
  • FIG. 10 is a schematic illustration of a user interface that illustrates a method of selecting anode electrode subsets and cathode electrode subsets on two different catheters according to an embodiment.
  • FIG. 11 is a schematic illustration of a user interface that illustrates a method of selecting a single anode electrode and a single selected cathode electrode on the same catheter according to an embodiment.
  • FIG. 12 is a schematic illustration of a waveform generated by the irreversible electroporation system and methods according to an embodiment, showing a balanced square wave.
  • FIG. 13 is a schematic illustration of a waveform generated by the irreversible electroporation system and methods according to an embodiment, showing a balanced biphasic square wave.
  • FIG. 14 is a schematic illustration of a waveform generated by the irreversible electroporation system and methods according to an embodiment, showing a progressive balanced biphasic square wave.
  • FIG. 15 is a schematic illustration of a signal generator according to an embodiment, showing a capacitor bank connected to a set of switches.
  • FIG. 16 is a schematic illustration of a voltage pulse-time plot produced by a high voltage DC signal generator according to an embodiment.
  • FIG. 17 is a schematic depiction of a sequence of three biphasic pulses delivered by a voltage generator and using methods according to an embodiment, showing a pre-polarizing negative voltage pulse followed by a positive polarizing pulse.
  • FIG. 18A is a schematic illustration of a distal portion of a catheter having two electrodes functioning as a cathode and an anode according to an embodiment.
  • FIG. 18B is a schematic illustration of a distal portion of a catheter according to an embodiment having a recessed distal anode electrode, the illustration showing the current flow between electrodes.
  • FIG. 18C is a schematic illustration of a distal portion of a catheter according to an embodiment, where electric field lines near the distal end of the catheter are schematically shown together with a region of focal ablation in tissue.
  • FIG. 18D is a schematic illustration of a distal portion of a catheter according to an embodiment, where the catheter lumen has flowing fluid, possibly with ultrasonic waves conducted through the fluid, and the distal anode electrode has channels for fluid flow to exit the distal end of the catheter.
  • FIG. 19A is an illustration of the simulation geometry showing a geometric model of the distal portion of a catheter and surrounding tissue types.
  • FIG. 19B is an illustration of the distal portion of a catheter with a proximal electrode disposed externally on the shaft of the catheter and a distal electrode that is recessed and disposed on the inner side of the shaft of the catheter.
  • FIG. 19C is an illustration of a longitudinal cross-section of the simulation geometry showing distal catheter geometry and tissue geometry together with electric field intensity contours for the case when the proximal electrode is disposed externally on the shaft of the catheter and the distal electrode is recessed and disposed on the inner side of the shaft of the catheter, according to an embodiment.
  • FIG. 19D is an illustration of a longitudinal cross-section of the simulation geometry showing distal catheter geometry and tissue geometry together with electric field intensity contours for the case when the proximal and distal electrodes are both disposed externally on the shaft of the catheter, according to an embodiment.
  • FIG. 20 is a schematic illustration of a balloon catheter according to an embodiment, where a balloon structure with an insulating exterior is located between anode and cathode electrodes for electroporation voltage delivery.
  • FIG. 21A is a schematic illustration of a balloon catheter according to an embodiment, where a balloon structure with an insulating exterior and with at least one ultrasonic transducer is located between anode and cathode electrodes for electroporation voltage delivery.
  • FIG. 21B is a schematic illustration of a balloon catheter according to an embodiment, where an annular ablation region abutting a vessel is shown.
  • FIG. 22 is a schematic illustration of a basket ablation catheter for electroporation energy delivery according to an embodiment.
  • the irreversible electroporation system described herein includes a DC voltage/signal generator and a controller capable of being configured to apply voltages to a selected multiplicity or a subset of electrodes, with anode and cathode subsets being selected independently.
  • the controller is additionally capable of applying control inputs whereby selected pairs of anode-cathode subsets of electrodes can be sequentially updated based on a pre-determined sequence.
  • an irreversible electroporation system includes a DC voltage/signal generator and a controller capable of being configured to apply voltages to a selected multiplicity or a subset of electrodes, with independent subset selections for anode and cathode. Further, the controller is capable of applying control inputs whereby selected pairs of anode-cathode subsets of electrodes can be sequentially updated based on a pre-determined sequence.
  • the generator can output waveforms that can be selected to generate a sequence of voltage pulses in either monophasic or biphasic forms and with either constant or progressively changing amplitudes.
  • a DC voltage pulse generation mechanism can use amplified voltage spikes generated by the action of a switch connected to a capacitor bank, resulting in a biphasic, asymmetric micro pulse waveform for cardiac ablation where the first phase provides a brief pre-polarizing pulse that is followed by a finishing pulse in the second phase. Such pre-polarization can result in more effective pulsed voltage electroporation delivery.
  • Methods of control and DC voltage application from a generator capable of selective excitation of sets of electrodes are disclosed.
  • Devices are disclosed for more effective DC voltage application through ionic fluid irrigation and ultrasonic agitation, possibly including insulating balloon constructions to displace electrodes from collateral structures, and for use in intravascular applications.
  • Such devices for generating irreversible electroporation can be utilized in cardiac therapy applications such as ablation to treat Ventricular Tachycardia (VT) as well as in intravascular applications.
  • VT Ventricular Tachycardia
  • the use of temperature to selectively ablate tissue is described, as the threshold of irreversible electroporation is temperature-dependent, utilizing focused kinetic energy to select the predominant tissue type or region it is desired to ablate
  • an apparatus in some embodiments, includes a voltage pulse generator and an electrode controller.
  • the voltage pulse generator is configured to produce a pulsed voltage waveform.
  • the electrode controller is configured to be operably coupled to the voltage pulse generator and a medical device including a series of electrodes.
  • the electrode controller is implemented in at least one of a memory or a processor, and includes a selection module and a pulse delivery module.
  • the selection module is configured to select a subset of electrodes from the series of electrodes.
  • the selection module is configured identify at least one electrode as an anode and at least one electrode as a cathode.
  • the pulse delivery module is configured to deliver an output signal associated with the pulsed voltage waveform to the subset of electrodes.
  • an apparatus includes a voltage pulse generator and an electrode controller.
  • the voltage pulse generator is configured to produce a pulsed voltage waveform.
  • the electrode controller is configured to be operably coupled to the voltage pulse generator and a medical device including a series of electrodes.
  • the electrode controller is implemented in at least one of a memory or a processor, and includes a selection module and a pulse delivery module.
  • the selection module is configured to select a set of anode/cathode pairs, each anode/cathode pair including at least one anode electrode and at least one cathode electrode.
  • the anode/cathode pair can include one anode and multiple cathodes (or vice-versa).
  • the pulse delivery module is configured to deliver an output signal associated with the pulsed voltage waveform to the plurality of anode/cathode pairs according to a sequential pattern.
  • a non-transitory processor readable medium storing code representing instructions to be executed by a processor includes code to cause the processor to identify a set of anode/cathode pairs from a set of electrodes of a multi-electrode catheter.
  • the multi-electrode catheter is configured to be disposed about a portion of a heart, and at least one anode/cathode pair includes at least one anode electrode and at least one cathode electrode.
  • the code further includes code to convey a pacing signal to a pacing lead configured to be operatively coupled to the heart.
  • the code further includes code to receive an electrocardiograph signal associated with a function of the heart.
  • the code further includes code to deliver a pulsed voltage waveform to the set of anode/cathode pairs according to a sequential pattern.
  • a method includes identifying, via a selection module of an electrode controller, a set of anode/cathode pairs from a set of electrodes of a multi-electrode catheter.
  • the multi-electrode catheter is configured to be disposed about a portion of a heart.
  • At least one anode/cathode pair includes at least one anode electrode and at least one cathode electrode.
  • a pacing signal is conveyed to a pacing lead configured to be operatively coupled to the heart.
  • the method further includes receiving, at a feedback module of the electrode controller, an electrocardiograph signal associated with a function of the heart.
  • the method further includes delivering, via a pulse delivery module of the electrode controller, a pulsed voltage waveform to the set of anode/cathode pairs according to a sequential pattern.
  • an apparatus includes a signal generator for the generation of DC voltage pulses.
  • the signal generator is configured to produce a biphasic waveform having a pre-polarizing pulse followed by a polarizing pulse.
  • the pre-polarizing pulse is generated by utilizing voltage spikes generated from switching on a discharge of a capacitor bank.
  • an apparatus in some embodiments, includes a catheter shaft, a cathode electrode and an anode electrode.
  • the catheter shaft has an outer side and an inner side.
  • the cathode electrode is coupled to a distal end portion of the catheter shaft such that a cathode surface is exposed on the outer side of the catheter shaft.
  • the anode electrode is coupled to the distal end portion distal relative to the cathode electrode.
  • the anode electrode is recessed within the catheter shaft and coupled to the catheter shaft such that an anode surface is exposed on the inner side of the catheter shaft.
  • an apparatus in some embodiments, includes a catheter shaft, an inflatable balloon, a first electrode and a second electrode.
  • the catheter shaft has a distal end portion.
  • the inflatable balloon is coupled to the distal end portion.
  • An outer surface of the balloon is an electrical insulator.
  • the first electrode is coupled to a proximal side of the balloon, and the second electrode is coupled to a distal side of the balloon.
  • an apparatus in some embodiments, includes a catheter shaft having a distal end portion, an expandable basket structure, a first electrode, a second electrode, and a set of spherical electrodes.
  • the expandable basket structure is coupled to the distal end portion of the catheter shaft.
  • the first electrode coupled to a proximal side of the expandable basket structure.
  • the second electrode is coupled to a distal side of the expandable basket structure.
  • the set of spherical electrodes is coupled to a corresponding set of rounded corners of the expandable basket structure.
  • a member is intended to mean a single member or a combination of members
  • a material is intended to mean one or more materials
  • a processor is intended to mean a single processor or multiple processors
  • memory is intended to mean one or more memories, or a combination thereof.
  • the terms “about” and “approximately” generally mean plus or minus 10% of the value stated. For example, about 0.5 would include 0.45 and 0.55, about 10 would include 9 to 11, about 1000 would include 900 to 1100.
  • a Pulmonary Vein isolation (PV isolation) ablation catheter device 15 with a multiplicity of electrodes (indicated by dark bands such as those marked as 17 ) disposed along its mid-section is wrapped in the epicardial space around the pulmonary veins 10 , 11 , 12 and 13 of a heart 7 in a subject or patient anatomy, with the ends 8 and 9 of the mid-section extending out and away to eventually emerge from the patient's chest.
  • the ablation catheter 15 and any of the catheters described herein can be similar to the ablation catheters described in PCT Publication No. WO2014/025394, entitled “Catheters, Catheter Systems, and Methods for Puncturing Through a Tissue Structure,” filed on Mar.
  • the ablation catheter 15 can be disposed about the pulmonary veins 10 , 11 , 12 and 13 using any suitable procedure and apparatus.
  • the ablation catheter 15 can be disposed about the pulmonary veins 10 , 11 , 12 and 13 and/or the heart 7 using a puncturing apparatus disposed via a subxiphoid pericardial access location and a guidewire-based delivery method as described in the '394 PCT Application. After the ends 8 and 9 of the mid-section extend and emerge out of the patient chest they can be cinched together to effectively hold the catheter in place or position.
  • a DC voltage for electroporation can be applied to subsets of electrodes identified as anode and cathode, respectively, on approximately opposite sides of the closed contour defined by the shape of the catheter 15 around the pulmonary veins.
  • the DC voltage is applied in brief pulses sufficient to cause irreversible electroporation.
  • the pulse or waveform can be in the range of 0.5 kV to 10 kV and more preferably in the range 1 kV to 2.5 kV, so that a threshold electric field value of around 200 Volts/cm is effectively achieved in the cardiac tissue to be ablated.
  • the marked electrodes can be automatically identified, or manually identified by suitable marking, on an X-ray or fluoroscopic image obtained at an appropriate angulation that permits identification of the geometric distance between anode and cathode electrodes, or their respective centroids.
  • the DC voltage generator setting for irreversible electroporation is then automatically identified by the electroporation system based on this distance measure.
  • the DC voltage value is selected directly by a user from a suitable dial, slider, touch screen, or any other user interface.
  • the DC voltage pulse results in a current flowing between the anode and cathode electrodes on opposite sides of the contour defined by the catheter shape, with said current flowing through the cardiac wall tissue and through the intervening blood in the cardiac chamber, with the current entering the cardiac tissue from the anode and returning back through the cathode electrodes.
  • the forward and return current paths are both inside the catheter. Areas of cardiac wall tissue where the electric field is sufficiently large for irreversible electroporation are ablated during the DC voltage pulse application.
  • the number of electrodes on the PV isolation ablation catheter can be in the range between 8 and 50, and more preferably in the range between 15 and 40.
  • FIG. 2A A schematic diagram of the electroporation system according to an embodiment is shown in FIG. 2A .
  • the system includes a DC voltage/signal generator 23 that is driven by a controller unit 21 that interfaces with a computer device 24 by means of a two-way communication link 29 .
  • the controller can perform channel selection and routing functions for applying DC voltages to appropriate electrodes that have been selected by a user or by the computer 24 , and apply the voltages via a multiplicity of leads (shown collectively as 26 ) to a catheter device 22 .
  • the catheter device can be any of the catheters shown and described herein or in the '394 PCT Application. Some leads from the controller 21 could also carry pacing signals to drive pacing of the heart through a separate pacing device (not shown).
  • the catheter device can also send back information such as ECG (electrocardiograph) recordings or data from other sensors back to the controller 21 as indicated by the data stream 25 , possibly on separate leads. While the DC voltage generator 23 sends a DC voltage to the controller 21 through leads 27 , the voltage generator is driven by control and timing inputs 28 from the controller unit 21 .
  • ECG electrocardiograph
  • the electrode controller can include one or more modules and can automatically perform channel selection (e.g., identification of a subset of electrodes to which the voltage pulses will be applied), identification of the desired anode/cathode pairs, or the like.
  • FIG. 2B shows an electroporation system according to an embodiment that includes an electrode controller 900 and a signal generator 925 .
  • the electrode controller 900 is coupled to a computer 920 or other input/output device, and is configured to be operable coupled to a medical device 930 .
  • the medical device 930 can be one or more multi-electrode catheters, of the types shown and described herein.
  • the medical device 930 can be coupled to, disposed about and/or in contact with a target tissue, such as the heart H.
  • a target tissue such as the heart H.
  • the electroporation system including the electrode controller 900 and the signal generator 925 , can deliver voltage pulses to the target tissue for therapeutic purposes.
  • the controller 900 can include a memory 911 , a processor 910 , and an input/output module (or interface) 901 .
  • the controller 900 can also include a pacing module 902 , a feedback module 905 , a pulse delivery module 908 , and a selection module 912 .
  • the electrode controller 900 is coupled to a computer 920 or other input/output device via the input/output module (or interface) 901 .
  • the processor 910 can be any processor configured to, for example, write data into and read data from the memory 911 , and execute the instructions and/or methods stored within the memory 911 . Furthermore, the processor 910 can be configured to control operation of the other modules within the controller (e.g., the pacing module 902 , the feedback module 905 , the pulse delivery module 908 , and the selection module 912 ). Specifically, the processor can receive a signal including user input, impedance, heart function or the like information and determine a set of electrodes to which voltage pulses should be applied, the desired timing and sequence of the voltage pulses and the like.
  • the processor can receive a signal including user input, impedance, heart function or the like information and determine a set of electrodes to which voltage pulses should be applied, the desired timing and sequence of the voltage pulses and the like.
  • the processor 910 can be, for example, an application-specific integrated circuit (ASIC) or a combination of ASICs, which are designed to perform one or more specific functions.
  • the microprocessor can be an analog or digital circuit, or a combination of multiple circuits.
  • the memory device 910 can be any suitable device such as, for example, a read only memory (ROM) component, a random access memory (RAM) component, electronically programmable read only memory (EPROM), erasable electronically programmable read only memory (EEPROM), registers, cache memory, and/or flash memory.
  • ROM read only memory
  • RAM random access memory
  • EPROM electronically programmable read only memory
  • EEPROM erasable electronically programmable read only memory
  • registers cache memory
  • flash memory any of the modules (the pacing module 902 , the feedback module 905 , the pulse delivery module 908 , and the selection module 912 ) can be implemented by the processor 910 and/or stored within the memory 910 .
  • the electrode controller 900 operably coupled to the signal generator 925 .
  • the signal generator includes circuitry, components and/or code to produce a series of DC voltage pulses for delivery to electrodes included within the medical device 930 .
  • the signal generator 925 can be configured to produce a biphasic waveform having a pre-polarizing pulse followed by a polarizing pulse.
  • the signal generator 925 can be any suitable signal generator of the types shown and described herein.
  • the pulse delivery module 908 of the electrode controller 900 includes circuitry, components and/or code to deliver an output signal associated with the pulsed voltage waveform produced by the signal generator 925 .
  • This signal (shown as signal 909 ) can be any signal of the types shown and described herein, and can be of a type and/or have characteristics to be therapeutically effective.
  • the pulse delivery module 908 receives input from the selection module 912 , and can therefore send the signal 909 to the appropriate subset of electrodes, as described herein.
  • the selection module 912 includes circuitry, components and/or code to select a subset of electrodes from the electrodes included within the medical device 930 , as described herein. In some embodiments, the selection module 912 is configured identify at least one electrode from the subset of electrodes as an anode and at least one electrode from the subset of electrodes as a cathode. In some embodiments, the selection module 912 is configured to select a subset of electrodes from more than one medical device 930 , as described herein.
  • the selection module 912 can select the subset of electrodes based on input received from the user via the input/output module 901 .
  • the user can use visualization techniques or other methods to identify the desired electrodes, and can manually enter those electrodes, as described herein.
  • the selection module 912 is configured to select the subset of electrodes based on a predetermined schedule of the set of electrodes.
  • the electrode controller 900 can be configured accommodate different medical devices 930 having different numbers and/or types of electrodes.
  • the selection module 912 can retrieve a predetermined schedule of electrodes to which a series of voltage pulses can be applied, based on the specific type of medical device 930 .
  • the selection module 912 is configured to select the subset of electrodes automatically based on at least one of an impedance associated with the subset of electrodes, a distance between the first electrode and the second electrode, and a characteristic associated with a target tissue.
  • the electrode controller 900 includes the feedback module 905 that can receive feedback from the medical device 930 (as identified by the signal 906 ).
  • the feedback module 905 includes circuitry, components and/or code to determine an impedance between various electrodes (as described herein).
  • the selection module 912 can select the subset of electrodes automatically based the impedance.
  • the electrode controller 900 optionally includes the pacing module 902 .
  • the pacing module 902 includes circuitry, components and/or code to produce a pacing signal (identified as signal 903 ) that can be delivered to the target tissue (or heart) via a pacing lead.
  • the pacing module 902 can facilitate any suitable “mode” of operation desired, such as a standard pacing, an overdrive pacing option (for pacing at a faster-than-normal heart rate), an external trigger option (for pacing from an externally generated trigger), and a diagnostic pacing option.
  • the resulting ECG waveform 32 has appropriate respective refractory time intervals 33 and 34 respectively, during which there are suitable time windows for application of irreversible electroporation as indicated by 35 and 36 .
  • the application of cardiac pacing results in a periodic, well-controlled sequence of electroporation time windows. Typically, this time window is of the order of hundreds of microseconds to about a millisecond or more. During this window, multiple DC voltage pulses can be applied to ensure that sufficient tissue ablation has occurred. The user can repeat the delivery of irreversible electroporation over several successive cardiac cycles for further confidence.
  • a feedback module e.g., feedback module 905
  • a pulse delivery module e.g., pulse delivery module 908
  • a feedback module can receive the electrocardiograph signal
  • a pulse delivery module e.g., pulse delivery module 908
  • a pulse delivery module can deliver the output signal to the subset of electrodes during a time window associated with at least one a pacing signal or the electrocardiograph signal.
  • the ablation controller and signal generator can be mounted on a rolling trolley, and the user can control the device using a touchscreen interface that is in the sterile field.
  • the computer 920 can be a touchscreen device.
  • the touchscreen can be for example an LCD touchscreen in a plastic housing mountable to a standard medical rail or post and can be used to select the electrodes for ablation and to ready the device to fire.
  • the interface can for example be covered with a clear sterile plastic drape.
  • the operator can select the number of electrodes involved in an automated sequence.
  • the touch screen graphically shows the catheters that are attached to the controller. In one embodiment the operator can select electrodes from the touchscreen with appropriate graphical buttons.
  • the operator can also select the pacing stimulus protocol (either internally generated or externally triggered) from the interface. Once pacing is enabled, and the ablation sequence is selected, the operator can initiate or verify pacing. Once the operator verifies that the heart is being paced, the ablation sequence can be initiated by holding down a hand-held trigger button that is in the sterile field.
  • the hand-held trigger button can be illuminated red to indicate that the device is “armed” and ready to ablate.
  • the trigger button can be compatible for use in a sterile field and when attached to the controller can be illuminated a different color, for example white.
  • the trigger button flashes in sequence with the pulse delivery in a specific color such as red.
  • the waveform of each delivered pulse is displayed on the touchscreen interface.
  • a graphic representation of the pre and post impedance between electrodes involved in the sequence can also be shown on the interface, and this data can be exported for file storage.
  • an impedance map can be generated based on voltage and current recordings across anode-cathode pairs or sets of electrodes, and an appropriate set of electrodes that are best suited for ablation delivery in a given region can be selected based on the impedance map or measurements, either manually by a user or automatically by the system.
  • Such an impedance map can be produced, for example, by the feedback module 905 , or any other suitable portion of the electrode controller 900 . For example, if the impedance across an anode/cathode combination of electrodes is a relatively low value (for example, less than 25 Ohms), at a given voltage the said combination would result in relatively large currents in the tissue and power dissipation in tissue.
  • this electrode combination would then be ruled out (e.g., via the selection module 912 ) for ablation due to safety considerations, and alternate electrode combinations would be sought by the user.
  • a pre-determined range of impedance values for example 30 Ohms to 300 Ohms, could be used as an allowed impedance range within which it is deemed safe to ablate.
  • an electrode controller can automatically determine a subset of electrodes to which voltage pulses should be applied.
  • the waveforms for the various electrodes can be displayed and recorded on the case monitor and simultaneously outputted to a standard connection for any electrophysiology (EP) data acquisition system.
  • EP electrophysiology
  • the waveforms acquired internally can be used to autonomously calculate impedances between each electrode pair.
  • the waveform amplitude, period, duty cycle, and delay can all be modified, for example via a suitable Ethernet connection.
  • Pacing for the heart is controlled by the device and outputted to the pacing leads and a protected pacing circuit output for monitoring by a lab.
  • FIG. 4 shows a schematic rendering of a portion of the user interface of the electroporation system.
  • the four windows A, B, C and D shown in the FIG. represent four different choices of electrode subsets for anode and cathode selection.
  • the PV isolation ablation catheter is represented by a string of numbered electrodes as indicated by 41 , wrapped around the area 42 of the pulmonary veins represented by the enclosed region in this schematic diagram.
  • the dashed-line vectors 46 represent approximate current vectors, with their tips at the cathodes and tails or bases at the anodes; in this FIG., the three electrodes marked 43 are cathodes, and the single electrode marked 44 is the anode.
  • the windows A, C and D in this FIG. show other choices of cathode and anode electrode subsets, in each case with accompanying approximate current density vectors shown by dashed arrows. It is clear from the FIG. that the user can select various subsets of electrodes as cathode or anode, depending on the region to be ablated along the length of the PV isolation catheter.
  • the user can make one selection of cathode and anode subsets, and the system can take this selection as input to generate an ablation sequence that moves around the ring or contour defined by the shape of the PV isolation catheter, for example moving clockwise at each step with a one-electrode displacement.
  • the pair of cathode and anode electrode subsets can be sequentially updated for ablation purposes, so that if there are N electrodes, after N updates the entire contour has been updated such that the tips of the current arrows shown as 46 have swept once around the contour completely.
  • the portion of the PV isolation catheter with electrodes may be longer than needed to wrap around a given patient's pulmonary veins; in this event, a smaller number of electrodes suffices to wrap around the contour of the pulmonary veins.
  • the set of electrodes wrapped around the pulmonary veins, represented by 51 are the electrodes that would be used in the ablation process, and are called out by the label 50 as the set of active electrodes, while the remaining five electrodes represented by 52 are not used in the ablation process as they are not located in suitable positions.
  • multiple catheters could be used for ablation, with anode and cathode subsets respectively chosen to lie on different catheters.
  • two catheters are connected to the controller unit of the electroporation system.
  • ablation procedures for the treatment of Atrial Fibrillation (AF) in addition to isolating the pulmonary veins, it is also useful to generate an ablation line that separates or isolates regions around the mitral valve.
  • AF Atrial Fibrillation
  • Such a line is often termed a “Mitral Isthmus Line,” and is a line running from an Inferior aspect of the PV isolation contour to the outer edge of the mitral valve in the left atrium.
  • a method of use of the systems described herein includes inserting a coronary sinus catheter with multiple electrodes into the coronary sinus. As shown in FIG. 6 , electrodes marked as 66 on the coronary sinus catheter 63 , and electrodes marked as 65 on the PV isolation catheter 62 , are further selected as active subsets of electrodes for ablation, as indicated in the indication window 61 for the anode and cathode subsets.
  • the electrodes of the coronary sinus catheter 63 are utilized to define the mitral isthmus line, and irreversible electroporation ablation can be effectively performed on the left atrial wall to generate a mitral isthmus ablation line.
  • the system (any of the generators and controllers described herein) can deliver rectangular-wave pulses with a peak maximum voltage of about 5 kV into a load with an impedance in the range of 30 Ohm to 3000 Ohm for a maximum duration of 200 ⁇ s, with a 100 ⁇ s maximum duration being still more preferred.
  • Pulses can be delivered in a multiplexed and synchronized manner to a multi-electrode catheter inside the body with a duty cycle of up to 50% (for short bursts).
  • the pulses can generally be delivered in bursts, such as for example a sequence of between 2 and 10 pulses interrupted by pauses of between 1 ms and 1000 ms.
  • the multiplexer controller is capable of running an automated sequence to deliver the impulses/impulse trains (from the DC voltage signal/impulse generator) to the tissue target within the body.
  • the controller system is capable of switching between subsets/nodes of electrodes located on the single use catheter or catheters (around or within the heart). Further, the controller can measure voltage and current and tabulate impedances in each electrode configuration (for display, planning, and internal diagnostic analysis). It can also generate two channels of cardiac pacing stimulus output, and is capable of synchronizing impulse delivery with the internally generated cardiac pacing and/or an external trigger signal. In one embodiment, it can provide sensing output/connection for access to bio potentials emanating from each electrode connected to the system (with connectivity characteristics being compatible with standard electrophysiological laboratory data acquisition equipment).
  • the controller e.g., the controller 900
  • the controller can automatically “recognize” the single-use disposable catheter when it is connected to the controller output (prompting internal diagnostics and user interface configuration options).
  • the controller can have at least two unique output connector ports to accommodate up to at least two catheters at once (for example, one 30-electrode socket and one 10-electrode socket; a 2-pole catheter would connect to the 10-pole socket).
  • the controller device can function as long as at least one recognized catheter is attached to it.
  • the controller can have several sequence configurations that provide the operator with at least some variety of programming options.
  • the controller can switch electrode configurations of a bipolar set of electrodes (cathode and anode) sequentially in a clockwise manner (for example, starting at step n, in the next step of the algorithm, cathode n+1 and anode n+1 are automatically selected, timed to the synchronizing trigger).
  • the 30-pole catheter the electrodes are arranged in a quasi-circumference around the target.
  • pulse delivery occurs so that the vector of current density changes as the automated sequencing of the controller switches “on” and “off” between different electrodes surrounding the tissue target sequence.
  • the current density vectors generally cross the target tissue but in some configurations the current density could be approximately tangential to the target.
  • the impulses are delivered to user-selected electrode subsets of catheters that are connected to the device (the vector of current density does not change with each synchronized delivery).
  • a third sequence configuration example is a default bipolar pulse sequence for the simplest 2-pole catheter.
  • the user can also configure the controller to deliver up to 2 channels of pacing stimulus to electrodes connected to the device output.
  • the user can control the application of DC voltage with a single handheld switch.
  • a sterile catheter or catheters can be connected to the voltage output of the generator via a connector cable that can be delivered to the sterile field.
  • the user activates the device with a touch screen interface (that can be protected with a single-use sterile transparent disposable cover commonly available in the catheter lab setting).
  • the generator can remain in a standby mode until the user is ready to apply pulses at which point the user/assistant can put the generator into a ready mode via the touchscreen interface. Subsequently the user can select the sequence, the active electrodes, and the cardiac pacing parameters.
  • the user can initiate electrically pacing the heart (using a pacing stimulus generated by the ablation controller or an external source synchronized to the ablation system).
  • the operator verifies that the heart is being paced and uses the hand-held trigger button to apply the synchronized bursts of high voltage pulses.
  • the system can continue delivering the burst pulse train with each cardiac cycle as long as the operator is holding down a suitable “fire” button or switch.
  • the generator output is synchronized with the heart rhythm so that short bursts are delivered at a pre-specified interval from the paced stimulus.
  • the train of pulses is complete, the pacing continues until the operator discontinues pacing.
  • FIG. 7 shows a portion of a graphical user interface according to an embodiment for focal ablation with a bipolar or 2-electrode catheter.
  • the graphical user interface can be a touchscreen interface.
  • a graphical icon 71 for a bipolar catheter is shown along with a depth selection button 72 for selecting a desired ablation depth.
  • the system can select an appropriate voltage value to apply in order to ensure that an electric field sufficient to cause irreversible electroporation is applied up to the desired depth.
  • a pacing selection interface on a portion of the user interface of the electroporation system is shown in FIG. 8 .
  • the pacing selection interface has various options such as an overdrive pacing option 81 for pacing at a faster-than-normal heart rate, an external trigger option 82 for pacing from an externally generated trigger, and a diagnostic pacing option 83 . By clicking the “Select” button for a given option, that option is selected.
  • FIG. 9 shows a portion the user interface of the electroporation system with pacing from an external trigger selected for the pacing option.
  • the selected option 86 is displayed along with the pacing characteristics and waveform 87 for the user to visualize.
  • FIG. 10 shows a portion the user interface of the electroporation system for selection of anode and cathode electrodes, with two catheters connected to the system.
  • One of the catheters is a PV isolation catheter 91 while the other is a multi-electrode catheter 92 .
  • the buttons 93 and 94 can implement the selection of marked electrode subsets on the catheters as respectively anode or cathode. Once the selection is made, the appropriate electrodes are colored differently to indicate anode or cathode electrode as shown marked respectively as 96 and 97 in FIG. 11 .
  • the controller and generator can output waveforms that can be selected to generate a sequence of voltage pulses in either monophasic or biphasic forms and with either constant or progressively changing amplitudes.
  • FIG. 12 shows a rectangular wave pulse train where the pulses 101 have a uniform height or maximum voltage.
  • FIG. 13 shows an example of a balanced biphasic rectangular pulse train, where each positive voltage pulse such as 103 is immediately followed by a negative voltage pulse such as 104 of equal amplitude and opposite sign. While in this example the biphasic pulses are balanced with equal amplitudes of the positive and negative voltages, in other embodiments an unbalanced biphasic waveform could also be used as may be convenient for a given application.
  • FIG. 14 shows a progressive balanced rectangular pulse train, where each distinct biphasic pulse has equal-amplitude positive and negative voltages, but each pulse such as 107 is larger in amplitude than its immediate predecessor 106 .
  • FIG. 14 shows a progressive balanced rectangular pulse train, where each distinct biphasic pulse has equal-amplitude positive and negative voltages, but each pulse such as 107 is larger in amplitude than its immediate predecessor 106 .
  • Other variations such as a progressive unbalanced rectangular pulse train, or indeed a wide variety of other variations of pulse amplitude with respect to time can be conceived and implemented by those skilled in the art based on the teachings herein.
  • the time duration of each irreversible electroporation rectangular voltage pulse could lie in the range from 1 nanosecond to 10 milliseconds, with the range 10 microseconds to 1 millisecond being more preferable and the range 50 microseconds to 300 microseconds being still more preferable.
  • the time interval between successive pulses of a pulse train could be in the range of 10 microseconds to 1 millisecond, with the range 50 microseconds to 300 microseconds being more preferable.
  • the number of pulses applied in a single pulse train (with delays between individual pulses lying in the ranges just mentioned) can range from 1 to 100, with the range 1 to 10 being more preferable.
  • a pulse train can be driven by a user-controlled switch or button, in one embodiment preferably mounted on a hand-held joystick-like device.
  • a pulse train can be generated for every push of such a control button, while in an alternate mode of operation pulse trains can be generated repeatedly during the refractory periods of a set of successive cardiac cycles, for as long as the user-controlled switch or button is engaged by the user.
  • a brief pre-polarization pulse can be applied just prior to the application of a polarizing rectangular pulse.
  • the rapid change in electric field in tissue, in addition to the electric field magnitude, driven by this type of pulse application incorporating a pre-polarizing pulse can promote a more rapid and effective tissue ablation in some applications.
  • a schematic diagram of a voltage/signal generator for the purpose of generating such a waveform employing intrinsic amplification of voltage spikes arising from switching is given in FIG. 15 .
  • a DC voltage is generated from the discharge of a suitable capacitor bank 111 (powered by a suitable charging circuit that is not shown and that would be familiar to those skilled in the art) with a suitable high-voltage diode or rectifier 112 serving to ensure voltage polarity. While in one embodiment of the signal generator the voltage discharge passes initially through a snubber or transient-suppression circuit 113 that strongly suppresses transients, in an alternate embodiment an alternate signal path is available via a switch unit 116 that detects and lets through a brief initial voltage spike after a possible voltage inversion. The signal then passes through an Insulated Gate Bipolar Transistor (IGBT) high-power switch 115 and is accessible at terminals 117 for connection to catheter electrodes.
  • IGBT Insulated Gate Bipolar Transistor
  • the switch unit 116 When no pre-polarizing pulse is required, the switch unit 116 would not be present, and the signal passes (after transient-suppression in the snubber circuit 113 ) initially through a Metal Oxide Semiconductor Field Effect Transistor (MOSFET) switch 114 before passing through the IGBT switch 115 .
  • MOSFET Metal Oxide Semiconductor Field Effect Transistor
  • the IGBT interfaces better with a wider range of load impedances (from tissue), while the faster switching speed of the MOSFET can drive a suitably fast turn-on/turn-off of the IGBT switch, so that using them in the sequence shown in FIG. 15 can be advantageous.
  • the time constant associated with the capacitor bank discharge is chosen to be significantly longer than an individual pulse duration. If the charging circuit of the capacitor bank is much more rapid, a sequence of very highly rectangular pulses can be generated from repeated capacitor bank discharges. As shown in FIG. 16 , when a capacitor bank is suddenly discharged by closing a switch, the voltage can briefly be amplified and spike as indicated by 122 before settling to a normal discharge pattern 121 . The inductance of leads connected to the capacitor forms a tank circuit with the capacitor, and in many cases this tank circuit is rapidly driven to resonance by the discharge, leading to the voltage amplification seen in the spiking behavior 122 .
  • the switch 116 plays a gatekeeping role akin to the notion of “Maxwell's demon” in statistical physics, allowing the passage of some types of intrinsically amplified voltage spikes, and accordingly the signal generator of FIG. 15 can also be termed a Maxwell amplifier.
  • FIG. 17 A schematic representation of a biphasic pulse with pre-polarization is shown in FIG. 17 , where each rectangular polarizing pulse such as 125 is preceded by a pre-polarizing negative voltage spike 126 derived from transient spiking from a generator of the type shown in FIG. 15 .
  • the value of the negative spike voltage peak V L could be determined by the spike control circuitry of the switch unit 116 as discussed above.
  • the biphasic pulses involve a time duration T 1 for the pre-polarizing spike, a duration T 2 for the rectangular polarizing pulse, with a time delay T d indicated by 127 in FIG. 17 between successive biphasic pulses.
  • T 2 could be of the order of 100 microseconds, while T 1 could lie in the range 5 microseconds to 50 microseconds and the delay time T d could be in the range 100 microseconds to 300 microseconds. All of these parameters can be determined by the design of the signal generator, and in various embodiments could also be determined by user control as may be convenient for a given clinical application. The specific examples and descriptions herein are exemplary in nature and variations can be developed by those skilled in the art based on the material taught herein without departing from the scope of the embodiments described herein.
  • FIG. 18A A catheter device for focal ablation with the electroporation system according to an embodiment is shown schematically in FIG. 18A .
  • the focal ablation catheter 131 has two electrodes disposed in the distal section of the catheter, with a relatively proximally placed cathode electrode 133 of length L 1 exposed on the catheter shaft and a relatively distally placed anode electrode 134 of length L 2 mounted on the inner section of the shaft.
  • the catheter shaft is made of a material with high dielectric strength such as for example a polymer comprising Teflon.
  • the distal electrode 134 is covered by the polymeric shaft and is not exposed to the blood pool on the shaft exterior.
  • Both electrodes are metallic, and in one embodiment the anode could be poly-metallic in construction, for example comprising regions of Titanium and regions of Platinum.
  • the anode 141 is recessed from the distal tip, and could be placed with its distal portion between 0.5 mm and 10 mm away from the distal end of the catheter. While the recessed and interior placement of the anode electrode is counterintuitive, it can be an effective means of enhancing electroporation efficacy and safety selectively for focal ablation. As indicated in the FIG., the schematically depicted (negative) current density flowing from the cathode to the anode indicated by the stream of arrows 142 bends around the distal edge 143 of the catheter shaft resulting in a region of high curvature of the current density, and correspondingly curved electric field lines as well.
  • FIG. 18C schematically shows electric field lines 152 as they curve to enter the distal catheter end 151 , resulting in a zone or region 153 distal to the catheter with a relatively uniform electric field.
  • the electric field in this region would not be as uniform with a standard, externally placed electrode on the catheter, and further would generally have regions of very high intensity.
  • anode electrode can be a hollow ring, in other embodiments it could have a different form such as a cylinder with multiple longitudinal holes or channels.
  • the interior lumen of the catheter can carry a fluid delivered out through the distal end of the catheter.
  • the fluid can be an ionic fluid such as isotonic or hypertonic saline and can enhance electrical conductivity in the distal region of the catheter and beyond the distal end ensuring a proper and more uniform distribution of local electric field in a distal region around the catheter.
  • the inner lumen 163 of the catheter carries a flowing fluid indicated by the arrows, while the anode 161 is in the shape of a cylinder that has longitudinal channels through which fluid can flow.
  • the anode electrode is shown in cross section 162 where the multiple through-channels are visible.
  • the saline or ionic fluid delivered through the channels can act as an ion bridge through which good electrical current conduction is possible in the vicinity of the catheter's distal end, resulting in a more uniform distribution of local electric field and electroporation energy delivery.
  • the flow of saline fluid itself can dislodge tissue debris or any bubbles generated by the electroporation-driven breakdown of tissue in the region around the distal catheter tip.
  • ultrasonic waves schematically shown as 164 in FIG. 18D can be applied to the fluid to further ensure that any bubbles that may be lodged on the catheter surface in its distal region are dislodged, again for purposes of maintaining relative uniformity of the local electric field.
  • the ultrasonic waves or ultrasound through the fluid can be generated by suitable piezoelectric transducers mounted more proximally along the shaft of the catheter, or even within the catheter handle.
  • ultrasound generation is coordinated with electroporation DC voltage application so that the kinetic energy of focused ultrasound is available “on demand.”
  • FIG. 19A shows a simulation geometry of a catheter 601 in a blood pool region 602 and abutting a myocardium region 603 adjacent to a pericardial region 605 , all regions being assumed cylindrical for the simulation; the section or plane 611 was chosen to plot electric field intensity contours. Further the myocardium region has a region of scar tissue 604 distal to the catheter.
  • FIG. 19B shows the catheter's distal region with distal tip 612 , distal (anode) recessed electrode 615 mounted internal to the shaft, and a proximal (cathode) electrode 616 .
  • FIG. 19C shows the geometry and the contours in the section 611 of FIG. 19A .
  • the cathode 616 and recessed anode 615 are indicated in FIG. 19C , as are the blood pool region 602 , the myocardium region 603 and the pericardial region 605 .
  • the electric field intensity contours corresponding to 1000 Volts/cm, 500 Volts/cm and 200 Volts/cm respectively are shown as contours 617 , 618 and 619 respectively.
  • FIG. 19D repeats the electric field simulation for a catheter with both electrodes mounted externally, showing the distal anode 622 and proximal cathode 623 in the same tissue geometry.
  • the resulting electric field intensity contours corresponding to 1000 Volts/cm, 500 Volts/cm and 200 Volts/cm respectively are shown as contours 626 , 627 and 628 respectively.
  • FIG. 19C Comparing the intensity contours of FIG. 19C and FIG. 19D , it is clear that the former FIG. shows a relatively more uniform intensity distribution in the myocardium region where excessively large electric field values (500 Volts/cm or more) are present to a much lesser extent, mitigating the possibility of locally large electric current densities and corresponding temperature increases.
  • the focal ablation catheter described above in various embodiments could be used in cardiac applications such as ablation delivery to treat Ventricular Tachycardia (VT), where targeted ablation delivery could be of great benefit.
  • the length L 2 of the distal anode electrode could be significantly longer than the length L 1 of the proximal cathode electrode.
  • the ratio L 2 /L 1 could have a value of at least 1.3, more preferably lie in the range 1.3 to 10, and still more preferably in the range 2 to 5.
  • the increased surface area of the exposed inner surface of the anode electrode can serve to reduce the current density near it, thereby enhancing safety and enhancing the efficacy of ion bridging current transfer with the saline fluid infusion.
  • the edges of the electrode can be beveled or rounded to ensure that there are no sharp corners or regions with high curvature.
  • electroporation ablation of cardiac tissue could be performed across a pair of nearby electrodes respectively on one or more epicardially placed catheters in one embodiment.
  • a single focal ablation endocardial catheter such as described above can be used to ablate on the endocardial side of a cardiac chamber.
  • a bipolar pair of electrodes on different catheters, one placed endocardially and the other epicardially could be used to drive irreversible electroporation.
  • a balloon ablation device for use with the electroporation system is schematically illustrated in FIG. 20 . While the device is shown to be situated in a blood vessel 301 , it can also be used in other anatomical areas such as a cardiac ventricle.
  • the device shaft 302 has an inflatable balloon 306 disposed in its distal portion. On either side of the balloon and mounted on the shaft are a proximal cathode electrode 303 and a distal anode electrode 304 .
  • the balloon surface 305 is coated with a thin layer of a good insulator such as a biocompatible metal oxide (for example, aluminum oxide).
  • the balloon When air is pumped in through the catheter shaft lumen and through appropriate openings (not shown) from the shaft into the balloon, the balloon can inflate, as the inflated shape in FIG. 20 depicts.
  • the balloon In ventricular applications such as cardiac ablation for VT, the balloon can serve to displace collateral structures away from the distal end of the catheter. Since the balloon surface is an insulator, when a DC voltage is applied between the electrodes, the current flow between electrodes and through the tissue is deflected around the balloon. The electric field is also correspondingly deflected around the surface of the balloon, and curves outward and can extend into the wall of the blood vessel, as shown by the schematic electric field lines 308 in the FIG.
  • the distal electrode 304 can be mounted on the outside of the shaft with external surface exposed, for intravascular ablation applications such as for example peripheral vascular applications for treatment of atherosclerosis where it is desired to ablate the vessel wall region or clear deposits.
  • the distal electrode 304 can be mounted on the inner side of the catheter shaft, so that the metal electrode is internally exposed.
  • the distal electrode could be recessed from the distal tip, as schematically shown in FIG. 20 . Such a device could be used in focal ablation applications.
  • FIG. 21A An alternate preferred embodiment of a balloon ablation device for use with the electroporation system according to an embodiment is shown schematically in FIG. 21A .
  • the device shaft 171 has an inflatable balloon 177 disposed in its distal portion.
  • a proximal cathode electrode 173 and a distal anode electrode 174 are coated with a thin layer of a good insulator such as a biocompatible metal oxide (for example, aluminum oxide).
  • the balloon When fluid is pumped in through the catheter shaft lumen, the balloon can inflate, as the inflated shape in FIG. 21A depicts.
  • the region of the shaft within the balloon can have at least one ultrasonic transducer 175 mounted thereon.
  • the wall 178 of the balloon has a varying cross section and is filled with a gas such as air.
  • a liquid-gas interface at the wall of the balloon. This interface can act as a mirror or reflecting surface for ultrasound.
  • ultrasound rays 179 emitted by the transducer 175 are reflected at the wall of the balloon and are subsequently focused on a ring-like region, shown with its annular regions 181 in a plane 180 and viewed edge-on in the illustration.
  • the annular region external to the balloon where the ultrasound is focused is shown in FIG. 21B as the dark annulus 203 surrounding the vessel wall 201 , shown in cross section.
  • the irreversible electroporation threshold of tissue is temperature dependent and is lowered with increasing temperature.
  • the electroporation threshold is decreased, and a relatively weaker electric field in this region can still generate irreversible electroporation, permitting selective tissue ablation.
  • the balloon can serve to displace collateral structures away from the distal end of the catheter. Since the balloon surface is an insulator, when a DC voltage is applied between the electrodes, the current flow between electrodes and through the tissue is deflected around the balloon. The electric field is also correspondingly deflected around the surface of the balloon, and curves outward and can extend into the wall of the blood vessel, as shown by the schematic electric field lines 191 in the FIG. With the lowered irreversible electroporation threshold in the annular region of focused ultrasound in the vessel wall, the electric field in the annular region is sufficient to selectively drive irreversible electroporation.
  • the distal electrode 174 can be mounted on the outside of the shaft with external surface exposed, for intravascular ablation applications such as for example peripheral vascular applications for treatment of atherosclerosis where it is desired to ablate the vessel wall region or clear deposits.
  • the distal electrode 174 can be mounted on the inner side of the catheter shaft, so that the metal electrode is internally exposed.
  • the distal electrode could be recessed from the distal tip, as schematically shown in FIG. 21A . Such a device could be used in focal ablation applications.
  • balloon ablation device While the specific embodiment of the balloon ablation device described above utilizes high-intensity focused ultrasound to selectively generate temperature increases in a given region in order to decrease the electroporation threshold, it must be noted that alternate energy delivery mechanisms such as microwaves could be utilized for the purpose of increasing tissue temperature by energy deposition in order to decrease the irreversible electroporation threshold electric field.
  • the balloon ablation devices described in the foregoing could also be used in pulmonary outflow tract applications to treat pulmonary hypertension, or in eosophageal or gastrointestinal applications where tissue ablation is an appropriate therapy.
  • FIG. 22 An ablation device for irreversible electroporation in the form of an expanding basket catheter is schematically illustrated in FIG. 22 .
  • Mounted on the shaft 501 of the device is a sliding member 505 which is attached to a system of struts 507 . While the system of struts is initially substantially aligned with the length of the shaft in a folded configuration (not shown), it can unfold or open out like an umbrella by movement of the sliding member 505 along the shaft, resulting in the basket-like unfolded structure shown in FIG. 23 .
  • the system of struts is only partially shown in the FIG.
  • the basket construction or set of expanding struts can comprise a superelastic alloy such as for instance an alloy of Nickel and Titanium often called Nitinol®; such a construction can be of use in a large vessel where a significant amount of expansion could be called for.
  • a superelastic alloy such as for instance an alloy of Nickel and Titanium often called Nitinol®; such a construction can be of use in a large vessel where a significant amount of expansion could be called for.
  • On either side of the basket-like structure and disposed along the shaft are two electrodes 502 and 503 . Bead-like electrodes 508 are present at corners of the strut assembly.
  • the device be guided to a desired location inside a large vascular or other anatomical vessel (for example, the pulmonary outflow tract), positioned suitably and then unfolded. Subsequently, irreversible electroporation ablation can be applied with the electrodes on the basket device.
  • the voltage applied can be suitably selected so that an appropriate electric field is generated in the ablative region near the bead electrodes.
  • the basket catheter can further incorporate energy sources such as focused ultrasound or microwaves in order to selectively raise temperatures in localized regions and thereby lower the irreversible electroporation threshold.
  • a method includes identifying, via a selection module of an electrode controller, a set of anode/cathode pairs from a set of electrodes of a multi-electrode catheter.
  • the method can be performed using any suitable controller, such as for example, the controller 900 described above.
  • the multi-electrode catheter is configured to be disposed about a portion of a heart. At least one of the anode/cathode pair including at least one anode electrode and at least one cathode electrode. In other embodiments, however, the anode/cathode pair can include multiple anode electrodes or cathode electrodes.
  • the identifying can be based on input received from an input/output module of the electrode controller (e.g., manual input). In other embodiments, the identifying can be based on a predetermined schedule of electrodes. In yet other embodiments, the identifying can be performed automatically based on an impedance map as described herein.
  • the method further includes conveying a pacing signal to a pacing lead configured to be operatively coupled to the heart, and receiving, at a feedback module of the electrode controller, an electrocardiograph signal associated with a function of the heart.
  • the method further includes delivering, via a pulse delivery module of the electrode controller, a pulsed voltage waveform to the plurality of anode/cathode pairs according to a sequential pattern.
  • Some embodiments described herein relate to a computer storage product with a non-transitory computer-readable medium (also can be referred to as a non-transitory processor-readable medium) having instructions or computer code thereon for performing various computer-implemented operations.
  • the computer-readable medium or processor-readable medium
  • the media and computer code may be those designed and constructed for the specific purpose or purposes.
  • non-transitory computer-readable media include, but are not limited to: magnetic storage media such as hard disks, floppy disks, and magnetic tape; optical storage media such as Compact Disc/Digital Video Discs (CD/DVDs), Compact Disc-Read Only Memories (CD-ROMs), and holographic devices; magneto-optical storage media such as optical disks; carrier wave signal processing modules; and hardware devices that are specially configured to store and execute program code, such as Application-Specific Integrated Circuits (ASICs), Programmable Logic Devices (PLDs), Read-Only Memory (ROM) and Random-Access Memory (RAM) devices.
  • ASICs Application-Specific Integrated Circuits
  • PLDs Programmable Logic Devices
  • ROM Read-Only Memory
  • RAM Random-Access Memory
  • Examples of computer code include, but are not limited to, micro-code or micro-instructions, machine instructions, such as produced by a compiler, code used to produce a web service, and files containing higher-level instructions that are executed by a computer using an interpreter.
  • embodiments may be implemented using imperative programming languages (e.g., C, Fortran, etc.), functional programming languages (Haskell, Erlang, etc.), logical programming languages (e.g., Prolog), object-oriented programming languages (e.g., Java, C++, etc.) or other suitable programming languages and/or development tools.
  • Additional examples of computer code include, but are not limited to, control signals, encrypted code, and compressed code.
  • controller 900 is shown as optionally including the pacing module 902 , in other embodiments, the controller 900 can interface with a separate pacing module.
  • controller 900 can interface with a separate pacing module.
  • methods and/or events described above indicate certain events and/or procedures occurring in certain order, the ordering of certain events and/or procedures may be modified.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Surgery (AREA)
  • Radiology & Medical Imaging (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cardiology (AREA)
  • Plasma & Fusion (AREA)
  • Otolaryngology (AREA)
  • Surgical Instruments (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Electrotherapy Devices (AREA)

Abstract

Catheter systems and methods for the selective and rapid application of DC voltage to drive irreversible electroporation are disclosed herein. In some embodiments, an apparatus includes a voltage pulse generator and an electrode controller. The voltage pulse generator is configured to produce a pulsed voltage waveform. The electrode controller is configured to be operably coupled to the voltage pulse generator and a medical device including a series of electrodes. The electrode controller includes a selection module and a pulse delivery module. The selection module is configured to select a subset of electrodes from the series of electrodes. The selection module is configured identify at least one electrode as an anode and at least one electrode as a cathode. The pulse delivery module is configured to deliver an output signal associated with the pulsed voltage waveform to the subset of electrodes.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • This application is a continuation of PCT Application No. PCT/US2015/029734 titled “METHODS AND APPARATUS FOR SELECTIVE TISSUE ABLATION”, filed May 7, 2015, which claims priority to U.S. Provisional Application Ser. No. 61/996,390, entitled “Method and Apparatus for Rapid and Selective Tissue Ablation,” filed May 7, 2014, the entire disclosures of which are incorporated herein by reference.
  • BACKGROUND
  • The embodiments described herein relate generally to medical devices for therapeutic electrical energy delivery, and more particularly to systems and methods for delivering electrical energy in the context of ablating tissue rapidly and selectively by the application of suitably timed pulsed voltages that generate irreversible electroporation of cell membranes.
  • The past two decades have seen advances in the technique of electroporation as it has progressed from the laboratory to clinical applications. Known methods include applying brief, high voltage DC pulses to tissue, thereby generating locally high electric fields, typically in the range of hundreds of Volts/centimeter. The electric fields disrupt cell membranes by generating pores in the cell membrane, which subsequently destroys the cell membrane and the cell. While the precise mechanism of this electrically-driven pore generation (or electroporation) awaits a detailed understanding, it is thought that the application of relatively large electric fields generates instabilities in the phospholipid bilayers in cell membranes, as well as mitochondria, causing the occurrence of a distribution of local gaps or pores in the membrane. If the applied electric field at the membrane exceeds a threshold value, typically dependent on cell size, the electroporation is irreversible and the pores remain open, permitting exchange of material across the membrane and leading to apoptosis or cell death. Subsequently, the surrounding tissue heals in a natural process.
  • While pulsed DC voltages are known to drive electroporation under the right circumstances, the examples of electroporation applications in medicine and delivery methods described in the prior art do not discuss specificity of how electrodes are selected to accomplish the desired ablation.
  • There is a need for selective energy delivery for electroporation and its modulation in various tissue types, as well as pulses that permit rapid action and completion of therapy delivery. There is also a need for more effective generation of voltage pulses and control methods, as well as appropriate devices or tools addressing a variety of specific clinical applications. Such more selective and effective electroporation delivery methods can broaden the areas of clinical application of electroporation including therapeutic treatment of a variety of cardiac arrhythmias.
  • SUMMARY
  • Catheter systems and methods are disclosed for the selective and rapid application of DC voltage to drive electroporation. In some embodiments, an apparatus includes a voltage pulse generator and an electrode controller. The voltage pulse generator is configured to produce a pulsed voltage waveform. The electrode controller is configured to be operably coupled to the voltage pulse generator and a medical device including a series of electrodes. The electrode controller includes a selection module and a pulse delivery module. The selection module is configured to select a subset of electrodes from the series of electrodes. The selection module is configured identify at least one electrode as an anode and at least one electrode as a cathode. The pulse delivery module is configured to deliver an output signal associated with the pulsed voltage waveform to the subset of electrodes.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a perspective view of a portion of a catheter with multiple electrodes disposed along its shaft and wrapped around the pulmonary veins of the heart such that the portion of the catheter is placed in the epicardial space of the heart.
  • FIG. 2A is a schematic illustration of an irreversible electroporation system that includes a DC voltage/signal generator, a controller capable of being configured to apply voltages to selected subsets of electrodes with independent subset selections for anode and cathode.
  • FIG. 2B is a schematic illustration of an irreversible electroporation system that includes a DC voltage/signal generator and a controller according to an embodiment.
  • FIG. 3 is an illustration of an ECG waveform showing the refractory periods during atrial and ventricular pacing, and the time windows for irreversible electroporation ablation.
  • FIG. 4 is a schematic illustration of a user interface according to an embodiment showing various configurations for subsets of electrodes on the catheter to be identified as anodes or cathodes, and the ablation vectors therebetween.
  • FIG. 5 is a schematic illustration of a user interface according to an embodiment, indicating the electrodes that are active and wrapped around the pulmonary veins of a patient anatomy, and that can be actively available for selection in bipolar ablation.
  • FIG. 6 is a schematic illustration of a user interface according to an embodiment that illustrates a method of ablating along a cardiac isthmus line using two catheters, one of which is wrapped around the pulmonary veins.
  • FIG. 7 is a schematic illustration of a user interface according to an embodiment that illustrates a method of focal ablation, wherein nearby electrodes on the same catheter are used for bipolar ablation with irreversible electroporation to ablate a region of contacting tissue at the distal catheter end, and showing a depth selection button that can be used to selectively adjust an ablation parameter.
  • FIG. 8 is a schematic illustration according to an embodiment, showing a graphic window for selection of type of pacing to be used for electroporation therapy delivery.
  • FIG. 9 is a schematic illustration of a user interface according to an embodiment, showing a graphic window with parameters associated with a selected pacing type.
  • FIG. 10 is a schematic illustration of a user interface that illustrates a method of selecting anode electrode subsets and cathode electrode subsets on two different catheters according to an embodiment.
  • FIG. 11 is a schematic illustration of a user interface that illustrates a method of selecting a single anode electrode and a single selected cathode electrode on the same catheter according to an embodiment.
  • FIG. 12 is a schematic illustration of a waveform generated by the irreversible electroporation system and methods according to an embodiment, showing a balanced square wave.
  • FIG. 13 is a schematic illustration of a waveform generated by the irreversible electroporation system and methods according to an embodiment, showing a balanced biphasic square wave.
  • FIG. 14 is a schematic illustration of a waveform generated by the irreversible electroporation system and methods according to an embodiment, showing a progressive balanced biphasic square wave.
  • FIG. 15 is a schematic illustration of a signal generator according to an embodiment, showing a capacitor bank connected to a set of switches.
  • FIG. 16 is a schematic illustration of a voltage pulse-time plot produced by a high voltage DC signal generator according to an embodiment.
  • FIG. 17 is a schematic depiction of a sequence of three biphasic pulses delivered by a voltage generator and using methods according to an embodiment, showing a pre-polarizing negative voltage pulse followed by a positive polarizing pulse.
  • FIG. 18A is a schematic illustration of a distal portion of a catheter having two electrodes functioning as a cathode and an anode according to an embodiment.
  • FIG. 18B is a schematic illustration of a distal portion of a catheter according to an embodiment having a recessed distal anode electrode, the illustration showing the current flow between electrodes.
  • FIG. 18C is a schematic illustration of a distal portion of a catheter according to an embodiment, where electric field lines near the distal end of the catheter are schematically shown together with a region of focal ablation in tissue.
  • FIG. 18D is a schematic illustration of a distal portion of a catheter according to an embodiment, where the catheter lumen has flowing fluid, possibly with ultrasonic waves conducted through the fluid, and the distal anode electrode has channels for fluid flow to exit the distal end of the catheter.
  • FIG. 19A is an illustration of the simulation geometry showing a geometric model of the distal portion of a catheter and surrounding tissue types.
  • FIG. 19B is an illustration of the distal portion of a catheter with a proximal electrode disposed externally on the shaft of the catheter and a distal electrode that is recessed and disposed on the inner side of the shaft of the catheter.
  • FIG. 19C is an illustration of a longitudinal cross-section of the simulation geometry showing distal catheter geometry and tissue geometry together with electric field intensity contours for the case when the proximal electrode is disposed externally on the shaft of the catheter and the distal electrode is recessed and disposed on the inner side of the shaft of the catheter, according to an embodiment.
  • FIG. 19D is an illustration of a longitudinal cross-section of the simulation geometry showing distal catheter geometry and tissue geometry together with electric field intensity contours for the case when the proximal and distal electrodes are both disposed externally on the shaft of the catheter, according to an embodiment.
  • FIG. 20 is a schematic illustration of a balloon catheter according to an embodiment, where a balloon structure with an insulating exterior is located between anode and cathode electrodes for electroporation voltage delivery.
  • FIG. 21A is a schematic illustration of a balloon catheter according to an embodiment, where a balloon structure with an insulating exterior and with at least one ultrasonic transducer is located between anode and cathode electrodes for electroporation voltage delivery.
  • FIG. 21B is a schematic illustration of a balloon catheter according to an embodiment, where an annular ablation region abutting a vessel is shown.
  • FIG. 22 is a schematic illustration of a basket ablation catheter for electroporation energy delivery according to an embodiment.
  • DETAILED DESCRIPTION
  • Systems and methods are disclosed for the selective and rapid application of DC voltage to drive electroporation. In some embodiments, the irreversible electroporation system described herein includes a DC voltage/signal generator and a controller capable of being configured to apply voltages to a selected multiplicity or a subset of electrodes, with anode and cathode subsets being selected independently. The controller is additionally capable of applying control inputs whereby selected pairs of anode-cathode subsets of electrodes can be sequentially updated based on a pre-determined sequence.
  • In some embodiments, an irreversible electroporation system includes a DC voltage/signal generator and a controller capable of being configured to apply voltages to a selected multiplicity or a subset of electrodes, with independent subset selections for anode and cathode. Further, the controller is capable of applying control inputs whereby selected pairs of anode-cathode subsets of electrodes can be sequentially updated based on a pre-determined sequence. The generator can output waveforms that can be selected to generate a sequence of voltage pulses in either monophasic or biphasic forms and with either constant or progressively changing amplitudes. In one embodiment, a DC voltage pulse generation mechanism is disclosed that can use amplified voltage spikes generated by the action of a switch connected to a capacitor bank, resulting in a biphasic, asymmetric micro pulse waveform for cardiac ablation where the first phase provides a brief pre-polarizing pulse that is followed by a finishing pulse in the second phase. Such pre-polarization can result in more effective pulsed voltage electroporation delivery. Methods of control and DC voltage application from a generator capable of selective excitation of sets of electrodes are disclosed. Devices are disclosed for more effective DC voltage application through ionic fluid irrigation and ultrasonic agitation, possibly including insulating balloon constructions to displace electrodes from collateral structures, and for use in intravascular applications. Such devices for generating irreversible electroporation can be utilized in cardiac therapy applications such as ablation to treat Ventricular Tachycardia (VT) as well as in intravascular applications. In some embodiments, the use of temperature to selectively ablate tissue is described, as the threshold of irreversible electroporation is temperature-dependent, utilizing focused kinetic energy to select the predominant tissue type or region it is desired to ablate
  • In some embodiments, an apparatus includes a voltage pulse generator and an electrode controller. The voltage pulse generator is configured to produce a pulsed voltage waveform. The electrode controller is configured to be operably coupled to the voltage pulse generator and a medical device including a series of electrodes. The electrode controller is implemented in at least one of a memory or a processor, and includes a selection module and a pulse delivery module. The selection module is configured to select a subset of electrodes from the series of electrodes. The selection module is configured identify at least one electrode as an anode and at least one electrode as a cathode. The pulse delivery module is configured to deliver an output signal associated with the pulsed voltage waveform to the subset of electrodes.
  • In some embodiments, an apparatus includes a voltage pulse generator and an electrode controller. The voltage pulse generator is configured to produce a pulsed voltage waveform. The electrode controller is configured to be operably coupled to the voltage pulse generator and a medical device including a series of electrodes. The electrode controller is implemented in at least one of a memory or a processor, and includes a selection module and a pulse delivery module. The selection module is configured to select a set of anode/cathode pairs, each anode/cathode pair including at least one anode electrode and at least one cathode electrode. In some embodiments, for example, the anode/cathode pair can include one anode and multiple cathodes (or vice-versa). The pulse delivery module is configured to deliver an output signal associated with the pulsed voltage waveform to the plurality of anode/cathode pairs according to a sequential pattern.
  • In some embodiments, a non-transitory processor readable medium storing code representing instructions to be executed by a processor includes code to cause the processor to identify a set of anode/cathode pairs from a set of electrodes of a multi-electrode catheter. The multi-electrode catheter is configured to be disposed about a portion of a heart, and at least one anode/cathode pair includes at least one anode electrode and at least one cathode electrode. The code further includes code to convey a pacing signal to a pacing lead configured to be operatively coupled to the heart. The code further includes code to receive an electrocardiograph signal associated with a function of the heart. The code further includes code to deliver a pulsed voltage waveform to the set of anode/cathode pairs according to a sequential pattern.
  • In some embodiments, a method includes identifying, via a selection module of an electrode controller, a set of anode/cathode pairs from a set of electrodes of a multi-electrode catheter. The multi-electrode catheter is configured to be disposed about a portion of a heart. At least one anode/cathode pair includes at least one anode electrode and at least one cathode electrode. A pacing signal is conveyed to a pacing lead configured to be operatively coupled to the heart. The method further includes receiving, at a feedback module of the electrode controller, an electrocardiograph signal associated with a function of the heart. The method further includes delivering, via a pulse delivery module of the electrode controller, a pulsed voltage waveform to the set of anode/cathode pairs according to a sequential pattern.
  • In some embodiments, an apparatus includes a signal generator for the generation of DC voltage pulses. The signal generator is configured to produce a biphasic waveform having a pre-polarizing pulse followed by a polarizing pulse. The pre-polarizing pulse is generated by utilizing voltage spikes generated from switching on a discharge of a capacitor bank.
  • In some embodiments, an apparatus includes a catheter shaft, a cathode electrode and an anode electrode. The catheter shaft has an outer side and an inner side. The cathode electrode is coupled to a distal end portion of the catheter shaft such that a cathode surface is exposed on the outer side of the catheter shaft. The anode electrode is coupled to the distal end portion distal relative to the cathode electrode. The anode electrode is recessed within the catheter shaft and coupled to the catheter shaft such that an anode surface is exposed on the inner side of the catheter shaft.
  • In some embodiments, an apparatus includes a catheter shaft, an inflatable balloon, a first electrode and a second electrode. The catheter shaft has a distal end portion. The inflatable balloon is coupled to the distal end portion. An outer surface of the balloon is an electrical insulator. The first electrode is coupled to a proximal side of the balloon, and the second electrode is coupled to a distal side of the balloon.
  • In some embodiments, an apparatus includes a catheter shaft having a distal end portion, an expandable basket structure, a first electrode, a second electrode, and a set of spherical electrodes. The expandable basket structure is coupled to the distal end portion of the catheter shaft. The first electrode coupled to a proximal side of the expandable basket structure. The second electrode is coupled to a distal side of the expandable basket structure. The set of spherical electrodes is coupled to a corresponding set of rounded corners of the expandable basket structure.
  • As used in this specification, the singular forms “a,” “an” and “the” include plural referents unless the context clearly dictates otherwise. Thus, for example, the term “a member” is intended to mean a single member or a combination of members, “a material” is intended to mean one or more materials, “a processor” is intended to mean a single processor or multiple processors; and “memory” is intended to mean one or more memories, or a combination thereof.
  • As used herein, the terms “about” and “approximately” generally mean plus or minus 10% of the value stated. For example, about 0.5 would include 0.45 and 0.55, about 10 would include 9 to 11, about 1000 would include 900 to 1100.
  • As shown in FIG. 1, in some embodiments a Pulmonary Vein isolation (PV isolation) ablation catheter device 15 with a multiplicity of electrodes (indicated by dark bands such as those marked as 17) disposed along its mid-section is wrapped in the epicardial space around the pulmonary veins 10, 11, 12 and 13 of a heart 7 in a subject or patient anatomy, with the ends 8 and 9 of the mid-section extending out and away to eventually emerge from the patient's chest. The ablation catheter 15 and any of the catheters described herein can be similar to the ablation catheters described in PCT Publication No. WO2014/025394, entitled “Catheters, Catheter Systems, and Methods for Puncturing Through a Tissue Structure,” filed on Mar. 14, 2013 (“the '394 PCT Application), which is incorporated herein by reference in its entirety. The ablation catheter 15 can be disposed about the pulmonary veins 10, 11, 12 and 13 using any suitable procedure and apparatus. For example, in some embodiments, the ablation catheter 15 can be disposed about the pulmonary veins 10, 11, 12 and 13 and/or the heart 7 using a puncturing apparatus disposed via a subxiphoid pericardial access location and a guidewire-based delivery method as described in the '394 PCT Application. After the ends 8 and 9 of the mid-section extend and emerge out of the patient chest they can be cinched together to effectively hold the catheter in place or position.
  • A DC voltage for electroporation can be applied to subsets of electrodes identified as anode and cathode, respectively, on approximately opposite sides of the closed contour defined by the shape of the catheter 15 around the pulmonary veins. The DC voltage is applied in brief pulses sufficient to cause irreversible electroporation. In any of the systems and methods described herein, the pulse or waveform can be in the range of 0.5 kV to 10 kV and more preferably in the range 1 kV to 2.5 kV, so that a threshold electric field value of around 200 Volts/cm is effectively achieved in the cardiac tissue to be ablated. In some embodiments, the marked electrodes can be automatically identified, or manually identified by suitable marking, on an X-ray or fluoroscopic image obtained at an appropriate angulation that permits identification of the geometric distance between anode and cathode electrodes, or their respective centroids. In one embodiment, the DC voltage generator setting for irreversible electroporation is then automatically identified by the electroporation system based on this distance measure. In an alternate embodiment, the DC voltage value is selected directly by a user from a suitable dial, slider, touch screen, or any other user interface. The DC voltage pulse results in a current flowing between the anode and cathode electrodes on opposite sides of the contour defined by the catheter shape, with said current flowing through the cardiac wall tissue and through the intervening blood in the cardiac chamber, with the current entering the cardiac tissue from the anode and returning back through the cathode electrodes. The forward and return current paths (leads) are both inside the catheter. Areas of cardiac wall tissue where the electric field is sufficiently large for irreversible electroporation are ablated during the DC voltage pulse application. The number of electrodes on the PV isolation ablation catheter can be in the range between 8 and 50, and more preferably in the range between 15 and 40.
  • A schematic diagram of the electroporation system according to an embodiment is shown in FIG. 2A. The system includes a DC voltage/signal generator 23 that is driven by a controller unit 21 that interfaces with a computer device 24 by means of a two-way communication link 29. The controller can perform channel selection and routing functions for applying DC voltages to appropriate electrodes that have been selected by a user or by the computer 24, and apply the voltages via a multiplicity of leads (shown collectively as 26) to a catheter device 22. The catheter device can be any of the catheters shown and described herein or in the '394 PCT Application. Some leads from the controller 21 could also carry pacing signals to drive pacing of the heart through a separate pacing device (not shown). The catheter device can also send back information such as ECG (electrocardiograph) recordings or data from other sensors back to the controller 21 as indicated by the data stream 25, possibly on separate leads. While the DC voltage generator 23 sends a DC voltage to the controller 21 through leads 27, the voltage generator is driven by control and timing inputs 28 from the controller unit 21.
  • In some embodiments, the electrode controller can include one or more modules and can automatically perform channel selection (e.g., identification of a subset of electrodes to which the voltage pulses will be applied), identification of the desired anode/cathode pairs, or the like. For example, FIG. 2B shows an electroporation system according to an embodiment that includes an electrode controller 900 and a signal generator 925. The electrode controller 900 is coupled to a computer 920 or other input/output device, and is configured to be operable coupled to a medical device 930. The medical device 930 can be one or more multi-electrode catheters, of the types shown and described herein. Further the medical device 930 can be coupled to, disposed about and/or in contact with a target tissue, such as the heart H. In this manner, as described herein, the electroporation system, including the electrode controller 900 and the signal generator 925, can deliver voltage pulses to the target tissue for therapeutic purposes.
  • The controller 900 can include a memory 911, a processor 910, and an input/output module (or interface) 901. The controller 900 can also include a pacing module 902, a feedback module 905, a pulse delivery module 908, and a selection module 912. The electrode controller 900 is coupled to a computer 920 or other input/output device via the input/output module (or interface) 901.
  • The processor 910 can be any processor configured to, for example, write data into and read data from the memory 911, and execute the instructions and/or methods stored within the memory 911. Furthermore, the processor 910 can be configured to control operation of the other modules within the controller (e.g., the pacing module 902, the feedback module 905, the pulse delivery module 908, and the selection module 912). Specifically, the processor can receive a signal including user input, impedance, heart function or the like information and determine a set of electrodes to which voltage pulses should be applied, the desired timing and sequence of the voltage pulses and the like. In other embodiments, the processor 910 can be, for example, an application-specific integrated circuit (ASIC) or a combination of ASICs, which are designed to perform one or more specific functions. In yet other embodiments, the microprocessor can be an analog or digital circuit, or a combination of multiple circuits.
  • The memory device 910 can be any suitable device such as, for example, a read only memory (ROM) component, a random access memory (RAM) component, electronically programmable read only memory (EPROM), erasable electronically programmable read only memory (EEPROM), registers, cache memory, and/or flash memory. Any of the modules (the pacing module 902, the feedback module 905, the pulse delivery module 908, and the selection module 912) can be implemented by the processor 910 and/or stored within the memory 910.
  • As shown, the electrode controller 900 operably coupled to the signal generator 925. The signal generator includes circuitry, components and/or code to produce a series of DC voltage pulses for delivery to electrodes included within the medical device 930. For example, in some embodiments, the signal generator 925 can be configured to produce a biphasic waveform having a pre-polarizing pulse followed by a polarizing pulse. The signal generator 925 can be any suitable signal generator of the types shown and described herein.
  • The pulse delivery module 908 of the electrode controller 900 includes circuitry, components and/or code to deliver an output signal associated with the pulsed voltage waveform produced by the signal generator 925. This signal (shown as signal 909) can be any signal of the types shown and described herein, and can be of a type and/or have characteristics to be therapeutically effective. In some embodiments, the pulse delivery module 908 receives input from the selection module 912, and can therefore send the signal 909 to the appropriate subset of electrodes, as described herein.
  • The selection module 912 includes circuitry, components and/or code to select a subset of electrodes from the electrodes included within the medical device 930, as described herein. In some embodiments, the selection module 912 is configured identify at least one electrode from the subset of electrodes as an anode and at least one electrode from the subset of electrodes as a cathode. In some embodiments, the selection module 912 is configured to select a subset of electrodes from more than one medical device 930, as described herein.
  • In some embodiments, the selection module 912 can select the subset of electrodes based on input received from the user via the input/output module 901. For example, in some embodiments, the user can use visualization techniques or other methods to identify the desired electrodes, and can manually enter those electrodes, as described herein.
  • In other embodiments, the selection module 912 is configured to select the subset of electrodes based on a predetermined schedule of the set of electrodes. For example, in some embodiments, the electrode controller 900 can be configured accommodate different medical devices 930 having different numbers and/or types of electrodes. In such embodiments, the selection module 912 can retrieve a predetermined schedule of electrodes to which a series of voltage pulses can be applied, based on the specific type of medical device 930.
  • In yet other embodiments, the selection module 912 is configured to select the subset of electrodes automatically based on at least one of an impedance associated with the subset of electrodes, a distance between the first electrode and the second electrode, and a characteristic associated with a target tissue. For example, in some embodiments, the electrode controller 900 includes the feedback module 905 that can receive feedback from the medical device 930 (as identified by the signal 906). The feedback module 905 includes circuitry, components and/or code to determine an impedance between various electrodes (as described herein). Thus, in such embodiments, the selection module 912 can select the subset of electrodes automatically based the impedance.
  • In some embodiments, the electrode controller 900 optionally includes the pacing module 902. The pacing module 902 includes circuitry, components and/or code to produce a pacing signal (identified as signal 903) that can be delivered to the target tissue (or heart) via a pacing lead. As described herein, the pacing module 902 can facilitate any suitable “mode” of operation desired, such as a standard pacing, an overdrive pacing option (for pacing at a faster-than-normal heart rate), an external trigger option (for pacing from an externally generated trigger), and a diagnostic pacing option.
  • As shown in FIG. 3, given atrial or ventricular pacing inputs to the heart (e.g., from the pacing module 902 of the electrode controller 900), the resulting ECG waveform 32 has appropriate respective refractory time intervals 33 and 34 respectively, during which there are suitable time windows for application of irreversible electroporation as indicated by 35 and 36. The application of cardiac pacing results in a periodic, well-controlled sequence of electroporation time windows. Typically, this time window is of the order of hundreds of microseconds to about a millisecond or more. During this window, multiple DC voltage pulses can be applied to ensure that sufficient tissue ablation has occurred. The user can repeat the delivery of irreversible electroporation over several successive cardiac cycles for further confidence. Thus, in some embodiments, a feedback module (e.g., feedback module 905) can receive the electrocardiograph signal, and a pulse delivery module (e.g., pulse delivery module 908) can deliver the output signal to the subset of electrodes during a time window associated with at least one a pacing signal or the electrocardiograph signal.
  • In some embodiments, the ablation controller and signal generator can be mounted on a rolling trolley, and the user can control the device using a touchscreen interface that is in the sterile field. Referring to FIG. 2B, in such embodiments, the computer 920 can be a touchscreen device. The touchscreen can be for example an LCD touchscreen in a plastic housing mountable to a standard medical rail or post and can be used to select the electrodes for ablation and to ready the device to fire. The interface can for example be covered with a clear sterile plastic drape. The operator can select the number of electrodes involved in an automated sequence. The touch screen graphically shows the catheters that are attached to the controller. In one embodiment the operator can select electrodes from the touchscreen with appropriate graphical buttons. The operator can also select the pacing stimulus protocol (either internally generated or externally triggered) from the interface. Once pacing is enabled, and the ablation sequence is selected, the operator can initiate or verify pacing. Once the operator verifies that the heart is being paced, the ablation sequence can be initiated by holding down a hand-held trigger button that is in the sterile field. The hand-held trigger button can be illuminated red to indicate that the device is “armed” and ready to ablate. The trigger button can be compatible for use in a sterile field and when attached to the controller can be illuminated a different color, for example white. When the device is firing, the trigger button flashes in sequence with the pulse delivery in a specific color such as red. The waveform of each delivered pulse is displayed on the touchscreen interface. A graphic representation of the pre and post impedance between electrodes involved in the sequence can also be shown on the interface, and this data can be exported for file storage.
  • In some embodiments, an impedance map can be generated based on voltage and current recordings across anode-cathode pairs or sets of electrodes, and an appropriate set of electrodes that are best suited for ablation delivery in a given region can be selected based on the impedance map or measurements, either manually by a user or automatically by the system. Such an impedance map can be produced, for example, by the feedback module 905, or any other suitable portion of the electrode controller 900. For example, if the impedance across an anode/cathode combination of electrodes is a relatively low value (for example, less than 25 Ohms), at a given voltage the said combination would result in relatively large currents in the tissue and power dissipation in tissue. In such circumstances, this electrode combination would then be ruled out (e.g., via the selection module 912) for ablation due to safety considerations, and alternate electrode combinations would be sought by the user. In a preferred embodiment, a pre-determined range of impedance values, for example 30 Ohms to 300 Ohms, could be used as an allowed impedance range within which it is deemed safe to ablate. Thus, in some embodiments, an electrode controller can automatically determine a subset of electrodes to which voltage pulses should be applied.
  • The waveforms for the various electrodes can be displayed and recorded on the case monitor and simultaneously outputted to a standard connection for any electrophysiology (EP) data acquisition system. With the high voltages involved with the device, the outputs to the EP data acquisition system needs to be protected from voltage and/or current surges. The waveforms acquired internally can be used to autonomously calculate impedances between each electrode pair. The waveform amplitude, period, duty cycle, and delay can all be modified, for example via a suitable Ethernet connection. Pacing for the heart is controlled by the device and outputted to the pacing leads and a protected pacing circuit output for monitoring by a lab.
  • While a touchscreen interface is one preferred embodiment, other user interfaces can be used to control the system such as a graphical display on a laptop or monitor display controlled by a standard computer mouse or joystick. FIG. 4 shows a schematic rendering of a portion of the user interface of the electroporation system. The four windows A, B, C and D shown in the FIG. represent four different choices of electrode subsets for anode and cathode selection. The PV isolation ablation catheter is represented by a string of numbered electrodes as indicated by 41, wrapped around the area 42 of the pulmonary veins represented by the enclosed region in this schematic diagram. Referring to B in the FIG., the dashed-line vectors 46 represent approximate current vectors, with their tips at the cathodes and tails or bases at the anodes; in this FIG., the three electrodes marked 43 are cathodes, and the single electrode marked 44 is the anode. The windows A, C and D in this FIG. show other choices of cathode and anode electrode subsets, in each case with accompanying approximate current density vectors shown by dashed arrows. It is clear from the FIG. that the user can select various subsets of electrodes as cathode or anode, depending on the region to be ablated along the length of the PV isolation catheter. In one embodiment, the user can make one selection of cathode and anode subsets, and the system can take this selection as input to generate an ablation sequence that moves around the ring or contour defined by the shape of the PV isolation catheter, for example moving clockwise at each step with a one-electrode displacement. In this manner, the pair of cathode and anode electrode subsets can be sequentially updated for ablation purposes, so that if there are N electrodes, after N updates the entire contour has been updated such that the tips of the current arrows shown as 46 have swept once around the contour completely.
  • In some cases, the portion of the PV isolation catheter with electrodes may be longer than needed to wrap around a given patient's pulmonary veins; in this event, a smaller number of electrodes suffices to wrap around the contour of the pulmonary veins. These define the number of “active” electrodes to be used in the ablation process. In the specific example shown in FIG. 5 for a 30-electrode PV isolation catheter, the set of electrodes wrapped around the pulmonary veins, represented by 51, are the electrodes that would be used in the ablation process, and are called out by the label 50 as the set of active electrodes, while the remaining five electrodes represented by 52 are not used in the ablation process as they are not located in suitable positions.
  • In one embodiment of the electroporation system disclosed herein, multiple catheters could be used for ablation, with anode and cathode subsets respectively chosen to lie on different catheters. In one exemplary use of such multi-device electroporation, two catheters are connected to the controller unit of the electroporation system. In some instances of ablation procedures for the treatment of Atrial Fibrillation (AF), in addition to isolating the pulmonary veins, it is also useful to generate an ablation line that separates or isolates regions around the mitral valve. Such a line is often termed a “Mitral Isthmus Line,” and is a line running from an Inferior aspect of the PV isolation contour to the outer edge of the mitral valve in the left atrium. In some embodiments, a method of use of the systems described herein includes inserting a coronary sinus catheter with multiple electrodes into the coronary sinus. As shown in FIG. 6, electrodes marked as 66 on the coronary sinus catheter 63, and electrodes marked as 65 on the PV isolation catheter 62, are further selected as active subsets of electrodes for ablation, as indicated in the indication window 61 for the anode and cathode subsets. Thus in effect the electrodes of the coronary sinus catheter 63 are utilized to define the mitral isthmus line, and irreversible electroporation ablation can be effectively performed on the left atrial wall to generate a mitral isthmus ablation line.
  • In a some embodiments, the system (any of the generators and controllers described herein) can deliver rectangular-wave pulses with a peak maximum voltage of about 5 kV into a load with an impedance in the range of 30 Ohm to 3000 Ohm for a maximum duration of 200 μs, with a 100 μs maximum duration being still more preferred. Pulses can be delivered in a multiplexed and synchronized manner to a multi-electrode catheter inside the body with a duty cycle of up to 50% (for short bursts). The pulses can generally be delivered in bursts, such as for example a sequence of between 2 and 10 pulses interrupted by pauses of between 1 ms and 1000 ms. The multiplexer controller is capable of running an automated sequence to deliver the impulses/impulse trains (from the DC voltage signal/impulse generator) to the tissue target within the body. The controller system is capable of switching between subsets/nodes of electrodes located on the single use catheter or catheters (around or within the heart). Further, the controller can measure voltage and current and tabulate impedances in each electrode configuration (for display, planning, and internal diagnostic analysis). It can also generate two channels of cardiac pacing stimulus output, and is capable of synchronizing impulse delivery with the internally generated cardiac pacing and/or an external trigger signal. In one embodiment, it can provide sensing output/connection for access to bio potentials emanating from each electrode connected to the system (with connectivity characteristics being compatible with standard electrophysiological laboratory data acquisition equipment).
  • In a some embodiments, the controller (e.g., the controller 900) can automatically “recognize” the single-use disposable catheter when it is connected to the controller output (prompting internal diagnostics and user interface configuration options). The controller can have at least two unique output connector ports to accommodate up to at least two catheters at once (for example, one 30-electrode socket and one 10-electrode socket; a 2-pole catheter would connect to the 10-pole socket). The controller device can function as long as at least one recognized catheter is attached to it. In a preferred embodiment, the controller can have several sequence configurations that provide the operator with at least some variety of programming options. In one configuration, the controller can switch electrode configurations of a bipolar set of electrodes (cathode and anode) sequentially in a clockwise manner (for example, starting at step n, in the next step of the algorithm, cathode n+1 and anode n+1 are automatically selected, timed to the synchronizing trigger). With the 30-pole catheter the electrodes are arranged in a quasi-circumference around the target. Thus in the first sequence, pulse delivery occurs so that the vector of current density changes as the automated sequencing of the controller switches “on” and “off” between different electrodes surrounding the tissue target sequence. The current density vectors generally cross the target tissue but in some configurations the current density could be approximately tangential to the target. In a second sequence configuration, the impulses are delivered to user-selected electrode subsets of catheters that are connected to the device (the vector of current density does not change with each synchronized delivery). A third sequence configuration example is a default bipolar pulse sequence for the simplest 2-pole catheter. The user can also configure the controller to deliver up to 2 channels of pacing stimulus to electrodes connected to the device output. The user can control the application of DC voltage with a single handheld switch. A sterile catheter or catheters can be connected to the voltage output of the generator via a connector cable that can be delivered to the sterile field. In one embodiment, the user activates the device with a touch screen interface (that can be protected with a single-use sterile transparent disposable cover commonly available in the catheter lab setting). The generator can remain in a standby mode until the user is ready to apply pulses at which point the user/assistant can put the generator into a ready mode via the touchscreen interface. Subsequently the user can select the sequence, the active electrodes, and the cardiac pacing parameters.
  • Once the catheter has been advanced to or around the cardiac target, the user can initiate electrically pacing the heart (using a pacing stimulus generated by the ablation controller or an external source synchronized to the ablation system). The operator verifies that the heart is being paced and uses the hand-held trigger button to apply the synchronized bursts of high voltage pulses. The system can continue delivering the burst pulse train with each cardiac cycle as long as the operator is holding down a suitable “fire” button or switch. During the application of the pulses, the generator output is synchronized with the heart rhythm so that short bursts are delivered at a pre-specified interval from the paced stimulus. When the train of pulses is complete, the pacing continues until the operator discontinues pacing.
  • FIG. 7 shows a portion of a graphical user interface according to an embodiment for focal ablation with a bipolar or 2-electrode catheter. In some embodiments, the graphical user interface can be a touchscreen interface. A graphical icon 71 for a bipolar catheter is shown along with a depth selection button 72 for selecting a desired ablation depth. In one embodiment of the system, based on the latter depth setting, the system can select an appropriate voltage value to apply in order to ensure that an electric field sufficient to cause irreversible electroporation is applied up to the desired depth.
  • In some embodiments, a pacing selection interface on a portion of the user interface of the electroporation system is shown in FIG. 8. The pacing selection interface has various options such as an overdrive pacing option 81 for pacing at a faster-than-normal heart rate, an external trigger option 82 for pacing from an externally generated trigger, and a diagnostic pacing option 83. By clicking the “Select” button for a given option, that option is selected.
  • As an example of a pacing option selected, FIG. 9 shows a portion the user interface of the electroporation system with pacing from an external trigger selected for the pacing option. The selected option 86 is displayed along with the pacing characteristics and waveform 87 for the user to visualize.
  • FIG. 10 shows a portion the user interface of the electroporation system for selection of anode and cathode electrodes, with two catheters connected to the system. One of the catheters is a PV isolation catheter 91 while the other is a multi-electrode catheter 92. The buttons 93 and 94 can implement the selection of marked electrode subsets on the catheters as respectively anode or cathode. Once the selection is made, the appropriate electrodes are colored differently to indicate anode or cathode electrode as shown marked respectively as 96 and 97 in FIG. 11.
  • The controller and generator can output waveforms that can be selected to generate a sequence of voltage pulses in either monophasic or biphasic forms and with either constant or progressively changing amplitudes. FIG. 12 shows a rectangular wave pulse train where the pulses 101 have a uniform height or maximum voltage. FIG. 13 shows an example of a balanced biphasic rectangular pulse train, where each positive voltage pulse such as 103 is immediately followed by a negative voltage pulse such as 104 of equal amplitude and opposite sign. While in this example the biphasic pulses are balanced with equal amplitudes of the positive and negative voltages, in other embodiments an unbalanced biphasic waveform could also be used as may be convenient for a given application.
  • Yet another example of a waveform or pulse shape that can be generated by the system is illustrated in FIG. 14, which shows a progressive balanced rectangular pulse train, where each distinct biphasic pulse has equal-amplitude positive and negative voltages, but each pulse such as 107 is larger in amplitude than its immediate predecessor 106. Other variations such as a progressive unbalanced rectangular pulse train, or indeed a wide variety of other variations of pulse amplitude with respect to time can be conceived and implemented by those skilled in the art based on the teachings herein.
  • The time duration of each irreversible electroporation rectangular voltage pulse could lie in the range from 1 nanosecond to 10 milliseconds, with the range 10 microseconds to 1 millisecond being more preferable and the range 50 microseconds to 300 microseconds being still more preferable. The time interval between successive pulses of a pulse train could be in the range of 10 microseconds to 1 millisecond, with the range 50 microseconds to 300 microseconds being more preferable. The number of pulses applied in a single pulse train (with delays between individual pulses lying in the ranges just mentioned) can range from 1 to 100, with the range 1 to 10 being more preferable. As described in the foregoing, a pulse train can be driven by a user-controlled switch or button, in one embodiment preferably mounted on a hand-held joystick-like device. In one mode of operation a pulse train can be generated for every push of such a control button, while in an alternate mode of operation pulse trains can be generated repeatedly during the refractory periods of a set of successive cardiac cycles, for as long as the user-controlled switch or button is engaged by the user.
  • In one embodiment of a biphasic waveform, a brief pre-polarization pulse can be applied just prior to the application of a polarizing rectangular pulse. The rapid change in electric field in tissue, in addition to the electric field magnitude, driven by this type of pulse application incorporating a pre-polarizing pulse can promote a more rapid and effective tissue ablation in some applications. A schematic diagram of a voltage/signal generator for the purpose of generating such a waveform employing intrinsic amplification of voltage spikes arising from switching is given in FIG. 15. A DC voltage is generated from the discharge of a suitable capacitor bank 111 (powered by a suitable charging circuit that is not shown and that would be familiar to those skilled in the art) with a suitable high-voltage diode or rectifier 112 serving to ensure voltage polarity. While in one embodiment of the signal generator the voltage discharge passes initially through a snubber or transient-suppression circuit 113 that strongly suppresses transients, in an alternate embodiment an alternate signal path is available via a switch unit 116 that detects and lets through a brief initial voltage spike after a possible voltage inversion. The signal then passes through an Insulated Gate Bipolar Transistor (IGBT) high-power switch 115 and is accessible at terminals 117 for connection to catheter electrodes. When no pre-polarizing pulse is required, the switch unit 116 would not be present, and the signal passes (after transient-suppression in the snubber circuit 113) initially through a Metal Oxide Semiconductor Field Effect Transistor (MOSFET) switch 114 before passing through the IGBT switch 115. The IGBT interfaces better with a wider range of load impedances (from tissue), while the faster switching speed of the MOSFET can drive a suitably fast turn-on/turn-off of the IGBT switch, so that using them in the sequence shown in FIG. 15 can be advantageous.
  • In order to generate a sequence of rectangular pulses, the time constant associated with the capacitor bank discharge is chosen to be significantly longer than an individual pulse duration. If the charging circuit of the capacitor bank is much more rapid, a sequence of very highly rectangular pulses can be generated from repeated capacitor bank discharges. As shown in FIG. 16, when a capacitor bank is suddenly discharged by closing a switch, the voltage can briefly be amplified and spike as indicated by 122 before settling to a normal discharge pattern 121. The inductance of leads connected to the capacitor forms a tank circuit with the capacitor, and in many cases this tank circuit is rapidly driven to resonance by the discharge, leading to the voltage amplification seen in the spiking behavior 122. Indeed, by suitably controlling lead inductance and resistance, the extent of spike generated (spike amplitude and duration) can be further controlled. Such additional inductance/resistance or spike control circuitry can be included in the switch unit 116 shown in FIG. 15. Thus the switch 116 plays a gatekeeping role akin to the notion of “Maxwell's demon” in statistical physics, allowing the passage of some types of intrinsically amplified voltage spikes, and accordingly the signal generator of FIG. 15 can also be termed a Maxwell amplifier.
  • A schematic representation of a biphasic pulse with pre-polarization is shown in FIG. 17, where each rectangular polarizing pulse such as 125 is preceded by a pre-polarizing negative voltage spike 126 derived from transient spiking from a generator of the type shown in FIG. 15. The value of the negative spike voltage peak VL could be determined by the spike control circuitry of the switch unit 116 as discussed above. The biphasic pulses involve a time duration T1 for the pre-polarizing spike, a duration T2 for the rectangular polarizing pulse, with a time delay Td indicated by 127 in FIG. 17 between successive biphasic pulses. Typical values of T2 could be of the order of 100 microseconds, while T1 could lie in the range 5 microseconds to 50 microseconds and the delay time Td could be in the range 100 microseconds to 300 microseconds. All of these parameters can be determined by the design of the signal generator, and in various embodiments could also be determined by user control as may be convenient for a given clinical application. The specific examples and descriptions herein are exemplary in nature and variations can be developed by those skilled in the art based on the material taught herein without departing from the scope of the embodiments described herein.
  • A catheter device for focal ablation with the electroporation system according to an embodiment is shown schematically in FIG. 18A. The focal ablation catheter 131 has two electrodes disposed in the distal section of the catheter, with a relatively proximally placed cathode electrode 133 of length L1 exposed on the catheter shaft and a relatively distally placed anode electrode 134 of length L2 mounted on the inner section of the shaft. The catheter shaft is made of a material with high dielectric strength such as for example a polymer comprising Teflon. Thus the distal electrode 134 is covered by the polymeric shaft and is not exposed to the blood pool on the shaft exterior. Both electrodes are metallic, and in one embodiment the anode could be poly-metallic in construction, for example comprising regions of Titanium and regions of Platinum.
  • As shown in FIG. 18B, the anode 141 is recessed from the distal tip, and could be placed with its distal portion between 0.5 mm and 10 mm away from the distal end of the catheter. While the recessed and interior placement of the anode electrode is counterintuitive, it can be an effective means of enhancing electroporation efficacy and safety selectively for focal ablation. As indicated in the FIG., the schematically depicted (negative) current density flowing from the cathode to the anode indicated by the stream of arrows 142 bends around the distal edge 143 of the catheter shaft resulting in a region of high curvature of the current density, and correspondingly curved electric field lines as well. If the anode electrode is recessed, the highest curvature region at the edge of the electrode where the strongest electric field occurs is also displaced proximally, so that the electric field around the distal tip of the catheter itself is not so large as to cause any increased local heating, while remaining large enough to cause irreversible electroporation. FIG. 18C schematically shows electric field lines 152 as they curve to enter the distal catheter end 151, resulting in a zone or region 153 distal to the catheter with a relatively uniform electric field. The electric field in this region would not be as uniform with a standard, externally placed electrode on the catheter, and further would generally have regions of very high intensity. The recessed interior placement of the distal electrode therefore results in superior and safe electroporation ablation delivery for focal ablation in a selective zone distal to the catheter tip. While in one embodiment the anode electrode can be a hollow ring, in other embodiments it could have a different form such as a cylinder with multiple longitudinal holes or channels.
  • In some embodiments, the interior lumen of the catheter can carry a fluid delivered out through the distal end of the catheter. The fluid can be an ionic fluid such as isotonic or hypertonic saline and can enhance electrical conductivity in the distal region of the catheter and beyond the distal end ensuring a proper and more uniform distribution of local electric field in a distal region around the catheter. As shown in FIG. 18D, the inner lumen 163 of the catheter carries a flowing fluid indicated by the arrows, while the anode 161 is in the shape of a cylinder that has longitudinal channels through which fluid can flow. The anode electrode is shown in cross section 162 where the multiple through-channels are visible. The saline or ionic fluid delivered through the channels can act as an ion bridge through which good electrical current conduction is possible in the vicinity of the catheter's distal end, resulting in a more uniform distribution of local electric field and electroporation energy delivery. Further, the flow of saline fluid itself can dislodge tissue debris or any bubbles generated by the electroporation-driven breakdown of tissue in the region around the distal catheter tip. In one embodiment, ultrasonic waves schematically shown as 164 in FIG. 18D can be applied to the fluid to further ensure that any bubbles that may be lodged on the catheter surface in its distal region are dislodged, again for purposes of maintaining relative uniformity of the local electric field. The ultrasonic waves or ultrasound through the fluid can be generated by suitable piezoelectric transducers mounted more proximally along the shaft of the catheter, or even within the catheter handle. In one embodiment, ultrasound generation is coordinated with electroporation DC voltage application so that the kinetic energy of focused ultrasound is available “on demand.”
  • The above statements of the advantages of the recessed inner electrode for the focal ablation catheter have been verified by the inventors in physically realistic simulations. FIG. 19A shows a simulation geometry of a catheter 601 in a blood pool region 602 and abutting a myocardium region 603 adjacent to a pericardial region 605, all regions being assumed cylindrical for the simulation; the section or plane 611 was chosen to plot electric field intensity contours. Further the myocardium region has a region of scar tissue 604 distal to the catheter. FIG. 19B shows the catheter's distal region with distal tip 612, distal (anode) recessed electrode 615 mounted internal to the shaft, and a proximal (cathode) electrode 616. With a DC voltage of 1000 Volts applied between the electrodes and using realistic physical property values, the resulting electric field intensity contours are illustrated in FIG. 19C, which shows the geometry and the contours in the section 611 of FIG. 19A. The cathode 616 and recessed anode 615 are indicated in FIG. 19C, as are the blood pool region 602, the myocardium region 603 and the pericardial region 605. The electric field intensity contours corresponding to 1000 Volts/cm, 500 Volts/cm and 200 Volts/cm respectively are shown as contours 617, 618 and 619 respectively.
  • FIG. 19D repeats the electric field simulation for a catheter with both electrodes mounted externally, showing the distal anode 622 and proximal cathode 623 in the same tissue geometry. As before, with a DC voltage of 1000 Volts applied between the electrodes and using the same realistic physical property values, the resulting electric field intensity contours corresponding to 1000 Volts/cm, 500 Volts/cm and 200 Volts/cm respectively are shown as contours 626, 627 and 628 respectively.
  • Comparing the intensity contours of FIG. 19C and FIG. 19D, it is clear that the former FIG. shows a relatively more uniform intensity distribution in the myocardium region where excessively large electric field values (500 Volts/cm or more) are present to a much lesser extent, mitigating the possibility of locally large electric current densities and corresponding temperature increases.
  • The focal ablation catheter described above in various embodiments could be used in cardiac applications such as ablation delivery to treat Ventricular Tachycardia (VT), where targeted ablation delivery could be of great benefit. In one embodiment, the length L2 of the distal anode electrode could be significantly longer than the length L1 of the proximal cathode electrode. The ratio L2/L1 could have a value of at least 1.3, more preferably lie in the range 1.3 to 10, and still more preferably in the range 2 to 5. The increased surface area of the exposed inner surface of the anode electrode can serve to reduce the current density near it, thereby enhancing safety and enhancing the efficacy of ion bridging current transfer with the saline fluid infusion. In addition or as an alternate method to reduce high current density due to exposed metal regions with high curvature, the edges of the electrode can be beveled or rounded to ensure that there are no sharp corners or regions with high curvature.
  • Thus, the methods described herein allow for a variety of approaches in the context of cardiac ablation. Considering for example the treatment of Ventricular Tachycardia (VT) as a clinical application, electroporation ablation of cardiac tissue could be performed across a pair of nearby electrodes respectively on one or more epicardially placed catheters in one embodiment. In an alternate embodiment, a single focal ablation endocardial catheter such as described above can be used to ablate on the endocardial side of a cardiac chamber. In still another alternate embodiment, a bipolar pair of electrodes on different catheters, one placed endocardially and the other epicardially could be used to drive irreversible electroporation.
  • A balloon ablation device for use with the electroporation system according to an embodiment is schematically illustrated in FIG. 20. While the device is shown to be situated in a blood vessel 301, it can also be used in other anatomical areas such as a cardiac ventricle. The device shaft 302 has an inflatable balloon 306 disposed in its distal portion. On either side of the balloon and mounted on the shaft are a proximal cathode electrode 303 and a distal anode electrode 304. The balloon surface 305 is coated with a thin layer of a good insulator such as a biocompatible metal oxide (for example, aluminum oxide). When air is pumped in through the catheter shaft lumen and through appropriate openings (not shown) from the shaft into the balloon, the balloon can inflate, as the inflated shape in FIG. 20 depicts. In ventricular applications such as cardiac ablation for VT, the balloon can serve to displace collateral structures away from the distal end of the catheter. Since the balloon surface is an insulator, when a DC voltage is applied between the electrodes, the current flow between electrodes and through the tissue is deflected around the balloon. The electric field is also correspondingly deflected around the surface of the balloon, and curves outward and can extend into the wall of the blood vessel, as shown by the schematic electric field lines 308 in the FIG. In one embodiment, the distal electrode 304 can be mounted on the outside of the shaft with external surface exposed, for intravascular ablation applications such as for example peripheral vascular applications for treatment of atherosclerosis where it is desired to ablate the vessel wall region or clear deposits. In an alternate embodiment, the distal electrode 304 can be mounted on the inner side of the catheter shaft, so that the metal electrode is internally exposed. Furthermore, the distal electrode could be recessed from the distal tip, as schematically shown in FIG. 20. Such a device could be used in focal ablation applications.
  • An alternate preferred embodiment of a balloon ablation device for use with the electroporation system according to an embodiment is shown schematically in FIG. 21A. As before, while the device is shown to be situated in a blood vessel 172, it can also be used in other anatomical areas such as a cardiac ventricle. The device shaft 171 has an inflatable balloon 177 disposed in its distal portion. On either side of the balloon and mounted on the shaft are a proximal cathode electrode 173 and a distal anode electrode 174. The balloon surface 176 is coated with a thin layer of a good insulator such as a biocompatible metal oxide (for example, aluminum oxide). When fluid is pumped in through the catheter shaft lumen, the balloon can inflate, as the inflated shape in FIG. 21A depicts. The region of the shaft within the balloon can have at least one ultrasonic transducer 175 mounted thereon. Further, while the interior of the balloon is inflated with fluid, the wall 178 of the balloon has a varying cross section and is filled with a gas such as air. Thus there is a liquid-gas interface at the wall of the balloon. This interface can act as a mirror or reflecting surface for ultrasound. As illustrated in the FIG., ultrasound rays 179 emitted by the transducer 175 are reflected at the wall of the balloon and are subsequently focused on a ring-like region, shown with its annular regions 181 in a plane 180 and viewed edge-on in the illustration. The annular region external to the balloon where the ultrasound is focused is shown in FIG. 21B as the dark annulus 203 surrounding the vessel wall 201, shown in cross section. When high-intensity ultrasound generated by the transducer in the catheter is focused in this manner, its energy is deposited in the annulus as heat and raises temperature locally. The irreversible electroporation threshold of tissue is temperature dependent and is lowered with increasing temperature. Thus in the annular region where temperature is increased due to the focused ultrasound, the electroporation threshold is decreased, and a relatively weaker electric field in this region can still generate irreversible electroporation, permitting selective tissue ablation.
  • As before, in ventricular applications such as cardiac ablation for VT, the balloon can serve to displace collateral structures away from the distal end of the catheter. Since the balloon surface is an insulator, when a DC voltage is applied between the electrodes, the current flow between electrodes and through the tissue is deflected around the balloon. The electric field is also correspondingly deflected around the surface of the balloon, and curves outward and can extend into the wall of the blood vessel, as shown by the schematic electric field lines 191 in the FIG. With the lowered irreversible electroporation threshold in the annular region of focused ultrasound in the vessel wall, the electric field in the annular region is sufficient to selectively drive irreversible electroporation. In one embodiment, the distal electrode 174 can be mounted on the outside of the shaft with external surface exposed, for intravascular ablation applications such as for example peripheral vascular applications for treatment of atherosclerosis where it is desired to ablate the vessel wall region or clear deposits. In an alternate embodiment, the distal electrode 174 can be mounted on the inner side of the catheter shaft, so that the metal electrode is internally exposed. Furthermore, the distal electrode could be recessed from the distal tip, as schematically shown in FIG. 21A. Such a device could be used in focal ablation applications.
  • While the specific embodiment of the balloon ablation device described above utilizes high-intensity focused ultrasound to selectively generate temperature increases in a given region in order to decrease the electroporation threshold, it must be noted that alternate energy delivery mechanisms such as microwaves could be utilized for the purpose of increasing tissue temperature by energy deposition in order to decrease the irreversible electroporation threshold electric field. The balloon ablation devices described in the foregoing could also be used in pulmonary outflow tract applications to treat pulmonary hypertension, or in eosophageal or gastrointestinal applications where tissue ablation is an appropriate therapy.
  • An ablation device for irreversible electroporation in the form of an expanding basket catheter is schematically illustrated in FIG. 22. Mounted on the shaft 501 of the device is a sliding member 505 which is attached to a system of struts 507. While the system of struts is initially substantially aligned with the length of the shaft in a folded configuration (not shown), it can unfold or open out like an umbrella by movement of the sliding member 505 along the shaft, resulting in the basket-like unfolded structure shown in FIG. 23. For purposes of clarity, the system of struts is only partially shown in the FIG. The basket construction or set of expanding struts can comprise a superelastic alloy such as for instance an alloy of Nickel and Titanium often called Nitinol®; such a construction can be of use in a large vessel where a significant amount of expansion could be called for. On either side of the basket-like structure and disposed along the shaft are two electrodes 502 and 503. Bead-like electrodes 508 are present at corners of the strut assembly. The device be guided to a desired location inside a large vascular or other anatomical vessel (for example, the pulmonary outflow tract), positioned suitably and then unfolded. Subsequently, irreversible electroporation ablation can be applied with the electrodes on the basket device.
  • In one embodiment the basket catheter with struts folded can have a lumen for passage of a suitable guidewire which could be used as a delivery system for appropriate placement of the basket catheter. Various choices of electrode configurations for ablation are possible for this device. In one preferred embodiment, either of electrodes 502 or 503 is selected as cathode, while the beads 508 are selected as anodes. With such a choice, a region of vessel wall that is located just proximal to or just distal to the beads can be selectively ablated, depending on whether electrode 502 or electrode 503 respectively is activated as cathode. The rounded shape of the beads and their location on the outer edge of the basket (and thus close to the vessel wall) results in good ablation characteristics at the vessel wall. The voltage applied can be suitably selected so that an appropriate electric field is generated in the ablative region near the bead electrodes. In alternate preferred embodiments, the basket catheter can further incorporate energy sources such as focused ultrasound or microwaves in order to selectively raise temperatures in localized regions and thereby lower the irreversible electroporation threshold.
  • In some embodiments, a method includes identifying, via a selection module of an electrode controller, a set of anode/cathode pairs from a set of electrodes of a multi-electrode catheter. The method can be performed using any suitable controller, such as for example, the controller 900 described above. The multi-electrode catheter is configured to be disposed about a portion of a heart. At least one of the anode/cathode pair including at least one anode electrode and at least one cathode electrode. In other embodiments, however, the anode/cathode pair can include multiple anode electrodes or cathode electrodes. In some embodiments, the identifying can be based on input received from an input/output module of the electrode controller (e.g., manual input). In other embodiments, the identifying can be based on a predetermined schedule of electrodes. In yet other embodiments, the identifying can be performed automatically based on an impedance map as described herein.
  • The method further includes conveying a pacing signal to a pacing lead configured to be operatively coupled to the heart, and receiving, at a feedback module of the electrode controller, an electrocardiograph signal associated with a function of the heart.
  • The method further includes delivering, via a pulse delivery module of the electrode controller, a pulsed voltage waveform to the plurality of anode/cathode pairs according to a sequential pattern.
  • Some embodiments described herein relate to a computer storage product with a non-transitory computer-readable medium (also can be referred to as a non-transitory processor-readable medium) having instructions or computer code thereon for performing various computer-implemented operations. The computer-readable medium (or processor-readable medium) is non-transitory in the sense that it does not include transitory propagating signals per se (e.g., a propagating electromagnetic wave carrying information on a transmission medium such as space or a cable). The media and computer code (also can be referred to as code) may be those designed and constructed for the specific purpose or purposes. Examples of non-transitory computer-readable media include, but are not limited to: magnetic storage media such as hard disks, floppy disks, and magnetic tape; optical storage media such as Compact Disc/Digital Video Discs (CD/DVDs), Compact Disc-Read Only Memories (CD-ROMs), and holographic devices; magneto-optical storage media such as optical disks; carrier wave signal processing modules; and hardware devices that are specially configured to store and execute program code, such as Application-Specific Integrated Circuits (ASICs), Programmable Logic Devices (PLDs), Read-Only Memory (ROM) and Random-Access Memory (RAM) devices.
  • Examples of computer code include, but are not limited to, micro-code or micro-instructions, machine instructions, such as produced by a compiler, code used to produce a web service, and files containing higher-level instructions that are executed by a computer using an interpreter. For example, embodiments may be implemented using imperative programming languages (e.g., C, Fortran, etc.), functional programming languages (Haskell, Erlang, etc.), logical programming languages (e.g., Prolog), object-oriented programming languages (e.g., Java, C++, etc.) or other suitable programming languages and/or development tools. Additional examples of computer code include, but are not limited to, control signals, encrypted code, and compressed code.
  • While various specific examples and embodiments of systems and tools for selective tissue ablation with irreversible electroporation were described in the foregoing for illustrative and exemplary purposes, it should be clear that a wide variety of variations and alternate embodiments could be conceived or constructed by those skilled in the art based on the teachings herein. While specific methods of control and DC voltage application from a generator capable of selective excitation of sets of electrodes were disclosed, persons skilled in the art would recognize that any of a wide variety of other control or user input methods and methods of electrode subset selection etc. can be implemented without departing from the scope of the present invention. Likewise, while the foregoing described a range of specific tools or devices for more effective and selective DC voltage application for irreversible electroporation through ionic fluid irrigation and ultrasonic agitation, including insulating balloon constructions, focal ablation tools, and a basket catheter with a multiplicity of, other device constructions or variations could be implemented by one skilled in the art by employing the principles and teachings disclosed herein without departing from the scope of the present invention, in the treatment of cardiac arrhythmias, in intravascular applications, or a variety of other medical applications.
  • Furthermore, while the present disclosure describes specific embodiments and tools involving irrigation with saline fluids and the use of temperature to selectively ablate tissue by taking advantage of the temperature-dependence of the threshold of irreversible electroporation, it should be clear to one skilled in the art that a variety of methods and devices for steady fluid delivery, or for tissue heating through the delivery of focused kinetic energy or electromagnetic radiation could be implemented utilizing the methods and principles taught herein without departing from the scope of the present invention.
  • Where schematics and/or embodiments described above indicate certain components arranged in certain orientations or positions, the arrangement of components may be modified. For example, although the controller 900 is shown as optionally including the pacing module 902, in other embodiments, the controller 900 can interface with a separate pacing module. Similarly, where methods and/or events described above indicate certain events and/or procedures occurring in certain order, the ordering of certain events and/or procedures may be modified.
  • Although various embodiments have been described as having particular features and/or combinations of components, other embodiments are possible having a combination of any features and/or components from any of embodiments as discussed above.

Claims (41)

1. An apparatus, comprising:
a voltage pulse generator configured to produce a pulsed voltage waveform; and
an electrode controller configured to be operably coupled to the voltage pulse generator and a medical device including a plurality of electrodes, the electrode controller implemented in at least one of a memory or a processor, the electrode controller including a selection module and a pulse delivery module, the selection module configured to select a subset of electrodes from the plurality of electrodes, the selection module configured identify at least a first electrode from the subset of electrodes as an anode and at least a second electrode from the subset of electrodes as a cathode, the pulse delivery module configured to deliver an output signal associated with the pulsed voltage waveform to the subset of electrodes.
2. The apparatus of claim 1, wherein the electrode controller includes an input/output module, the selection module configured to select the subset of electrodes based on input received from the input/output module.
3. The apparatus of claim 1, wherein the selection module is configured to select the subset of electrodes based on a predetermined schedule of the plurality of electrodes.
4. The apparatus of claim 1, wherein the selection module is configured to select the subset of electrodes automatically based on at least one of an impedance associated with the subset of electrodes, a distance between the first electrode and the second electrode, and a characteristic associated with a target tissue.
5. The apparatus of claim 1, wherein the electrode controller includes a feedback module configured to determine an impedance between the first electrode and the second electrode, the selection module configured to select the subset of electrodes automatically based the impedance.
6. The apparatus of claim 1, wherein the electrode controller includes a feedback module configured to determine an impedance map associated with the plurality of electrodes, the selection module configured to select the subset of electrodes automatically based the impedance map.
7. The apparatus of claim 1, wherein the electrode controller includes an input/output module configured to produce a signal associated with a graphical map of the plurality of electrodes and the subset of electrodes.
8. The apparatus of claim 1, wherein the subset of electrodes includes a plurality of anode/cathode pairs, a first anode/cathode pair including the first electrode and the second electrode, the pulse delivery module configured to deliver the output signal to the plurality of anode/cathode pairs in a sequential pattern.
9. The apparatus of claim 8, wherein the selection module is configured to determine the sequential pattern based on at least one of an impedance associated with the plurality of anode/cathode pairs, a distance between the plurality of anode/cathode pairs, and a characteristic associated with a target tissue.
10. The apparatus of claim 1, wherein:
the medical device is a first medical device;
the plurality of electrodes is a first plurality of electrodes;
the electrode controller is configured to be operably coupled to a second medical device different from the first medical device, the second medical device including a second plurality of electrodes, the selection module is configured to select the subset of electrodes such that a first portion of the subset of electrodes is from the first plurality of electrodes and a second portion of the subset of electrodes is from the second plurality of electrodes.
11. The apparatus of claim 1, wherein the pulse delivery module configured to deliver the output signal having a predetermined voltage pulse amplitude.
12. The apparatus of claim 1, wherein:
the electrode controller configured to be operably coupled to a pacing lead; and
the electrode controller includes a pacing module and a feedback module, the pacing module configured to produce a pacing signal to the pacing lead to electrically pace a heart, the feedback module configured to receive an electrocardiograph signal associated with a function of the heart, the pulse delivery module configured to deliver the output signal to the subset of electrodes during a time window associated with at least one the pacing signal or the electrocardiograph signal.
13. The apparatus of claim 12, wherein the feedback module is configured to determine an impedance between the first electrode and the second electrode, the selection module configured to select the subset of electrodes automatically based the impedance.
14. The apparatus of claim 1, wherein the voltage pulse generator is configured to produce a biphasic waveform including a pre-polarizing pulse followed by a polarizing pulse, the pre-polarizing pulse being generated by utilizing voltage spikes generated from switching on the discharge of a capacitor bank.
15. An apparatus, comprising:
a voltage pulse generator configured to produce a pulsed voltage waveform; and
an electrode controller configured to be operably coupled to the voltage pulse generator and a medical device including a plurality of electrodes, the electrode controller implemented in at least one of a memory or a processor, the electrode controller including a selection module and a pulse delivery module, the selection module configured to select a plurality of anode/cathode pairs, each anode/cathode pair of the plurality of anode/cathode pairs including at least one anode electrode and at least one cathode electrode, the pulse delivery module configured to deliver an output signal associated with the pulsed voltage waveform to the plurality of anode/cathode pairs according to a sequential pattern.
16. The apparatus of claim 15, wherein the selection module is configured to select the at least one anode electrode from a first anode/cathode pair as the anode electrode and the at least one cathode electrode from the first anode/cathode pair as the cathode electrode.
17. The apparatus of claim 15, wherein the selection module is configured to select the plurality of anode/cathode pairs automatically based on at least one of an impedance associated with the plurality of anode/cathode pairs, a distance between a first electrode and a second electrode, and a characteristic associated with a target tissue.
18. The apparatus of claim 15, wherein the electrode controller includes a feedback module configured to determine an impedance between a first electrode from the plurality of electrodes and a second electrode from the plurality of electrodes, the selection module configured to select the plurality of anode/cathode pairs automatically based the impedance.
19. The apparatus of claim 15, wherein the medical device is a multi-electrode catheter configured to be inserted into the coronary sinus.
20. The apparatus of claim 15, wherein the selection module is configured to determine the sequential pattern based on at least one of an impedance associated with the plurality of anode/cathode pairs, a distance between the plurality of anode/cathode pairs, and a characteristic associated with a target tissue.
21. A method, comprising:
identifying, via a selection module of an electrode controller, a plurality of anode/cathode pairs from a plurality of electrodes of a multi-electrode catheter, the multi-electrode catheter configured to be disposed about a portion of a heart, at least one anode/cathode pair including at least one anode electrode and at least one cathode electrode;
conveying a pacing signal to a pacing lead configured to be operatively coupled to the heart;
receiving, at a feedback module of the electrode controller, an electrocardiograph signal associated with a function of the heart; and
delivering, via a pulse delivery module of the electrode controller, a pulsed voltage waveform to the plurality of anode/cathode pairs according to a sequential pattern.
22. The method of claim 21, wherein the identifying is based on an input received from an input/output module of the electrode controller.
23. The method of claim 21, wherein the identifying is based on a predetermined schedule of the plurality of electrodes.
24. The method of claim 21, further comprising:
determining an impedance between the at least one anode electrode and at least one cathode electrode,
the identifying being performed automatically by the selection module based at least in part on the impedance.
25. The method of claim 21, further comprising:
determining the sequential pattern based on at least one of an impedance associated with the plurality of anode/cathode pairs, a distance between the plurality of anode/cathode pairs, and a characteristic associated with the heart.
26. The method of claim 21, wherein:
the multi-electrode catheter is a first catheter;
the plurality of electrodes is a first plurality of electrodes; and
the identifying includes identifying at least one anode/cathode pair including at least one anode electrode from the first catheter and at least one cathode electrode from the second catheter, the second catheter distinct from the first catheter.
27. A non-transitory processor readable medium storing code representing instructions to be executed by a processor, the code comprising code to cause the processor to:
identify a plurality of anode/cathode pairs from a plurality of electrodes of a multi-electrode catheter, the multi-electrode catheter configured to be disposed about a portion of a heart, at least one anode/cathode pair including at least one anode electrode and at least one cathode electrode;
convey a pacing signal to a pacing lead configured to be operatively coupled to the heart;
receive an electrocardiograph signal associated with a function of the heart; and
deliver a pulsed voltage waveform to the plurality of anode/cathode pairs according to a sequential pattern.
28. An apparatus, comprising:
a signal generator for the generation of DC voltage pulses, the signal generator configured to produce a biphasic waveform having a pre-polarizing pulse followed by a polarizing pulse, the pre-polarizing pulse being generated by utilizing voltage spikes generated from switching on a discharge of a capacitor bank.
29. The apparatus of claim 28, wherein the signal generator is configured to customize the pre-polarizing pulse by tuning component parameters in transient control circuitry.
30. An apparatus, comprising:
a catheter shaft having an outer side and an inner side;
a cathode electrode coupled to a distal end portion of the catheter shaft such that a cathode surface is exposed on the outer side of the catheter shaft; and
an anode electrode coupled to the distal end portion distal relative to the cathode electrode, the anode electrode being recessed within the catheter shaft and coupled to the catheter shaft such that an anode surface is exposed on the inner side of the catheter shaft.
31. The apparatus of claim 30, wherein a ratio of an anode electrode length to a cathode electrode length is larger than three.
32. The apparatus of claim 30, wherein the anode electrode is in the form of an annular cylinder.
33. The apparatus of claim 30, wherein the anode electrode is in the form of cylinder with a distribution of channels configured to receive a fluid flow.
34. The apparatus of claim 30, wherein the catheter shaft defines an inner lumen through which ionic fluid is pumped for delivery to the distal end portion of the catheter.
35. The apparatus of claim 30, further comprising;
at least one ultrasonic transducer configured to generate ultrasound waves through a fluid disposed within the catheter shaft.
36. An apparatus, comprising:
a catheter shaft having a distal end portion;
an inflatable balloon coupled to the distal end portion, an outer surface of the balloon being an electrical insulator;
a first electrode coupled to a proximal side of the balloon; and
a second electrode coupled to a distal side of the balloon.
37. The apparatus of claim 36, wherein the first electrode is a cathode and the second electrode is an anode.
38. The apparatus of claim 36, wherein the balloon is configured to displace collateral anatomical structures when in an expanded configuration.
39. The apparatus of claim 36, further comprising:
an ultrasound transducer disposed on a portion of the shaft inside the balloon, the balloon being inflatable with a liquid, with at least a portion of the wall of the balloon being filled with a gas, where the balloon is configured to reflect at least a portion of the ultrasound energy from the ultrasound transducer to a kinetic energy focusing zone in a target tissue to cause an increase in temperature.
40. An apparatus, comprising:
a catheter shaft having a distal end portion;
an expandable basket structure coupled to the distal end portion;
a first electrode coupled to a proximal side of the expandable basket structure;
a second electrode coupled to a distal side of the expandable basket structure; and
a plurality of spherical electrodes coupled to a corresponding plurality of rounded corners of the expandable basket structure.
41. The apparatus of claim 40, wherein the catheter shaft defines an inner lumen configured to receive a guide wire such that the catheter shaft can be delivered by the guide wire to a desired target location in a subject anatomy.
US15/341,512 2014-05-07 2016-11-02 Methods and apparatus for selective tissue ablation Abandoned US20170065339A1 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
US15/341,512 US20170065339A1 (en) 2014-05-07 2016-11-02 Methods and apparatus for selective tissue ablation
US15/795,062 US11259869B2 (en) 2014-05-07 2017-10-26 Methods and apparatus for selective tissue ablation
US17/349,299 US20220000548A1 (en) 2014-05-07 2021-06-16 Methods and apparatus for selective tissue ablation
US18/664,140 US20240299088A1 (en) 2014-05-07 2024-05-14 Methods and apparatus for selective tissue ablation
US18/664,163 US20240299089A1 (en) 2014-05-07 2024-05-14 Methods and apparatus for selective tissue ablation
US18/674,607 US20240307116A1 (en) 2014-05-07 2024-05-24 Methods and apparatus for selective tissue ablation
US18/674,613 US20240307117A1 (en) 2014-05-07 2024-05-24 Methods and apparatus for selective tissue ablation
US18/674,533 US20240315770A1 (en) 2014-05-07 2024-05-24 Methods and apparatus for selective tissue ablation
US18/674,492 US20240315769A1 (en) 2014-05-07 2024-05-24 Methods and apparatus for selective tissue ablation
US18/674,511 US20240307114A1 (en) 2014-05-07 2024-05-24 Methods and apparatus for selective tissue ablation
US18/674,565 US20240307115A1 (en) 2014-05-07 2024-05-24 Methods and apparatus for selective tissue ablation

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461996390P 2014-05-07 2014-05-07
PCT/US2015/029734 WO2015171921A2 (en) 2014-05-07 2015-05-07 Methods and apparatus for selective tissue ablation
US15/341,512 US20170065339A1 (en) 2014-05-07 2016-11-02 Methods and apparatus for selective tissue ablation

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2015/029734 Continuation WO2015171921A2 (en) 2014-05-07 2015-05-07 Methods and apparatus for selective tissue ablation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US15/795,062 Continuation US11259869B2 (en) 2014-05-07 2017-10-26 Methods and apparatus for selective tissue ablation

Publications (1)

Publication Number Publication Date
US20170065339A1 true US20170065339A1 (en) 2017-03-09

Family

ID=53277039

Family Applications (11)

Application Number Title Priority Date Filing Date
US15/341,512 Abandoned US20170065339A1 (en) 2014-05-07 2016-11-02 Methods and apparatus for selective tissue ablation
US15/795,062 Active 2035-10-05 US11259869B2 (en) 2014-05-07 2017-10-26 Methods and apparatus for selective tissue ablation
US17/349,299 Pending US20220000548A1 (en) 2014-05-07 2021-06-16 Methods and apparatus for selective tissue ablation
US18/664,140 Pending US20240299088A1 (en) 2014-05-07 2024-05-14 Methods and apparatus for selective tissue ablation
US18/664,163 Pending US20240299089A1 (en) 2014-05-07 2024-05-14 Methods and apparatus for selective tissue ablation
US18/674,492 Pending US20240315769A1 (en) 2014-05-07 2024-05-24 Methods and apparatus for selective tissue ablation
US18/674,511 Pending US20240307114A1 (en) 2014-05-07 2024-05-24 Methods and apparatus for selective tissue ablation
US18/674,565 Pending US20240307115A1 (en) 2014-05-07 2024-05-24 Methods and apparatus for selective tissue ablation
US18/674,533 Pending US20240315770A1 (en) 2014-05-07 2024-05-24 Methods and apparatus for selective tissue ablation
US18/674,607 Pending US20240307116A1 (en) 2014-05-07 2024-05-24 Methods and apparatus for selective tissue ablation
US18/674,613 Pending US20240307117A1 (en) 2014-05-07 2024-05-24 Methods and apparatus for selective tissue ablation

Family Applications After (10)

Application Number Title Priority Date Filing Date
US15/795,062 Active 2035-10-05 US11259869B2 (en) 2014-05-07 2017-10-26 Methods and apparatus for selective tissue ablation
US17/349,299 Pending US20220000548A1 (en) 2014-05-07 2021-06-16 Methods and apparatus for selective tissue ablation
US18/664,140 Pending US20240299088A1 (en) 2014-05-07 2024-05-14 Methods and apparatus for selective tissue ablation
US18/664,163 Pending US20240299089A1 (en) 2014-05-07 2024-05-14 Methods and apparatus for selective tissue ablation
US18/674,492 Pending US20240315769A1 (en) 2014-05-07 2024-05-24 Methods and apparatus for selective tissue ablation
US18/674,511 Pending US20240307114A1 (en) 2014-05-07 2024-05-24 Methods and apparatus for selective tissue ablation
US18/674,565 Pending US20240307115A1 (en) 2014-05-07 2024-05-24 Methods and apparatus for selective tissue ablation
US18/674,533 Pending US20240315770A1 (en) 2014-05-07 2024-05-24 Methods and apparatus for selective tissue ablation
US18/674,607 Pending US20240307116A1 (en) 2014-05-07 2024-05-24 Methods and apparatus for selective tissue ablation
US18/674,613 Pending US20240307117A1 (en) 2014-05-07 2024-05-24 Methods and apparatus for selective tissue ablation

Country Status (3)

Country Link
US (11) US20170065339A1 (en)
EP (3) EP3495018B1 (en)
WO (1) WO2015171921A2 (en)

Cited By (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9861802B2 (en) 2012-08-09 2018-01-09 University Of Iowa Research Foundation Catheters, catheter systems, and methods for puncturing through a tissue structure
US9987081B1 (en) 2017-04-27 2018-06-05 Iowa Approach, Inc. Systems, devices, and methods for signal generation
US9999465B2 (en) 2014-10-14 2018-06-19 Iowa Approach, Inc. Method and apparatus for rapid and safe pulmonary vein cardiac ablation
US10130423B1 (en) 2017-07-06 2018-11-20 Farapulse, Inc. Systems, devices, and methods for focal ablation
US10172673B2 (en) 2016-01-05 2019-01-08 Farapulse, Inc. Systems devices, and methods for delivery of pulsed electric field ablative energy to endocardial tissue
US20190083169A1 (en) * 2008-05-09 2019-03-21 Angiodynamics, Inc. Techniques for Controlling an Irreversible Electroporation System
US20190117970A1 (en) * 2017-10-23 2019-04-25 Cardiac Pacemakers, Inc. Electric field shaping leads for treatment of cancer
US10322286B2 (en) 2016-01-05 2019-06-18 Farapulse, Inc. Systems, apparatuses and methods for delivery of ablative energy to tissue
WO2019118436A1 (en) 2017-12-11 2019-06-20 Mayo Foundation For Medical Education And Research Methods and systems for electroporation
US10368936B2 (en) 2014-11-17 2019-08-06 Kardium Inc. Systems and methods for selecting, activating, or selecting and activating transducers
US10433906B2 (en) 2014-06-12 2019-10-08 Farapulse, Inc. Method and apparatus for rapid and selective transurethral tissue ablation
US10470826B2 (en) 2012-05-21 2019-11-12 Kardium Inc. Systems and methods for selecting, activating, or selecting and activating transducers
US10485608B2 (en) 2011-01-21 2019-11-26 Kardium Inc. Catheter system
US10499986B2 (en) 2007-11-16 2019-12-10 Kardium Inc. Medical device for use in bodily lumens, for example an atrium
EP3578124A1 (en) * 2018-06-05 2019-12-11 National University of Ireland Galway Electrophysiology apparatus
CN110573102A (en) * 2017-04-24 2019-12-13 美敦力 enhanced electroporation of cardiac tissue
US10507302B2 (en) 2016-06-16 2019-12-17 Farapulse, Inc. Systems, apparatuses, and methods for guide wire delivery
US10512505B2 (en) 2018-05-07 2019-12-24 Farapulse, Inc. Systems, apparatuses and methods for delivery of ablative energy to tissue
US10517672B2 (en) 2014-01-06 2019-12-31 Farapulse, Inc. Apparatus and methods for renal denervation ablation
US10568576B2 (en) 2012-05-21 2020-02-25 Kardium Inc. Systems and methods for activating transducers
US10617867B2 (en) 2017-04-28 2020-04-14 Farapulse, Inc. Systems, devices, and methods for delivery of pulsed electric field ablative energy to esophageal tissue
US10624693B2 (en) 2014-06-12 2020-04-21 Farapulse, Inc. Method and apparatus for rapid and selective tissue ablation with cooling
US10625080B1 (en) 2019-09-17 2020-04-21 Farapulse, Inc. Systems, apparatuses, and methods for detecting ectopic electrocardiogram signals during pulsed electric field ablation
US10660702B2 (en) 2016-01-05 2020-05-26 Farapulse, Inc. Systems, devices, and methods for focal ablation
US10687892B2 (en) 2018-09-20 2020-06-23 Farapulse, Inc. Systems, apparatuses, and methods for delivery of pulsed electric field ablative energy to endocardial tissue
US10702337B2 (en) 2016-06-27 2020-07-07 Galary, Inc. Methods, apparatuses, and systems for the treatment of pulmonary disorders
US10722184B2 (en) 2014-11-17 2020-07-28 Kardium Inc. Systems and methods for selecting, activating, or selecting and activating transducers
US10820941B2 (en) 2006-06-28 2020-11-03 Kardium Inc. Apparatus and method for intra-cardiac mapping and ablation
JP2020179169A (en) * 2019-04-24 2020-11-05 株式会社Mitテクノロジー Drug, etc. administration device, actuation method thereof, and supporter
US10827977B2 (en) 2012-05-21 2020-11-10 Kardium Inc. Systems and methods for activating transducers
US10842572B1 (en) 2019-11-25 2020-11-24 Farapulse, Inc. Methods, systems, and apparatuses for tracking ablation devices and generating lesion lines
US10893905B2 (en) 2017-09-12 2021-01-19 Farapulse, Inc. Systems, apparatuses, and methods for ventricular focal ablation
CN112716599A (en) * 2020-02-28 2021-04-30 圣犹达医疗用品心脏病学部门有限公司 Electrode assembly including expandable spacer member
US20210137587A1 (en) * 2017-04-10 2021-05-13 St. Jude Medical, Cardiology Division, Inc. Electroporation system and method of energizing a catheter
US11020180B2 (en) 2018-05-07 2021-06-01 Farapulse, Inc. Epicardial ablation catheter
US11033236B2 (en) 2018-05-07 2021-06-15 Farapulse, Inc. Systems, apparatuses, and methods for filtering high voltage noise induced by pulsed electric field ablation
CN112969425A (en) * 2018-11-07 2021-06-15 美敦力公司 Methods of identifying and eliminating arcs and arc-induced plasmas during tissue energy delivery
US11065047B2 (en) 2019-11-20 2021-07-20 Farapulse, Inc. Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses
US20210267672A1 (en) * 2020-02-28 2021-09-02 St. Jude Medical, Cardiology Division, Inc. Electrode assembly including expandable isolation member
US11207123B2 (en) 2018-11-16 2021-12-28 Applied Medical Resources Corporation Electrosurgical system
US20220022952A1 (en) * 2020-07-24 2022-01-27 Boston Scientific Scimed Inc Electric Field Application for Single Shot Cardiac Ablation by Irreversible Electroporation
US20220022953A1 (en) * 2020-07-24 2022-01-27 Boston Scientific Scimed, Inc. Esophagus catheter for irreversible electroporation
US11259867B2 (en) 2011-01-21 2022-03-01 Kardium Inc. High-density electrode-based medical device system
US11259869B2 (en) 2014-05-07 2022-03-01 Farapulse, Inc. Methods and apparatus for selective tissue ablation
US20220087736A1 (en) * 2020-09-23 2022-03-24 Biosense Webster (Israel) Ltd. Electrode shorting
US11298173B2 (en) 2011-01-21 2022-04-12 Kardium Inc. Enhanced medical device for use in bodily cavities, for example an atrium
EP4014870A1 (en) 2020-12-17 2022-06-22 Biosense Webster (Israel) Ltd Gui for highlighting signals prior, during, and post ablation using multi-electrode catheters
US11376064B2 (en) * 2016-06-07 2022-07-05 Dot Medical Ltd. Apparatus and method for cardiac ablation
US11389232B2 (en) 2006-06-28 2022-07-19 Kardium Inc. Apparatus and method for intra-cardiac mapping and ablation
CN114983557A (en) * 2022-04-29 2022-09-02 天津市鹰泰利安康医疗科技有限责任公司 Device and method for catheter-mediated irreversible electroporation ablation of tissue
US11497541B2 (en) 2019-11-20 2022-11-15 Boston Scientific Scimed, Inc. Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses
US11690669B2 (en) 2017-05-12 2023-07-04 St. Jude Medical, Cardiology Division, Inc. Electroporation systems and catheters for electroporation systems
US11691006B2 (en) 2019-04-22 2023-07-04 Boston Scientific Scimed, Inc. Electrical stimulation devices for cancer treatment
US11707629B2 (en) 2009-05-28 2023-07-25 Angiodynamics, Inc. System and method for synchronizing energy delivery to the cardiac rhythm
US11723710B2 (en) 2016-11-17 2023-08-15 Angiodynamics, Inc. Techniques for irreversible electroporation using a single-pole tine-style internal device communicating with an external surface electrode
US11779395B2 (en) 2011-09-28 2023-10-10 Angiodynamics, Inc. Multiple treatment zone ablation probe
US11813019B2 (en) 2018-08-22 2023-11-14 Healium Medical Ltd Catheter ultrasound transducer container
WO2023250356A1 (en) * 2022-06-23 2023-12-28 Medtronic, Inc. Application of non-therapeutic waveforms with gradient sensing to predict pulsed field ablation (pfa) fields
US11883655B2 (en) 2020-02-24 2024-01-30 Boston Scientific Scimed, Inc. Systems and methods for treatment of pancreatic cancer
US11896295B2 (en) 2011-01-21 2024-02-13 Kardium Inc. High-density electrode-based medical device system
US11931096B2 (en) 2010-10-13 2024-03-19 Angiodynamics, Inc. System and method for electrically ablating tissue of a patient
US11957405B2 (en) 2013-06-13 2024-04-16 Angiodynamics, Inc. Methods of sterilization and treating infection using irreversible electroporation
WO2024081897A1 (en) * 2022-10-14 2024-04-18 Pulse Biosciences, Inc. Multi-strut ablation and sensing catheter devices and methods
US11969197B2 (en) 2017-10-13 2024-04-30 Mayo Foundation For Medical Education And Research Methods and devices for electroporation for treatment of ventricular fibrillation
US12042208B2 (en) 2018-05-03 2024-07-23 Boston Scientific Scimed, Inc. Systems, devices, and methods for ablation using surgical clamps
US12102376B2 (en) 2012-02-08 2024-10-01 Angiodynamics, Inc. System and method for increasing a target zone for electrical ablation
US12109412B2 (en) 2019-04-22 2024-10-08 Boston Scientific Scimed, Inc. Combination electrical and chemotherapeutic treatment of cancer
US12114911B2 (en) 2014-08-28 2024-10-15 Angiodynamics, Inc. System and method for ablating a tissue site by electroporation with real-time pulse monitoring
US12137968B2 (en) 2021-03-19 2024-11-12 Boston Scientific Scimed, Inc. Methods and apparatus for multi-catheter tissue ablation

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3142584A1 (en) * 2014-05-16 2017-03-22 Iowa Approach Inc. Methods and apparatus for multi-catheter tissue ablation
US10271893B2 (en) * 2014-12-15 2019-04-30 Medtronic Ablation Frontiers Llc Timed energy delivery
DE202016009215U1 (en) * 2015-08-06 2024-04-29 Medtronic, Inc. Cardiac ablation using pulsed field
CN108778173A (en) 2016-01-05 2018-11-09 法拉普尔赛股份有限公司 Systems, devices and methods for impulse electric field ablation energy to be delivered to endocardial tissue
CN113813045A (en) * 2016-01-05 2021-12-21 法拉普尔赛股份有限公司 Systems, devices, and methods for delivering ablation energy to tissue
CN106388932B (en) * 2016-07-12 2017-10-10 上海睿刀医疗科技有限公司 Irreversible electroporation device
US11052246B2 (en) * 2017-07-28 2021-07-06 Medtronic, Inc. Expandable elements for delivery of electric fields
JP6941030B2 (en) * 2017-11-08 2021-09-29 日本光電工業株式会社 Electrode catheter
US11457976B2 (en) 2018-01-10 2022-10-04 Medtronic, Inc. Directionally focused ablation device
CN113747851A (en) * 2019-03-22 2021-12-03 波士顿科学医学有限公司 Automated electrode recommendation for ablation systems
US11583332B2 (en) 2019-12-24 2023-02-21 Biosense Webster (Israel) Ltd. Combined cardiac pacing and irreversible electroporation (IRE) treatment
JP7428816B2 (en) * 2020-02-28 2024-02-06 セント・ジュード・メディカル,カーディオロジー・ディヴィジョン,インコーポレイテッド Electrode assembly including expandable isolation member
US20210307815A1 (en) * 2020-04-07 2021-10-07 Biosense Webster (Israel) Ltd. Basket Catheter with Solid Conducting Spines as Electrodes for IRE
EP4138695A1 (en) * 2020-04-21 2023-03-01 Boston Scientific Scimed, Inc. Adaptive ecg triggering in an ablation system
US20230181081A1 (en) * 2020-04-29 2023-06-15 St. Jude Medical, Cardiology Division, Inc. Amplifier interface for multi-electrode catheter
WO2021263007A1 (en) * 2020-06-24 2021-12-30 Medtronic, Inc. Split biphasic waveform for embolic reduction
US20220000543A1 (en) * 2020-07-06 2022-01-06 Biosense Webster (Israel) Ltd. Bipolar tissue ablation in accordance with a predefined periodic set of time slots
US12076071B2 (en) 2020-08-14 2024-09-03 Kardium Inc. Systems and methods for treating tissue with pulsed field ablation
US12048479B2 (en) 2020-09-10 2024-07-30 Biosense Webster (Israel) Ltd. Surface mounted electrode catheter
US11638819B2 (en) 2020-09-11 2023-05-02 Galvanize Therapeutics, Inc. Signal generators for use with tissue modification systems
US20220202481A1 (en) 2020-12-28 2022-06-30 Biosense Webster (Israel) Ltd. Controlling Inter-Electrode Currents During Ablation
US20240149035A1 (en) * 2021-03-01 2024-05-09 Fibralign Corporation Conductive Biocompatible Scaffold For Electroporation
MX2023011506A (en) 2021-04-07 2023-12-07 Btl Medical Dev A S Pulsed field ablation device and method.
EP4340762A1 (en) * 2021-05-20 2024-03-27 Boston Scientific Scimed Inc. Apparatus and methods for reducing microbubbles formation during cardiac ablation
MX2023015018A (en) 2021-07-06 2024-05-08 Btl Medical Dev A S Pulsed field ablation device and method.
US20230048486A1 (en) * 2021-08-16 2023-02-16 Biosense Webster (Israel) Ltd. Language for generating ablation protocols and system configurations
CN114094988B (en) * 2022-01-18 2022-09-09 杭州维纳安可医疗科技有限责任公司 Pulse generating circuit, equipment and method with pulse detection function
CN114366280B (en) * 2022-03-22 2022-11-08 上海睿刀医疗科技有限公司 Pulse processing device, pulse processing method, electronic apparatus, and storage medium
WO2024075034A1 (en) 2022-10-05 2024-04-11 Btl Medical Technologies S.R.O. Pulsed field ablation device and method

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020077627A1 (en) * 2000-07-25 2002-06-20 Johnson Theodore C. Method for detecting and treating tumors using localized impedance measurement
US20060024359A1 (en) * 1995-06-07 2006-02-02 Walker Jeffrey P Drug delivery system and method
US20060293730A1 (en) * 2005-06-24 2006-12-28 Boris Rubinsky Methods and systems for treating restenosis sites using electroporation
US20120095459A1 (en) * 2010-10-13 2012-04-19 Peter Callas System and Method for Electrically Ablating Tissue of a Patient
US20130030430A1 (en) * 2011-07-29 2013-01-31 Stewart Mark T Intracardiac tools and methods for delivery of electroporation therapies
WO2014025394A1 (en) * 2012-08-09 2014-02-13 University Of Iowa Research Foundation Catheters, catheter systems, and methods for puncturing through a tissue structure

Family Cites Families (573)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200104A (en) 1977-11-17 1980-04-29 Valleylab, Inc. Contact area measurement apparatus for use in electrosurgery
US4470407A (en) 1982-03-11 1984-09-11 Laserscope, Inc. Endoscopic device
US4739759A (en) 1985-02-26 1988-04-26 Concept, Inc. Microprocessor controlled electrosurgical generator
US5547467A (en) * 1988-01-21 1996-08-20 Massachusettes Institute Of Technology Method for rapid temporal control of molecular transport across tissue
US5344435A (en) 1988-07-28 1994-09-06 Bsd Medical Corporation Urethral inserted applicator prostate hyperthermia
FR2639238B1 (en) 1988-11-21 1991-02-22 Technomed Int Sa APPARATUS FOR SURGICAL TREATMENT OF TISSUES BY HYPERTHERMIA, PREFERABLY THE PROSTATE, COMPRISING MEANS OF THERMAL PROTECTION COMPRISING PREFERABLY RADIOREFLECTIVE SCREEN MEANS
US5257635A (en) 1988-11-25 1993-11-02 Sensor Electronics, Inc. Electrical heating catheter
US5749914A (en) 1989-01-06 1998-05-12 Advanced Coronary Intervention Catheter for obstructed stent
US5342301A (en) 1992-08-13 1994-08-30 Advanced Polymers Incorporated Multi-lumen balloons and catheters made therewith
EP0588864A4 (en) 1991-05-24 1996-01-10 Ep Technologies Combination monophasic action potential/ablation catheter and high-performance filter system
US6029671A (en) 1991-07-16 2000-02-29 Heartport, Inc. System and methods for performing endovascular procedures
US5697281A (en) 1991-10-09 1997-12-16 Arthrocare Corporation System and method for electrosurgical cutting and ablation
US5524338A (en) 1991-10-22 1996-06-11 Pi Medical Corporation Method of making implantable microelectrode
US5304214A (en) 1992-01-21 1994-04-19 Med Institute, Inc. Transurethral ablation catheter
US5306296A (en) 1992-08-21 1994-04-26 Medtronic, Inc. Annuloplasty and suture rings
US5242441A (en) 1992-02-24 1993-09-07 Boaz Avitall Deflectable catheter with rotatable tip electrode
US5281213A (en) 1992-04-16 1994-01-25 Implemed, Inc. Catheter for ice mapping and ablation
US5443463A (en) 1992-05-01 1995-08-22 Vesta Medical, Inc. Coagulating forceps
US5341807A (en) 1992-06-30 1994-08-30 American Cardiac Ablation Co., Inc. Ablation catheter positioning system
US5662108A (en) 1992-09-23 1997-09-02 Endocardial Solutions, Inc. Electrophysiology mapping system
US5313943A (en) 1992-09-25 1994-05-24 Ep Technologies, Inc. Catheters and methods for performing cardiac diagnosis and treatment
US5700243A (en) 1992-10-30 1997-12-23 Pdt Systems, Inc. Balloon perfusion catheter
US5334193A (en) 1992-11-13 1994-08-02 American Cardiac Ablation Co., Inc. Fluid cooled ablation catheter
US6068653A (en) * 1992-11-13 2000-05-30 Scimed Life Systems, Inc. Electrophysiology catheter device
US5545161A (en) 1992-12-01 1996-08-13 Cardiac Pathways Corporation Catheter for RF ablation having cooled electrode with electrically insulated sleeve
US6749604B1 (en) 1993-05-10 2004-06-15 Arthrocare Corporation Electrosurgical instrument with axially-spaced electrodes
US5531685A (en) 1993-06-11 1996-07-02 Catheter Research, Inc. Steerable variable stiffness device
FR2708860B1 (en) 1993-08-11 1995-10-13 Ela Medical Sa Protection circuit for implantable electronic device.
US5558091A (en) 1993-10-06 1996-09-24 Biosense, Inc. Magnetic determination of position and orientation
US5545193A (en) 1993-10-15 1996-08-13 Ep Technologies, Inc. Helically wound radio-frequency emitting electrodes for creating lesions in body tissue
US5722400A (en) 1995-02-16 1998-03-03 Daig Corporation Guiding introducers for use in the treatment of left ventricular tachycardia
US5921924A (en) 1993-12-03 1999-07-13 Avitall; Boaz Mapping and ablation catheter system utilizing multiple control elements
US5454370A (en) 1993-12-03 1995-10-03 Avitall; Boaz Mapping and ablation electrode configuration
US5928269A (en) 1994-04-04 1999-07-27 Alt; Eckhard Apparatus and method for temporary atrial defibrillation with external defibrillator and implanted transvenous catheter and electrodes
US5578040A (en) 1994-06-14 1996-11-26 Smith; Albert C. Ocular repair system and apparatus
US5617854A (en) 1994-06-22 1997-04-08 Munsif; Anand Shaped catheter device and method
US6071274A (en) 1996-12-19 2000-06-06 Ep Technologies, Inc. Loop structures for supporting multiple electrode elements
US5836947A (en) 1994-10-07 1998-11-17 Ep Technologies, Inc. Flexible structures having movable splines for supporting electrode elements
US5885278A (en) 1994-10-07 1999-03-23 E.P. Technologies, Inc. Structures for deploying movable electrode elements
US5876336A (en) 1994-10-11 1999-03-02 Ep Technologies, Inc. Systems and methods for guiding movable electrode elements within multiple-electrode structure
US5722402A (en) 1994-10-11 1998-03-03 Ep Technologies, Inc. Systems and methods for guiding movable electrode elements within multiple-electrode structures
US5624430A (en) 1994-11-28 1997-04-29 Eton; Darwin Magnetic device to assist transcorporeal guidewire placement
US5647871A (en) 1995-03-10 1997-07-15 Microsurge, Inc. Electrosurgery with cooled electrodes
US5810762A (en) 1995-04-10 1998-09-22 Genetronics, Inc. Electroporation system with voltage control feedback for clinical applications
US6059779A (en) * 1995-04-28 2000-05-09 Target Therapeutics, Inc. Delivery catheter for electrolytically detachable implant
US6090104A (en) 1995-06-07 2000-07-18 Cordis Webster, Inc. Catheter with a spirally wound flat ribbon electrode
US5702438A (en) 1995-06-08 1997-12-30 Avitall; Boaz Expandable recording and ablation catheter system
US5788692A (en) 1995-06-30 1998-08-04 Fidus Medical Technology Corporation Mapping ablation catheter
US6023638A (en) 1995-07-28 2000-02-08 Scimed Life Systems, Inc. System and method for conducting electrophysiological testing using high-voltage energy pulses to stun tissue
US5706823A (en) 1995-08-18 1998-01-13 Quinton Instrument Company Electrophysiology filtering system
DE69631681T2 (en) 1995-10-06 2004-07-29 Cordis Webster, Inc., Diamond Bar ELECTRODE CATHETER WITH DIVIDED TIP
DE29519651U1 (en) 1995-12-14 1996-02-01 Muntermann, Axel, 35583 Wetzlar Device for linear radio frequency catheter ablation of endomyocardial tissue
BR9612395A (en) 1995-12-29 1999-07-13 Gyrus Medical Ltd Electrosurgical instrument and an electrosurgical electrode set
US7141049B2 (en) 1999-03-09 2006-11-28 Thermage, Inc. Handpiece for treatment of tissue
US5836874A (en) 1996-04-08 1998-11-17 Ep Technologies, Inc. Multi-function electrode structures for electrically analyzing and heating body tissue
US5868736A (en) 1996-04-12 1999-02-09 Ep Technologies, Inc. Systems and methods to control tissue heating or ablation with porous electrode structures
CA2243595A1 (en) * 1996-01-19 1997-07-24 Ep Technologies, Inc. Multi-function electrode structures for electrically analyzing and heating body tissue
US5800482A (en) 1996-03-06 1998-09-01 Cardiac Pathways Corporation Apparatus and method for linear lesion ablation
US5830224A (en) 1996-03-15 1998-11-03 Beth Israel Deaconess Medical Center Catheter apparatus and methodology for generating a fistula on-demand between closely associated blood vessels at a pre-chosen anatomic site in-vivo
US5779699A (en) 1996-03-29 1998-07-14 Medtronic, Inc. Slip resistant field focusing ablation catheter electrode
US5836942A (en) 1996-04-04 1998-11-17 Minnesota Mining And Manufacturing Company Biomedical electrode with lossy dielectric properties
US5863291A (en) 1996-04-08 1999-01-26 Cardima, Inc. Linear ablation assembly
US5904709A (en) 1996-04-17 1999-05-18 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Microwave treatment for cardiac arrhythmias
US5672170A (en) 1996-06-20 1997-09-30 Cynosure, Inc. Laser transmyocardial revascularization arrangement
US6006131A (en) 1996-08-13 1999-12-21 Uab Research Foundation Dual current pathway atrial defibrillation apparatus
DE59610941D1 (en) 1996-09-27 2004-04-22 Sulzer Osypka Gmbh Device for performing diagnostic and / or therapeutic cardiac interventions with a catheter
US6464697B1 (en) 1998-02-19 2002-10-15 Curon Medical, Inc. Stomach and adjoining tissue regions in the esophagus
US7052493B2 (en) 1996-10-22 2006-05-30 Epicor Medical, Inc. Methods and devices for ablation
US6311692B1 (en) 1996-10-22 2001-11-06 Epicor, Inc. Apparatus and method for diagnosis and therapy of electrophysiological disease
US6805128B1 (en) 1996-10-22 2004-10-19 Epicor Medical, Inc. Apparatus and method for ablating tissue
US6096036A (en) 1998-05-05 2000-08-01 Cardiac Pacemakers, Inc. Steerable catheter with preformed distal shape and method for use
US6002955A (en) 1996-11-08 1999-12-14 Medtronic, Inc. Stabilized electrophysiology catheter and method for use
US6035238A (en) 1997-08-13 2000-03-07 Surx, Inc. Noninvasive devices, methods, and systems for shrinking of tissues
US6076012A (en) 1996-12-19 2000-06-13 Ep Technologies, Inc. Structures for supporting porous electrode elements
US5916213A (en) 1997-02-04 1999-06-29 Medtronic, Inc. Systems and methods for tissue mapping and ablation
US6039757A (en) 1997-03-12 2000-03-21 Cardiosynopsis, Inc. In situ formed fenestrated stent
US6223085B1 (en) 1997-05-06 2001-04-24 Urologix, Inc. Device and method for preventing restenosis
US6012457A (en) 1997-07-08 2000-01-11 The Regents Of The University Of California Device and method for forming a circumferential conduction block in a pulmonary vein
US5849028A (en) 1997-05-16 1998-12-15 Irvine Biomedical, Inc. Catheter and method for radiofrequency ablation of cardiac tissue
US5978704A (en) 1997-06-03 1999-11-02 Uab Research Foundation Method and apparatus for treating cardiac arrhythmia
US5938660A (en) 1997-06-27 1999-08-17 Daig Corporation Process and device for the treatment of atrial arrhythmia
US6966908B2 (en) 1997-07-08 2005-11-22 Atrionix, Inc. Tissue ablation device assembly and method for electrically isolating a pulmonary vein ostium from an atrial wall
US6245064B1 (en) 1997-07-08 2001-06-12 Atrionix, Inc. Circumferential ablation device assembly
WO1999002096A1 (en) 1997-07-08 1999-01-21 The Regents Of The University Of California Circumferential ablation device assembly and method
US6164283A (en) 1997-07-08 2000-12-26 The Regents Of The University Of California Device and method for forming a circumferential conduction block in a pulmonary vein
US6009351A (en) 1997-07-14 1999-12-28 Urologix, Inc. System and method for transurethral heating with rectal cooling
US6014579A (en) 1997-07-21 2000-01-11 Cardiac Pathways Corp. Endocardial mapping catheter with movable electrode
JP2002512552A (en) 1997-07-22 2002-04-23 イーメッド コーポレイション Delivery of drugs into heart tissue by iontophoresis.
US6216034B1 (en) 1997-08-01 2001-04-10 Genetronics, Inc. Method of programming an array of needle electrodes for electroporation therapy of tissue
US5895404A (en) 1997-09-29 1999-04-20 Ruiz; Carlos E. Apparatus and methods for percutaneously forming a passageway between adjacent vessels or portions of a vessel
US6464699B1 (en) 1997-10-10 2002-10-15 Scimed Life Systems, Inc. Method and apparatus for positioning a diagnostic or therapeutic element on body tissue and mask element for use with same
US6071281A (en) 1998-05-05 2000-06-06 Ep Technologies, Inc. Surgical method and apparatus for positioning a diagnostic or therapeutic element within the body and remote power control unit for use with same
US6645200B1 (en) 1997-10-10 2003-11-11 Scimed Life Systems, Inc. Method and apparatus for positioning a diagnostic or therapeutic element within the body and tip electrode for use with same
JP2001521774A (en) 1997-10-31 2001-11-13 シー・アール・バード・インコーポレーテッド Ring-shaped electrode structure for diagnostic and ablation catheters
US6120500A (en) 1997-11-12 2000-09-19 Daig Corporation Rail catheter ablation and mapping system
US5928270A (en) 1997-12-02 1999-07-27 Cardiocommand, Inc. Method and apparatus for incremental cardioversion or defibrillation
US6447505B2 (en) 1998-02-11 2002-09-10 Cosman Company, Inc. Balloon catheter method for intra-urethral radio-frequency urethral enlargement
US6517534B1 (en) 1998-02-11 2003-02-11 Cosman Company, Inc. Peri-urethral ablation
US20020087148A1 (en) 1998-02-24 2002-07-04 Brock David L. Flexible instrument
US6167291A (en) 1998-03-12 2000-12-26 Cardima, Inc. Protected pin connector for an electrophysiology catheter
DE19817553A1 (en) 1998-04-15 1999-10-21 Biotronik Mess & Therapieg Ablation arrangement
US6030384A (en) 1998-05-01 2000-02-29 Nezhat; Camran Bipolar surgical instruments having focused electrical fields
US6592581B2 (en) 1998-05-05 2003-07-15 Cardiac Pacemakers, Inc. Preformed steerable catheter with movable outer sleeve and method for use
US6045550A (en) 1998-05-05 2000-04-04 Cardiac Peacemakers, Inc. Electrode having non-joined thermocouple for providing multiple temperature-sensitive junctions
US6146381A (en) 1998-05-05 2000-11-14 Cardiac Pacemakers, Inc. Catheter having distal region for deflecting axial forces
US6171305B1 (en) 1998-05-05 2001-01-09 Cardiac Pacemakers, Inc. RF ablation apparatus and method having high output impedance drivers
US6527767B2 (en) 1998-05-20 2003-03-04 New England Medical Center Cardiac ablation system and method for treatment of cardiac arrhythmias and transmyocardial revascularization
US6231518B1 (en) 1998-05-26 2001-05-15 Comedicus Incorporated Intrapericardial electrophysiological procedures
US6287306B1 (en) 1998-06-22 2001-09-11 Daig Corporation Even temperature linear lesion ablation catheter
US6251107B1 (en) 1998-06-25 2001-06-26 Cardima, Inc. Ep catheter
US6322559B1 (en) 1998-07-06 2001-11-27 Vnus Medical Technologies, Inc. Electrode catheter having coil structure
US6623480B1 (en) 1998-07-24 2003-09-23 University Of Kentucky Research Foundation Flexible recording/high energy electrode catheter with anchor for ablation of atrial flutter by radio frequency energy
US7435247B2 (en) 1998-08-11 2008-10-14 Arthrocare Corporation Systems and methods for electrosurgical tissue treatment
US6251128B1 (en) 1998-09-01 2001-06-26 Fidus Medical Technology Corporation Microwave ablation catheter with loop configuration
US8308719B2 (en) 1998-09-21 2012-11-13 St. Jude Medical, Atrial Fibrillation Division, Inc. Apparatus and method for ablating tissue
US6807447B2 (en) 1998-09-25 2004-10-19 Ep Medsystems, Inc. Triple array defibrillation catheter and method of using the same
US6033403A (en) 1998-10-08 2000-03-07 Irvine Biomedical, Inc. Long electrode catheter system and methods thereof
US6638278B2 (en) 1998-11-23 2003-10-28 C. R. Bard, Inc. Intracardiac grasp catheter
IT1302900B1 (en) 1998-12-04 2000-10-10 Riccardo Fenici AMAGNETIC CATHETER FOR THE SINGLE-CATHETER REGISTRATION OF MULTIPLE SINGLE-PHASE ACTION POTENTIALS, LOCABLE THREE-DIMENSIONALLY AND
US20070066972A1 (en) 2001-11-29 2007-03-22 Medwaves, Inc. Ablation catheter apparatus with one or more electrodes
US6219582B1 (en) 1998-12-30 2001-04-17 Daig Corporation Temporary atrial cardioversion catheter
US6206831B1 (en) 1999-01-06 2001-03-27 Scimed Life Systems, Inc. Ultrasound-guided ablation catheter and methods of use
US6325797B1 (en) 1999-04-05 2001-12-04 Medtronic, Inc. Ablation catheter and method for isolating a pulmonary vein
US6702811B2 (en) 1999-04-05 2004-03-09 Medtronic, Inc. Ablation catheter assembly with radially decreasing helix and method of use
US20010007070A1 (en) 1999-04-05 2001-07-05 Medtronic, Inc. Ablation catheter assembly and method for isolating a pulmonary vein
US6270476B1 (en) 1999-04-23 2001-08-07 Cryocath Technologies, Inc. Catheter
US6272384B1 (en) 1999-05-27 2001-08-07 Urologix, Inc. Microwave therapy apparatus
US7171263B2 (en) 1999-06-04 2007-01-30 Impulse Dynamics Nv Drug delivery device
US6391024B1 (en) 1999-06-17 2002-05-21 Cardiac Pacemakers, Inc. RF ablation apparatus and method having electrode/tissue contact assessment scheme and electrocardiogram filtering
US6300108B1 (en) 1999-07-21 2001-10-09 The Regents Of The University Of California Controlled electroporation and mass transfer across cell membranes
DE19938558A1 (en) 1999-08-17 2001-02-22 Axel Muntermann Catheters with improved electrical properties and treatment methods for improving the electrical properties of catheters
US6607520B2 (en) 1999-09-15 2003-08-19 The General Hospital Corporation Coiled ablation catheter system
US6370412B1 (en) 1999-10-07 2002-04-09 Massachusetts Institute Of Technology Method and apparatus for guiding ablative therapy of abnormal biological electrical excitation
US6613062B1 (en) 1999-10-29 2003-09-02 Medtronic, Inc. Method and apparatus for providing intra-pericardial access
US6529756B1 (en) 1999-11-22 2003-03-04 Scimed Life Systems, Inc. Apparatus for mapping and coagulating soft tissue in or around body orifices
US6892091B1 (en) 2000-02-18 2005-05-10 Biosense, Inc. Catheter, method and apparatus for generating an electrical map of a chamber of the heart
DE10008918A1 (en) 2000-02-25 2001-08-30 Biotronik Mess & Therapieg Ablation catheter to generate linear lesions in heart muscle; has catheter body with linear, cylindrical ablation electrode and at least one insulated sensing electrode
EP1267986B1 (en) 2000-03-31 2006-05-10 Medtronic, Inc. Deflection Mechanism
US7497844B2 (en) 2000-03-31 2009-03-03 Medtronic, Inc. System and method for positioning implantable medical devices within coronary veins
US6652517B1 (en) 2000-04-25 2003-11-25 Uab Research Foundation Ablation catheter, system, and method of use thereof
US20020107514A1 (en) 2000-04-27 2002-08-08 Hooven Michael D. Transmural ablation device with parallel jaws
US6932811B2 (en) 2000-04-27 2005-08-23 Atricure, Inc. Transmural ablation device with integral EKG sensor
US6546935B2 (en) 2000-04-27 2003-04-15 Atricure, Inc. Method for transmural ablation
US6743239B1 (en) 2000-05-25 2004-06-01 St. Jude Medical, Inc. Devices with a bendable tip for medical procedures
US8251986B2 (en) 2000-08-17 2012-08-28 Angiodynamics, Inc. Method of destroying tissue cells by eletroporation
US7081114B2 (en) 2000-11-29 2006-07-25 St. Jude Medical, Atrial Fibrillation Division, Inc. Electrophysiology/ablation catheter having lariat configuration of variable radius
US6728563B2 (en) 2000-11-29 2004-04-27 St. Jude Medical, Daig Division, Inc. Electrophysiology/ablation catheter having “halo” configuration
US6723092B2 (en) 2000-12-15 2004-04-20 Tony R. Brown Atrial fibrillation RF treatment device and method
US6620157B1 (en) 2000-12-28 2003-09-16 Senorx, Inc. High frequency power source
DE10102089C1 (en) 2001-01-18 2002-07-25 Wolf Gmbh Richard Surgical instrument
DE10102254A1 (en) 2001-01-19 2002-08-08 Celon Ag Medical Instruments Device for the electrothermal treatment of the human or animal body
US7229402B2 (en) 2001-02-09 2007-06-12 Cardiac Output Technologies, Inc. Minimally invasive ventricular assist technology and method
US6743226B2 (en) 2001-02-09 2004-06-01 Cosman Company, Inc. Adjustable trans-urethral radio-frequency ablation
US7137975B2 (en) * 2001-02-13 2006-11-21 Aciont, Inc. Method for increasing the battery life of an alternating current iontophoresis device using a barrier-modifying agent
US6666863B2 (en) 2001-03-01 2003-12-23 Scimed Life Systems, Inc. Device and method for percutaneous myocardial revascularization
US6666862B2 (en) 2001-03-01 2003-12-23 Cardiac Pacemakers, Inc. Radio frequency ablation system and method linking energy delivery with fluid flow
US6743225B2 (en) 2001-03-27 2004-06-01 Uab Research Foundation Electrophysiologic measure of endpoints for ablation lesions created in fibrillating substrates
US6619291B2 (en) 2001-04-24 2003-09-16 Edwin J. Hlavka Method and apparatus for catheter-based annuloplasty
JP4279559B2 (en) 2001-04-27 2009-06-17 シー・アール・バード・インコーポレーテッド Electrophysiological catheter for mapping and / or ablation
US6972016B2 (en) 2001-05-01 2005-12-06 Cardima, Inc. Helically shaped electrophysiology catheter
US6771996B2 (en) 2001-05-24 2004-08-03 Cardiac Pacemakers, Inc. Ablation and high-resolution mapping catheter system for pulmonary vein foci elimination
US6685702B2 (en) 2001-07-06 2004-02-03 Rodolfo C. Quijano Device for treating tissue and methods thereof
US20030018374A1 (en) 2001-07-16 2003-01-23 Paulos Lonnie E. Treatment probe using RF energy
US6994706B2 (en) 2001-08-13 2006-02-07 Minnesota Medical Physics, Llc Apparatus and method for treatment of benign prostatic hyperplasia
US8623012B2 (en) 2001-08-15 2014-01-07 Nuortho Surgical, Inc. Electrosurgical plenum
CA2460174A1 (en) 2001-09-24 2003-04-03 Novoste Corporation Methods and apparatus employing ionizing radiation for treatment of cardiac arrhythmia
US7344533B2 (en) 2001-09-28 2008-03-18 Angiodynamics, Inc. Impedance controlled tissue ablation apparatus and method
US7285116B2 (en) 2004-05-15 2007-10-23 Irvine Biomedical Inc. Non-contact tissue ablation device and methods thereof
US8175680B2 (en) 2001-11-09 2012-05-08 Boston Scientific Scimed, Inc. Systems and methods for guiding catheters using registered images
US6669693B2 (en) 2001-11-13 2003-12-30 Mayo Foundation For Medical Education And Research Tissue ablation device and methods of using
US7542807B2 (en) 2001-12-04 2009-06-02 Endoscopic Technologies, Inc. Conduction block verification probe and method of use
US6740084B2 (en) 2001-12-18 2004-05-25 Ethicon, Inc. Method and device to enhance RF electrode performance
WO2003053289A1 (en) 2001-12-21 2003-07-03 Simcha Milo Implantation system for annuloplasty rings
US7493156B2 (en) 2002-01-07 2009-02-17 Cardiac Pacemakers, Inc. Steerable guide catheter with pre-shaped rotatable shaft
US8062251B2 (en) 2002-02-01 2011-11-22 Vascular Designs, Inc. Multi-function catheter and use thereof
US6926714B1 (en) 2002-02-05 2005-08-09 Jasbir S. Sra Method for pulmonary vein isolation and catheter ablation of other structures in the left atrium in atrial fibrillation
US6932816B2 (en) 2002-02-19 2005-08-23 Boston Scientific Scimed, Inc. Apparatus for converting a clamp into an electrophysiology device
US6733499B2 (en) 2002-02-28 2004-05-11 Biosense Webster, Inc. Catheter having circular ablation assembly
US6869414B2 (en) 2002-03-22 2005-03-22 Cardiac Pacemakers, Inc. Pre-shaped catheter with proximal articulation and pre-formed distal end
US7617005B2 (en) 2002-04-08 2009-11-10 Ardian, Inc. Methods and apparatus for thermally-induced renal neuromodulation
US7756583B2 (en) 2002-04-08 2010-07-13 Ardian, Inc. Methods and apparatus for intravascularly-induced neuromodulation
US7653438B2 (en) 2002-04-08 2010-01-26 Ardian, Inc. Methods and apparatus for renal neuromodulation
US8774913B2 (en) 2002-04-08 2014-07-08 Medtronic Ardian Luxembourg S.A.R.L. Methods and apparatus for intravasculary-induced neuromodulation
US8347891B2 (en) 2002-04-08 2013-01-08 Medtronic Ardian Luxembourg S.A.R.L. Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen
DE10218427A1 (en) 2002-04-24 2003-11-06 Biotronik Mess & Therapieg Ablation device for cardiac tissue, in particular for creating a circular lesion around a vascular mouth in the heart
US6764486B2 (en) 2002-04-24 2004-07-20 Biotronik Mess- und Therapieger{haeck over (a)}te GmbH & Co. Ingenieurbüro Berlin Ablation device for cardiac tissue, especially for forming a circular lesion around a vessel orifice in the heart
US20030204161A1 (en) 2002-04-25 2003-10-30 Bozidar Ferek-Petric Implantable electroporation therapy device and method for using same
US6780178B2 (en) 2002-05-03 2004-08-24 The Board Of Trustees Of The Leland Stanford Junior University Method and apparatus for plasma-mediated thermo-electrical ablation
AU2003239474A1 (en) 2002-05-17 2003-12-02 Stan F. Obino Device and method for the treatment of cardiac disorders
AU2003237671A1 (en) 2002-05-27 2003-12-12 Celon Ag Medical Instruments Device for electrosurgically destroying body tissue
US20030229379A1 (en) 2002-06-06 2003-12-11 Maynard Ramsey Method for cardioversion or defibrillation using electrical impulses at pacing strength
US7367974B2 (en) 2004-09-20 2008-05-06 Wisconsin Alumni Research Foundation Electrode array for tissue ablation
US20040082859A1 (en) 2002-07-01 2004-04-29 Alan Schaer Method and apparatus employing ultrasound energy to treat body sphincters
US7001383B2 (en) 2002-10-21 2006-02-21 Biosense, Inc. Real-time monitoring and mapping of ablation lesion formation in the heart
US20040082947A1 (en) 2002-10-25 2004-04-29 The Regents Of The University Of Michigan Ablation catheters
US9730100B2 (en) 2002-10-28 2017-08-08 MeshDynamics Terse message networks
US9819747B2 (en) 2008-11-24 2017-11-14 MeshDynamics Chirp networks
WO2004045672A2 (en) 2002-11-15 2004-06-03 The Government Of The United States As Represented By The Secretary Of The Department Of Health And Human Services Variable curve catheter
US20060167448A1 (en) 2002-11-15 2006-07-27 Kozel Peter D Electrophysiology catheter with ablation electrode
US7195628B2 (en) 2002-12-11 2007-03-27 St. Jude Medical, Atrial Fibrillation Division, Inc. Atrial fibrillation therapy with pulmonary vein support
AU2003300295A1 (en) 2002-12-20 2004-07-22 Cardiac Inventions Unlimited, Inc. Left ventricular pacing lead and implantation method
US6984232B2 (en) 2003-01-17 2006-01-10 St. Jude Medical, Daig Division, Inc. Ablation catheter assembly having a virtual electrode comprising portholes
US8192425B2 (en) 2006-09-29 2012-06-05 Baylis Medical Company Inc. Radiofrequency perforation apparatus
US6960207B2 (en) 2003-01-21 2005-11-01 St Jude Medical, Daig Division, Inc. Ablation catheter having a virtual electrode comprising portholes and a porous conductor
US7387629B2 (en) 2003-01-21 2008-06-17 St. Jude Medical, Atrial Fibrillation Division, Inc. Catheter design that facilitates positioning at tissue to be diagnosed or treated
US7622172B2 (en) 2003-02-19 2009-11-24 Erick Keenan Composite flexible and conductive catheter electrode
WO2004086994A1 (en) 2003-03-28 2004-10-14 C.R. Bard, Inc. Method and apparatus for electrosurgical ablation
US6985776B2 (en) 2003-04-25 2006-01-10 Medtronic, Inc. Method and apparatus for coronary sinus cannulation
US6980843B2 (en) 2003-05-21 2005-12-27 Stereotaxis, Inc. Electrophysiology catheter
US7163537B2 (en) 2003-06-02 2007-01-16 Biosense Webster, Inc. Enhanced ablation and mapping catheter and method for treating atrial fibrillation
US7044946B2 (en) 2003-06-10 2006-05-16 Cryocath Technologies Inc. Surgical clamp having treatment elements
US7540853B2 (en) 2003-06-30 2009-06-02 Cardiac Pacemakers, Inc. Method and apparatus for diverting blood flow during ablation procedures
US6973339B2 (en) 2003-07-29 2005-12-06 Biosense, Inc Lasso for pulmonary vein mapping and ablation
US20060009755A1 (en) 2003-09-04 2006-01-12 Sra Jasbir S Method and system for ablation of atrial fibrillation and other cardiac arrhythmias
US7229437B2 (en) 2003-09-22 2007-06-12 St. Jude Medical, Atrial Fibrillation Division, Inc. Medical device having integral traces and formed electrodes
US8147486B2 (en) 2003-09-22 2012-04-03 St. Jude Medical, Atrial Fibrillation Division, Inc. Medical device with flexible printed circuit
US7435248B2 (en) 2003-09-26 2008-10-14 Boston Scientific Scimed, Inc. Medical probes for creating and diagnosing circumferential lesions within or around the ostium of a vessel
US7480532B2 (en) * 2003-10-22 2009-01-20 Cvrx, Inc. Baroreflex activation for pain control, sedation and sleep
US7179256B2 (en) 2003-10-24 2007-02-20 Biosense Webster, Inc. Catheter with ablation needle and mapping assembly
US7207989B2 (en) 2003-10-27 2007-04-24 Biosense Webster, Inc. Method for ablating with needle electrode
FR2861997A1 (en) 2003-11-06 2005-05-13 Fred Zacouto Cardiac muscle stimulation device e.g. defibrillator, for use during tachycardia treatment, has impulse generator that sends stimulation pulse without delay at end of refractory period
WO2005046487A1 (en) 2003-11-06 2005-05-26 Nmt Medical, Inc. Transseptal puncture apparatus
US7896873B2 (en) 2003-12-01 2011-03-01 Biotronik Crm Patent Ag Electrode catheter for the electrotherapy of cardiac tissue
EP1696812B1 (en) 2003-12-24 2015-07-22 The Regents of The University of California Tissue ablation with irreversible electroporation
US20050187545A1 (en) 2004-02-20 2005-08-25 Hooven Michael D. Magnetic catheter ablation device and method
US7972298B2 (en) 2004-03-05 2011-07-05 Hansen Medical, Inc. Robotic catheter system
US7850642B2 (en) 2004-03-05 2010-12-14 Hansen Medical, Inc. Methods using a robotic catheter system
WO2006119467A2 (en) 2005-05-04 2006-11-09 Impulse Dynamics Nv Protein activity modification
US7282057B2 (en) 2004-03-30 2007-10-16 Wilson-Cook Medical, Inc. Pediatric atresia magnets
KR101193709B1 (en) * 2004-04-19 2012-10-23 프로리듬, 인크. Ablation devices with sensor structures
US20050261672A1 (en) * 2004-05-18 2005-11-24 Mark Deem Systems and methods for selective denervation of heart dysrhythmias
US7250049B2 (en) 2004-05-27 2007-07-31 St. Jude Medical, Atrial Fibrillation Division, Inc. Ablation catheter with suspension system incorporating rigid and flexible components
EP1750607A2 (en) 2004-06-02 2007-02-14 Medtronic, Inc. Loop ablation apparatus and method
US7527625B2 (en) 2004-08-04 2009-05-05 Olympus Corporation Transparent electrode for the radiofrequency ablation of tissue
US7556627B2 (en) 2004-09-13 2009-07-07 Ethicon Endo-Surgery, Inc. Mucosal ablation device
US7282049B2 (en) 2004-10-08 2007-10-16 Sherwood Services Ag Electrosurgical system employing multiple electrodes and method thereof
US20060089637A1 (en) 2004-10-14 2006-04-27 Werneth Randell L Ablation catheter
FR2877207B1 (en) 2004-10-29 2007-02-23 Jacques Hamou DEVICE FOR RESECTING ORGANIC TISSUE USED IN PARTICULAR IN UROLOGY OR HYSTEROSCOPY
US8409191B2 (en) 2004-11-04 2013-04-02 Boston Scientific Scimed, Inc. Preshaped ablation catheter for ablating pulmonary vein ostia within the heart
US7429261B2 (en) 2004-11-24 2008-09-30 Ablation Frontiers, Inc. Atrial ablation catheter and method of use
US7468062B2 (en) 2004-11-24 2008-12-23 Ablation Frontiers, Inc. Atrial ablation catheter adapted for treatment of septal wall arrhythmogenic foci and method of use
US7731715B2 (en) 2004-12-10 2010-06-08 Edwards Lifesciences Corporation Ablative treatment of atrial fibrillation via the coronary sinus
US7869865B2 (en) 2005-01-07 2011-01-11 Biosense Webster, Inc. Current-based position sensing
US20070225589A1 (en) 2005-01-11 2007-09-27 Viswanathan Raju R Single catheter diagnosis, navigation and treatment of arrhythmias
WO2006079965A2 (en) 2005-01-31 2006-08-03 Koninklijke Philips Electronics N.V. System and method for the guidance of a catheter in electrophysiologic interventions
US9821158B2 (en) 2005-02-17 2017-11-21 Metacure Limited Non-immediate effects of therapy
US7578816B2 (en) 2005-04-22 2009-08-25 Abl Technologies, Llc Method and system of increasing safety of cardiac ablation procedures
US7588567B2 (en) 2005-04-22 2009-09-15 Abl Technologies, Llc Method and system of stopping energy delivery of an ablation procedure with a computer based device for increasing safety of ablation procedures
US7512447B2 (en) 2005-04-25 2009-03-31 Medtronic, Inc. Medical electrical electrodes with conductive polymer
US20060264752A1 (en) * 2005-04-27 2006-11-23 The Regents Of The University Of California Electroporation controlled with real time imaging
US8571635B2 (en) 2005-04-28 2013-10-29 Boston Scientific Scimed, Inc. Automated activation/deactivation of imaging device based on tracked medical device position
US20060270900A1 (en) 2005-05-26 2006-11-30 Chin Albert K Apparatus and methods for performing ablation
US8932208B2 (en) 2005-05-26 2015-01-13 Maquet Cardiovascular Llc Apparatus and methods for performing minimally-invasive surgical procedures
US9861836B2 (en) 2005-06-16 2018-01-09 Biosense Webster, Inc. Less invasive methods for ablation of fat pads
WO2007001981A2 (en) 2005-06-20 2007-01-04 Ablation Frontiers Ablation catheter
US8114070B2 (en) * 2005-06-24 2012-02-14 Angiodynamics, Inc. Methods and systems for treating BPH using electroporation
US20060293731A1 (en) 2005-06-24 2006-12-28 Boris Rubinsky Methods and systems for treating tumors using electroporation
US20070005053A1 (en) 2005-06-30 2007-01-04 Dando Jeremy D Ablation catheter with contoured openings in insulated electrodes
AU2006264300B2 (en) 2005-07-06 2012-03-08 Vascular Pathways Inc. Intravenous catheter insertion device and method of use
US20070021744A1 (en) 2005-07-07 2007-01-25 Creighton Francis M Iv Apparatus and method for performing ablation with imaging feedback
CA2615267A1 (en) 2005-07-11 2007-01-18 Ablation Frontiers, Inc. Low power tissue ablation system
ITBO20050495A1 (en) 2005-07-22 2007-01-23 Fiab Spa EXOGUE PIPELINE
US7955262B2 (en) * 2005-07-26 2011-06-07 Syneron Medical Ltd. Method and apparatus for treatment of skin using RF and ultrasound energies
US7681579B2 (en) 2005-08-02 2010-03-23 Biosense Webster, Inc. Guided procedures for treating atrial fibrillation
US8657814B2 (en) 2005-08-22 2014-02-25 Medtronic Ablation Frontiers Llc User interface for tissue ablation system
US7416552B2 (en) 2005-08-22 2008-08-26 St. Jude Medical, Atrial Fibrillation Division, Inc. Multipolar, multi-lumen, virtual-electrode catheter with at least one surface electrode and method for ablation
WO2007030415A2 (en) 2005-09-07 2007-03-15 The Foundry, Inc. Apparatus and method for disrupting subcutaneous structures
US7623899B2 (en) 2005-09-16 2009-11-24 Biosense Webster, Inc. Catheter with flexible pre-shaped tip section
CN101316560B (en) 2005-12-02 2011-01-26 皇家飞利浦电子股份有限公司 Automating the ablation procedure to minimize the need for manual intervention
US10362959B2 (en) 2005-12-06 2019-07-30 St. Jude Medical, Atrial Fibrillation Division, Inc. System and method for assessing the proximity of an electrode to tissue in a body
US8603084B2 (en) 2005-12-06 2013-12-10 St. Jude Medical, Atrial Fibrillation Division, Inc. System and method for assessing the formation of a lesion in tissue
US8403925B2 (en) 2006-12-06 2013-03-26 St. Jude Medical, Atrial Fibrillation Division, Inc. System and method for assessing lesions in tissue
US8406866B2 (en) 2005-12-06 2013-03-26 St. Jude Medical, Atrial Fibrillation Division, Inc. System and method for assessing coupling between an electrode and tissue
US9492226B2 (en) 2005-12-06 2016-11-15 St. Jude Medical, Atrial Fibrillation Division, Inc. Graphical user interface for real-time RF lesion depth display
US8449535B2 (en) 2005-12-06 2013-05-28 St. Jude Medical, Atrial Fibrillation Division, Inc. System and method for assessing coupling between an electrode and tissue
WO2007076045A2 (en) 2005-12-24 2007-07-05 Crossman Arthur W Circumferential ablation guide wire system and related method of using the same
JP4855482B2 (en) 2005-12-30 2012-01-18 シー・アール・バード・インコーポレーテッド Method and apparatus for exfoliating heart tissue
US7857809B2 (en) 2005-12-30 2010-12-28 Biosense Webster, Inc. Injection molded irrigated tip electrode and catheter having the same
US20070167740A1 (en) 2005-12-30 2007-07-19 Grunewald Debby E Magnetic stabilization of catheter location sensor
US7879029B2 (en) 2005-12-30 2011-02-01 Biosense Webster, Inc. System and method for selectively energizing catheter electrodes
US20070156135A1 (en) 2006-01-03 2007-07-05 Boris Rubinsky System and methods for treating atrial fibrillation using electroporation
US7513896B2 (en) 2006-01-24 2009-04-07 Covidien Ag Dual synchro-resonant electrosurgical apparatus with bi-directional magnetic coupling
US7374567B2 (en) 2006-01-25 2008-05-20 Heuser Richard R Catheter system for connecting adjacent blood vessels
US7918850B2 (en) 2006-02-17 2011-04-05 Biosense Wabster, Inc. Lesion assessment by pacing
EP2007466A4 (en) 2006-03-31 2012-01-18 Automated Medical Instr Inc System and method for advancing, orienting, and immobilizing on internal body tissue a catheter or other therapeutic device
US7615044B2 (en) 2006-05-03 2009-11-10 Greatbatch Ltd. Deflectable sheath handle assembly and method therefor
US20070270792A1 (en) 2006-05-08 2007-11-22 Willard Hennemann Interferometric characterization of ablated tissue
US20140276782A1 (en) 2013-03-15 2014-09-18 Larry D. Paskar Catheter system
US7729752B2 (en) 2006-06-13 2010-06-01 Rhythmia Medical, Inc. Non-contact cardiac mapping, including resolution map
US7515954B2 (en) 2006-06-13 2009-04-07 Rhythmia Medical, Inc. Non-contact cardiac mapping, including moving catheter and multi-beat integration
US7783352B1 (en) 2006-06-23 2010-08-24 Pacesetter, Inc. Optimizing anti-tachycardia pacing for terminating atrial fibrillation
US9119633B2 (en) 2006-06-28 2015-09-01 Kardium Inc. Apparatus and method for intra-cardiac mapping and ablation
US8920411B2 (en) 2006-06-28 2014-12-30 Kardium Inc. Apparatus and method for intra-cardiac mapping and ablation
DE202007019566U1 (en) * 2006-06-28 2013-10-31 Medtronic Ardian Luxembourg S.à.r.l. Devices and systems for thermally-induced renal neuromodulation
US8328752B2 (en) 2006-06-30 2012-12-11 Cvdevices, Llc Devices, systems, and methods for promotion of infarct healing and reinforcement of border zone
US8048072B2 (en) 2006-07-12 2011-11-01 Les Hospitaux Universitaires de Geneva Medical device for tissue ablation
US20080033426A1 (en) 2006-07-27 2008-02-07 Machell Charles H Catheter system and method of use thereof
US8273081B2 (en) 2006-09-08 2012-09-25 Stereotaxis, Inc. Impedance-based cardiac therapy planning method with a remote surgical navigation system
US7809442B2 (en) * 2006-10-13 2010-10-05 Apnex Medical, Inc. Obstructive sleep apnea treatment devices, systems and methods
AU2007231704B2 (en) 2006-11-29 2011-02-24 Cathrx Ltd Heat treating a biological site in a patient's body
US20080132884A1 (en) 2006-12-01 2008-06-05 Boris Rubinsky Systems for treating tissue sites using electroporation
US20080132885A1 (en) 2006-12-01 2008-06-05 Boris Rubinsky Methods for treating tissue sites using electroporation
WO2008078294A1 (en) 2006-12-22 2008-07-03 Philips Intellectual Property & Standards Gmbh Transmission line for use in magnetic resonance system
US7883508B2 (en) 2006-12-29 2011-02-08 St. Jude Medical, Atrial Fibrillation Division, Inc. Contact-sensitive pressure-sensitive conductive composite electrode and method for ablation
US8449537B2 (en) 2006-12-29 2013-05-28 St. Jude Medical, Atrial Fibrillation Division, Inc. Ablation catheter with thermally mediated catheter body for mitigating blood coagulation and creating larger lesion
US8226648B2 (en) 2007-12-31 2012-07-24 St. Jude Medical, Atrial Fibrillation Division, Inc. Pressure-sensitive flexible polymer bipolar electrode
WO2008086493A2 (en) 2007-01-10 2008-07-17 Hansen Medical, Inc. Robotic catheter system
US9924998B2 (en) 2007-01-12 2018-03-27 Atricure, Inc. Ablation system, clamp and method of use
US20080200913A1 (en) 2007-02-07 2008-08-21 Viswanathan Raju R Single Catheter Navigation for Diagnosis and Treatment of Arrhythmias
US7655004B2 (en) 2007-02-15 2010-02-02 Ethicon Endo-Surgery, Inc. Electroporation ablation apparatus, system, and method
WO2008118737A1 (en) 2007-03-22 2008-10-02 University Of Virginia Patent Foundation Electrode catheter for ablation purposes and related method thereof
US11058354B2 (en) 2007-03-19 2021-07-13 University Of Virginia Patent Foundation Access needle with direct visualization and related methods
US9468396B2 (en) 2007-03-19 2016-10-18 University Of Virginia Patent Foundation Systems and methods for determining location of an access needle in a subject
JP5336465B2 (en) 2007-03-26 2013-11-06 ボストン サイエンティフィック リミテッド High resolution electrophysiology catheter
US8597288B2 (en) 2008-10-01 2013-12-03 St. Jude Medical, Artial Fibrillation Division, Inc. Vacuum-stabilized ablation system
EP2142129A4 (en) 2007-04-19 2011-04-20 Miramar Labs Inc Methods and apparatus for reducing sweat production
EP2142127B1 (en) 2007-04-19 2013-06-12 S.D.M.H.PTY. Ltd. Tissue ablation device with electrodes deployable to form a planar array of elliptical electrodes
WO2008141150A2 (en) 2007-05-09 2008-11-20 Irvine Biomedical, Inc. Basket catheter having multiple electrodes
US8588885B2 (en) 2007-05-09 2013-11-19 St. Jude Medical, Atrial Fibrillation Division, Inc. Bendable catheter arms having varied flexibility
US8100900B2 (en) 2007-05-11 2012-01-24 Board Of Trustees Of The Leland Stanford Junior University System for delivering therapy
US8641704B2 (en) 2007-05-11 2014-02-04 Medtronic Ablation Frontiers Llc Ablation therapy system and method for treating continuous atrial fibrillation
US8216221B2 (en) * 2007-05-21 2012-07-10 Estech, Inc. Cardiac ablation systems and methods
US7742810B2 (en) * 2007-05-23 2010-06-22 Boston Scientific Neuromodulation Corporation Short duration pre-pulsing to reduce stimulation-evoked side-effects
US10220187B2 (en) 2010-06-16 2019-03-05 St. Jude Medical, Llc Ablation catheter having flexible tip with multiple flexible electrode segments
US8160690B2 (en) 2007-06-14 2012-04-17 Hansen Medical, Inc. System and method for determining electrode-tissue contact based on amplitude modulation of sensed signal
US20090024084A1 (en) 2007-07-16 2009-01-22 Peritec Biosciences Ltd. Multi-lumen catheter assembly and method of providing relative motion thereto
US20090062788A1 (en) 2007-08-31 2009-03-05 Long Gary L Electrical ablation surgical instruments
WO2009036459A1 (en) 2007-09-14 2009-03-19 Lazure Technologies, Llc Multi-tine probe and treatment by activation of opposing tines
US20090076502A1 (en) 2007-09-14 2009-03-19 Lazure Technologies, Llc. Prostate cancer ablation
US8308763B2 (en) 2007-10-05 2012-11-13 Coaptus Medical Corporation Systems and methods for transeptal cardiac procedures, including separable guidewires
US8500697B2 (en) 2007-10-19 2013-08-06 Pressure Products Medical Supplies, Inc. Transseptal guidewire
WO2009061860A1 (en) 2007-11-05 2009-05-14 Stereotaxis, Inc. Magnetically guided energy delivery apparatus
US20100241185A1 (en) 2007-11-09 2010-09-23 University Of Virginia Patent Foundation Steerable epicardial pacing catheter system placed via the subxiphoid process
US8906011B2 (en) 2007-11-16 2014-12-09 Kardium Inc. Medical device for use in bodily lumens, for example an atrium
US9717501B2 (en) 2007-11-21 2017-08-01 St. Jude Medical, Atrial Fibrillation Division, Inc. Methods and systems for occluding vessels during cardiac ablation including optional electroanatomical guidance
US9452288B2 (en) 2007-12-06 2016-09-27 Boston Scientific Neuromodulation Corporation Multimodal neurostimulation systems and methods
US8353907B2 (en) 2007-12-21 2013-01-15 Atricure, Inc. Ablation device with internally cooled electrodes
AU2008340270A1 (en) 2007-12-21 2009-07-02 Medical And Surgical Review, P.C. Methods and devices for endoscopically creating an anastomosis
US8562600B2 (en) 2007-12-27 2013-10-22 St. Jude Medical, Atrial Fibrillation Division, Inc. Integration of control software with a medical device and system
US9204927B2 (en) 2009-05-13 2015-12-08 St. Jude Medical, Atrial Fibrillation Division, Inc. System and method for presenting information representative of lesion formation in tissue during an ablation procedure
WO2009089415A1 (en) 2008-01-09 2009-07-16 Mayo Foundation For Medical Education And Research Mapping and ablation catheter system
US8708952B2 (en) 2008-01-16 2014-04-29 Catheter Robotics, Inc. Remotely controlled catheter insertion system
WO2009094588A2 (en) 2008-01-24 2009-07-30 Coherex Medical, Inc. Systems and methods for reduction of atrial fibrillation
US8617145B2 (en) 2008-01-25 2013-12-31 Intrepid Medical, Inc. Methods of treating a cardiac arrhythmia by thoracoscopic production of a Cox maze III lesion set
US8157848B2 (en) * 2008-02-01 2012-04-17 Siemens Medical Solutions Usa, Inc. System for characterizing patient tissue impedance for monitoring and treatment
US20090228003A1 (en) 2008-03-04 2009-09-10 Prorhythm, Inc. Tissue ablation device using radiofrequency and high intensity focused ultrasound
US9011425B2 (en) 2008-03-12 2015-04-21 Afreeze Gmbh Ablation system
US20100004623A1 (en) 2008-03-27 2010-01-07 Angiodynamics, Inc. Method for Treatment of Complications Associated with Arteriovenous Grafts and Fistulas Using Electroporation
US8538509B2 (en) 2008-04-02 2013-09-17 Rhythmia Medical, Inc. Intracardiac tracking system
US10702326B2 (en) 2011-07-15 2020-07-07 Virginia Tech Intellectual Properties, Inc. Device and method for electroporation based treatment of stenosis of a tubular body part
US9867652B2 (en) 2008-04-29 2018-01-16 Virginia Tech Intellectual Properties, Inc. Irreversible electroporation using tissue vasculature to treat aberrant cell masses or create tissue scaffolds
US8926606B2 (en) 2009-04-09 2015-01-06 Virginia Tech Intellectual Properties, Inc. Integration of very short electric pulses for minimally to noninvasive electroporation
US8992517B2 (en) 2008-04-29 2015-03-31 Virginia Tech Intellectual Properties Inc. Irreversible electroporation to treat aberrant cell masses
US9198733B2 (en) 2008-04-29 2015-12-01 Virginia Tech Intellectual Properties, Inc. Treatment planning for electroporation-based therapies
US11254926B2 (en) 2008-04-29 2022-02-22 Virginia Tech Intellectual Properties, Inc. Devices and methods for high frequency electroporation
US10117707B2 (en) 2008-04-29 2018-11-06 Virginia Tech Intellectual Properties, Inc. System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies
WO2009137800A2 (en) 2008-05-09 2009-11-12 Angiodynamics, Inc. Electroporation device and method
US9474574B2 (en) 2008-05-21 2016-10-25 Atricure, Inc. Stabilized ablation systems and methods
US20090306651A1 (en) 2008-06-09 2009-12-10 Clint Schneider Catheter assembly with front-loaded tip
US8206385B2 (en) 2008-06-09 2012-06-26 St. Jude Medical, Atrial Fibrillation Division, Inc. Catheter assembly with front-loaded tip and multi-contact connector
US20110288544A1 (en) 2008-07-17 2011-11-24 Maestroheart Sa Medical device for tissue ablation
US8585695B2 (en) 2008-07-22 2013-11-19 Hue-Teh Shih Systems and methods for noncontact ablation
US8221411B2 (en) * 2008-07-28 2012-07-17 Medtronic, Inc. Systems and methods for cardiac tissue electroporation ablation
JP4545210B2 (en) 2008-09-11 2010-09-15 日本ライフライン株式会社 Defibrillation catheter
US9119533B2 (en) 2008-10-07 2015-09-01 Mc10, Inc. Systems, methods, and devices having stretchable integrated circuitry for sensing and delivering therapy
EP2813192A3 (en) 2008-10-21 2015-04-15 Microcube, LLC Methods and devices for applying energy to bodily tissues
US8137343B2 (en) 2008-10-27 2012-03-20 Rhythmia Medical, Inc. Tracking system using field mapping
US8414508B2 (en) 2008-10-30 2013-04-09 Vytronus, Inc. System and method for delivery of energy to tissue while compensating for collateral tissue
US9220924B2 (en) 2008-10-30 2015-12-29 Vytronus, Inc. System and method for energy delivery to tissue while monitoring position, lesion depth, and wall motion
US9192789B2 (en) 2008-10-30 2015-11-24 Vytronus, Inc. System and method for anatomical mapping of tissue and planning ablation paths therein
US9192769B2 (en) 2008-10-31 2015-11-24 Medtronic, Inc. Shunt-current reduction techniques for an implantable therapy system
US9795442B2 (en) 2008-11-11 2017-10-24 Shifamed Holdings, Llc Ablation catheters
US9717557B2 (en) 2008-11-11 2017-08-01 Apama Medical, Inc. Cardiac ablation catheters and methods of use thereof
US8475445B2 (en) 2008-12-01 2013-07-02 Daniel Soroff Spectral analysis of intracardiac electrograms to predict identification of radiofrequency ablation sites
US8475450B2 (en) 2008-12-30 2013-07-02 Biosense Webster, Inc. Dual-purpose lasso catheter with irrigation
US8361066B2 (en) 2009-01-12 2013-01-29 Ethicon Endo-Surgery, Inc. Electrical ablation devices
US20100191232A1 (en) 2009-01-27 2010-07-29 Boveda Marco Medical Llc Catheters and methods for performing electrophysiological interventions
US8231603B2 (en) 2009-02-10 2012-07-31 Angiodynamics, Inc. Irreversible electroporation and tissue regeneration
JP5693471B2 (en) 2009-02-11 2015-04-01 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. Insulated ablation catheter device and use thereof
US10166067B2 (en) 2009-02-12 2019-01-01 St. Jude Medical, Atrial Fibrillation Division, Inc. Ablation catheter and method for electically isolating cardiac tissue
JP2012518470A (en) 2009-02-20 2012-08-16 ボストン サイエンティフィック サイムド,インコーポレイテッド Asymmetric bi-directional movable catheter sheath
US8747297B2 (en) 2009-03-02 2014-06-10 Olympus Corporation Endoscopic heart surgery method
EP2413833A1 (en) 2009-03-31 2012-02-08 AngioDynamics, Inc. System and method for estimating a treatment region for a medical treatment device and for interactively planning a treatment of a patient
US8632534B2 (en) 2009-04-03 2014-01-21 Angiodynamics, Inc. Irreversible electroporation (IRE) for congestive obstructive pulmonary disease (COPD)
US11382681B2 (en) 2009-04-09 2022-07-12 Virginia Tech Intellectual Properties, Inc. Device and methods for delivery of high frequency electrical pulses for non-thermal ablation
US11638603B2 (en) 2009-04-09 2023-05-02 Virginia Tech Intellectual Properties, Inc. Selective modulation of intracellular effects of cells using pulsed electric fields
US8287532B2 (en) 2009-04-13 2012-10-16 Biosense Webster, Inc. Epicardial mapping and ablation catheter
US8709006B2 (en) 2009-04-14 2014-04-29 Old Dominion Research Foundation System and method for applying plasma sparks to tissue
US9566107B2 (en) 2009-04-22 2017-02-14 St. Jude Medical, Atrial Fibrillation Division, Inc. Method and apparatus for radiofrequency ablation with increased depth and/or decreased volume of ablated tissue
US8571647B2 (en) 2009-05-08 2013-10-29 Rhythmia Medical, Inc. Impedance based anatomy generation
JP5786108B2 (en) 2009-05-08 2015-09-30 セント・ジュード・メディカル・ルクセンブルク・ホールディング・エスエーアールエル Method and apparatus for controlling lesion size in catheter ablation therapy
US8103338B2 (en) 2009-05-08 2012-01-24 Rhythmia Medical, Inc. Impedance based anatomy generation
US8551096B2 (en) 2009-05-13 2013-10-08 Boston Scientific Scimed, Inc. Directional delivery of energy and bioactives
US8430875B2 (en) 2009-05-19 2013-04-30 Estech, Inc. (Endoscopic Technologies, Inc.) Magnetic navigation systems and methods
WO2010138919A2 (en) 2009-05-28 2010-12-02 Angiodynamics, Inc. System and method for synchronizing energy delivery to the cardiac rhythm
JP5859431B2 (en) 2009-06-08 2016-02-10 エムアールアイ・インターヴェンションズ,インコーポレイテッド MRI guided intervention system capable of tracking flexible internal devices and generating dynamic visualization in near real time
GB2472216A (en) 2009-07-28 2011-02-02 Gyrus Medical Ltd Bipolar electrosurgical instrument with four electrodes
US20110028962A1 (en) 2009-07-31 2011-02-03 Randell Werneth Adjustable pulmonary vein ablation catheter
US9216055B2 (en) 2009-08-05 2015-12-22 Scr Inc. Systems, devices and methods for treating the heart with ablation
US9042969B2 (en) 2009-08-12 2015-05-26 Angel Medical Systems, Inc. Heart rate correction system and methods for the detection of cardiac events
US20110054487A1 (en) 2009-09-02 2011-03-03 Circulite, Inc. Coaxial transseptal guide-wire and needle assembly
US20150321021A1 (en) 2009-09-03 2015-11-12 The Johns Hopkins University Method and device for treating cardiac arrhythmias
US9642534B2 (en) 2009-09-11 2017-05-09 University Of Virginia Patent Foundation Systems and methods for determining location of an access needle in a subject
US9282910B2 (en) 2011-05-02 2016-03-15 The Regents Of The University Of California System and method for targeting heart rhythm disorders using shaped ablation
US20110098694A1 (en) 2009-10-28 2011-04-28 Ethicon Endo-Surgery, Inc. Methods and instruments for treating cardiac tissue through a natural orifice
US9861438B2 (en) 2009-12-11 2018-01-09 Biosense Webster (Israel), Ltd. Pre-formed curved ablation catheter
US8608735B2 (en) 2009-12-30 2013-12-17 Biosense Webster (Israel) Ltd. Catheter with arcuate end section
US9005198B2 (en) * 2010-01-29 2015-04-14 Ethicon Endo-Surgery, Inc. Surgical instrument comprising an electrode
US20110190727A1 (en) 2010-02-02 2011-08-04 Boston Scientific Scimed, Inc. Intervascular catheter, system and method
US8556891B2 (en) 2010-03-03 2013-10-15 Medtronic Ablation Frontiers Llc Variable-output radiofrequency ablation power supply
US20120046570A1 (en) 2010-03-08 2012-02-23 Alpha Orthopaedics, Inc. Methods and devices for real time monitoring of collagen content and for altering collagen status
EP2555674B1 (en) 2010-04-08 2019-06-12 The Regents of The University of California Methods, system and apparatus for the detection, diagnosis and treatment of biological rhythm disorders
AU2011238925B2 (en) * 2010-04-09 2016-06-16 Vessix Vascular, Inc. Power generating and control apparatus for the treatment of tissue
CN103096963B (en) 2010-04-13 2016-02-17 森特里心脏股份有限公司 The method entered for pericardium and device
CN104997574B (en) 2010-04-13 2017-06-06 森特里心脏股份有限公司 For the method and apparatus to Cardiac interventional and placing device
US9510894B2 (en) 2010-04-28 2016-12-06 Biosense Webster (Israel) Ltd. Irrigated ablation catheter having irrigation ports with reduced hydraulic resistance
US9943363B2 (en) 2010-04-28 2018-04-17 Biosense Webster, Inc. Irrigated ablation catheter with improved fluid flow
WO2011140331A1 (en) 2010-05-05 2011-11-10 Automated Medical Instruments, Inc. Anchored cardiac ablation catheter
US9924997B2 (en) 2010-05-05 2018-03-27 Ablacor Medical Corporation Anchored ablation catheter
US9655677B2 (en) 2010-05-12 2017-05-23 Shifamed Holdings, Llc Ablation catheters including a balloon and electrodes
ES2567189T3 (en) 2010-06-08 2016-04-20 Toray Industries, Inc. Catheter for measuring electrical potential
ITRM20100314A1 (en) 2010-06-09 2011-12-10 Luca Viviana De CATHETER WITH REVERSIBLE STABILITY, FOR STABILIZATION DURING THE ABLATION TRANSCATETERE BY MEANS OF RADIO FREQUENCY.
SG186835A1 (en) 2010-06-28 2013-02-28 Colibri Heart Valve Llc Method and apparatus for the endoluminal delivery of intravascular devices
CN103037792B (en) 2010-07-30 2016-07-13 Umc乌德勒支控股有限公司 The combination of generator, generator and conduit and the method for offer electric pulse
US20120029512A1 (en) 2010-07-30 2012-02-02 Willard Martin R Balloon with surface electrodes and integral cooling for renal nerve ablation
JP2012050538A (en) 2010-08-31 2012-03-15 Terumo Corp Ablation device
US9289606B2 (en) * 2010-09-02 2016-03-22 St. Jude Medical, Atrial Fibrillation Division, Inc. System for electroporation therapy
US20120078320A1 (en) 2010-09-29 2012-03-29 Medtronic, Inc. Prioritized programming of multi-electrode pacing leads
US20120089089A1 (en) 2010-10-12 2012-04-12 Ethicon Endo-Surgery, Inc. Methods of magnetically guiding and axially aligning distal ends of surgical devices
AU2011236083A1 (en) 2010-10-20 2012-05-10 Maria G. Aboytes Catheter apparatuses having expandable mesh structures for renal neuromodulation and associated systems and methods
WO2012068505A1 (en) 2010-11-19 2012-05-24 St. Jude Medical, Atrial Fibrillation Division, Inc. Electrode catheter device with indifferent electrode for direct current tissue therapies
WO2012068471A1 (en) 2010-11-19 2012-05-24 Boston Scientific Scimed, Inc. Renal nerve detection and ablation apparatus and method
US20120158021A1 (en) 2010-12-19 2012-06-21 Mitralign, Inc. Steerable guide catheter having preformed curved shape
WO2012088149A2 (en) 2010-12-20 2012-06-28 Virginia Tech Intellectual Properties, Inc. High-frequency electroporation for cancer therapy
US9308041B2 (en) 2010-12-22 2016-04-12 Biosense Webster (Israel) Ltd. Lasso catheter with rotating ultrasound transducer
DE102010064101B4 (en) 2010-12-23 2017-02-23 Siemens Healthcare Gmbh Pair of endocardial and epicardial catheters and catheters
US20120303019A1 (en) 2010-12-25 2012-11-29 Xue Zhao Kind of cardiac ablation catheter with guide-wire
US9149327B2 (en) 2010-12-27 2015-10-06 St. Jude Medical Luxembourg Holding S.À.R.L. Prediction of atrial wall electrical reconnection based on contact force measured during RF ablation
WO2012092275A1 (en) 2010-12-27 2012-07-05 Endosense S.A. Prediction of atrial wall electrical reconnection based on contact force measured during rf ablation
US9572620B2 (en) 2010-12-29 2017-02-21 Kyungmoo Ryu System and method for treating arrhythmias in the heart using information obtained from heart wall motion
US9095262B2 (en) 2011-01-05 2015-08-04 Mehdi Razavi Guided ablation devices, systems, and methods
US9044245B2 (en) 2011-01-05 2015-06-02 Medtronic Ablation Frontiers Llc Multipolarity epicardial radiofrequency ablation
US9002442B2 (en) 2011-01-13 2015-04-07 Rhythmia Medical, Inc. Beat alignment and selection for cardiac mapping
US9486273B2 (en) 2011-01-21 2016-11-08 Kardium Inc. High-density electrode-based medical device system
CA2764494A1 (en) 2011-01-21 2012-07-21 Kardium Inc. Enhanced medical device for use in bodily cavities, for example an atrium
US9314620B2 (en) 2011-02-28 2016-04-19 Ethicon Endo-Surgery, Inc. Electrical ablation devices and methods
KR102017532B1 (en) 2011-03-08 2019-09-03 넥서스 컨트롤 시스템즈 엘엘씨 Ablation catheter device with safety features
US9937002B2 (en) 2011-03-08 2018-04-10 Nexus Control Systems, Llc Ablation catheter system with safety features
EP2696791A4 (en) 2011-04-13 2014-10-29 Vytronus Inc Integrated ablation and mapping system
KR101248959B1 (en) 2011-05-12 2013-04-01 신경민 Electrode device having flexible tube for high frequency thermotherapy
US9545529B2 (en) * 2011-05-19 2017-01-17 Alma Lasers Ltd. Concurrent treatment with thermal and acoustic energy
US9072518B2 (en) 2011-05-31 2015-07-07 Atricure, Inc. High-voltage pulse ablation systems and methods
US20120310230A1 (en) 2011-06-01 2012-12-06 Angiodynamics, Inc. Coaxial dual function probe and method of use
US20120316557A1 (en) 2011-06-08 2012-12-13 Tyco Healthcare Group Lp Septoplasty Instrument
EP2720751B1 (en) 2011-06-15 2015-04-15 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Apparatus for and method of terminating a high frequency arrhythmic electric state of a biological tissue
US10506948B2 (en) 2011-07-05 2019-12-17 Cardioinsight Technologies, Inc. Localization for electrocardiographic mapping
WO2013013099A1 (en) 2011-07-19 2013-01-24 Adagio Medical, Inc. Methods and devices for the treatment of atrial fibrillation
WO2013055815A1 (en) 2011-10-11 2013-04-18 Boston Scientific Scimed, Inc. Off -wall electrode device for nerve modulation
WO2013096199A1 (en) 2011-12-20 2013-06-27 Cardiac Pacemakers, Inc. Ectopic-triggered para-his stimulation
US8825130B2 (en) 2011-12-30 2014-09-02 St. Jude Medical, Atrial Fibrillation Division, Inc. Electrode support structure assemblies
US9687289B2 (en) 2012-01-04 2017-06-27 Biosense Webster (Israel) Ltd. Contact assessment based on phase measurement
CN104039257A (en) 2012-01-10 2014-09-10 波士顿科学医学有限公司 Electrophysiology system
US9414881B2 (en) 2012-02-08 2016-08-16 Angiodynamics, Inc. System and method for increasing a target zone for electrical ablation
US8808273B2 (en) 2012-02-10 2014-08-19 Biosense Webster (Israel) Ltd. Electrophysiology catheter with mechanical use limiter
US9095350B2 (en) 2012-05-01 2015-08-04 Medtronic Ablation Frontiers Llc Impedance detection of venous placement of multi-electrode catheters
WO2013165584A1 (en) 2012-05-04 2013-11-07 St. Jude Medical, Atrial Fibrillation Division, Inc. System and method for controlling delivery of ablation energy to tissue
US9011423B2 (en) 2012-05-21 2015-04-21 Kardium, Inc. Systems and methods for selecting, activating, or selecting and activating transducers
US9554847B2 (en) 2012-07-02 2017-01-31 Biosense Webster (Israel) Ltd. Real time assessment of ablation from electrocardiogram signals
US9101374B1 (en) 2012-08-07 2015-08-11 David Harris Hoch Method for guiding an ablation catheter based on real time intracardiac electrical signals and apparatus for performing the method
US9277957B2 (en) 2012-08-15 2016-03-08 Ethicon Endo-Surgery, Inc. Electrosurgical devices and methods
US20140052216A1 (en) 2012-08-15 2014-02-20 Ethicon Endo-Surgery, Inc. Methods for promoting wound healing
US9801681B2 (en) 2012-08-17 2017-10-31 Medtronic Ablation Frontiers Llc Catheters and methods for intracardiac electrical mapping
US9168004B2 (en) 2012-08-20 2015-10-27 Biosense Webster (Israel) Ltd. Machine learning in determining catheter electrode contact
WO2014031800A1 (en) 2012-08-22 2014-02-27 Energize Medical Llc Therapeutic energy systems
EP2890292B1 (en) 2012-08-31 2021-01-13 Acutus Medical, Inc. Catheter system for the heart
JP2014054430A (en) 2012-09-13 2014-03-27 Nippon Koden Corp Catheter
US11096741B2 (en) 2012-10-10 2021-08-24 Biosense Webster (Israel) Ltd. Ablation power control based on contact force
US9827036B2 (en) 2012-11-13 2017-11-28 Pulnovo Medical (Wuxi) Co., Ltd. Multi-pole synchronous pulmonary artery radiofrequency ablation catheter
US9757185B2 (en) 2012-11-29 2017-09-12 Gyrus Acmi, Inc. Quadripolar forceps
WO2014089373A1 (en) 2012-12-05 2014-06-12 University Of Rochester Catheter with integrated transeptal puncture needle
US9023036B2 (en) 2012-12-07 2015-05-05 Biosense Webster (Israel) Ltd. Lasso catheter with tip electrode
US9474850B2 (en) 2012-12-11 2016-10-25 Biosense Webster (Israel) Ltd. Lasso catheter with guide wire
US9078667B2 (en) 2012-12-11 2015-07-14 St. Jude Medical, Atrial Fibrillation Division, Inc. Catheter having reduced force concentration at tissue contact site
JP2016507272A (en) 2012-12-21 2016-03-10 ヴォルカノ コーポレイションVolcano Corporation Functional gain measurement technique and display
US9204820B2 (en) 2012-12-31 2015-12-08 Biosense Webster (Israel) Ltd. Catheter with combined position and pressure sensing structures
US10537286B2 (en) 2013-01-08 2020-01-21 Biosense Webster (Israel) Ltd. Catheter with multiple spines of different lengths arranged in one or more distal assemblies
AU2014210802A1 (en) 2013-01-31 2015-07-23 Renal Dynamics Ltd. Ablation catheter with insulation
US9031642B2 (en) 2013-02-21 2015-05-12 Medtronic, Inc. Methods for simultaneous cardiac substrate mapping using spatial correlation maps between neighboring unipolar electrograms
US9474486B2 (en) 2013-03-08 2016-10-25 St. Jude Medical, Atrial Fibrillation Division, Inc. Basket for a multi-electrode array catheter
US9519021B2 (en) 2013-03-11 2016-12-13 Covidien Lp Systems and methods for detecting abnormalities within a circuit of an electrosurgical generator
US9486272B2 (en) 2013-03-12 2016-11-08 Biosense Webster (Israel) Ltd. Force feedback device and method for catheters
US9345540B2 (en) * 2013-03-15 2016-05-24 Medtronic Ablation Frontiers Llc Contact specific RF therapy balloon
EP2967738A1 (en) 2013-03-15 2016-01-20 Medtronic Ardian Luxembourg S.à.r.l. Treatment device with electrode contact surface configured for enhancing uniformity of electrical energy distribution and associated devices and methods
ES2719955T3 (en) 2013-03-27 2019-07-17 Autonomix Medical Inc Systems for evaluation and modification of traffic and neurological receptors
US10575743B2 (en) 2013-04-11 2020-03-03 Biosense Webster (Israel) Ltd. High electrode density basket catheter
US20160113709A1 (en) 2013-06-05 2016-04-28 Tel Hashomer Medical Research Infrastructure And Services Ltd Myocardial ablation by irreversible electroporation
WO2015021113A1 (en) 2013-08-06 2015-02-12 Memorial Sloan Kettering Cancer Center System, method and computer-accessible medium for in-vivo tissue ablation and/or damage
AU2014311594A1 (en) 2013-08-29 2016-03-10 Boston Scientific Neuromodulation Corporation Systems for adjusting the compliance voltage in a neuromodulation device
US9931046B2 (en) 2013-10-25 2018-04-03 Ablative Solutions, Inc. Intravascular catheter with peri-vascular nerve activity sensors
US10076258B2 (en) 2013-11-01 2018-09-18 Boston Scientific Scimed, Inc. Cardiac mapping using latency interpolation
US20150141978A1 (en) 2013-11-20 2015-05-21 Boston Scientific Scimed, Inc. Ablation medical devices and methods for making and using ablation medical devices
US20150173828A1 (en) 2013-12-23 2015-06-25 Boaz Avitall Small loop ablation catheter
WO2015099786A1 (en) 2013-12-27 2015-07-02 Empire Technology Development Llc Devices and techniques for ablative treatment
WO2015103574A1 (en) 2014-01-06 2015-07-09 Iowa Approach Inc. Apparatus and methods for renal denervation ablation
CN105939686A (en) 2014-01-06 2016-09-14 衣阿华方法股份有限公司 Devices and methods for delivering therapeutic electrical impulses
WO2015123163A1 (en) 2014-02-11 2015-08-20 St. Jude Medical, Cardiology Division, Inc. Ablation catheter and associated methods
CA2940086C (en) 2014-02-17 2022-07-26 Children's National Medical Center Delivery tool and method for devices in the pericardial space
JP6393768B2 (en) 2014-02-25 2018-09-19 セント・ジュード・メディカル,カーディオロジー・ディヴィジョン,インコーポレイテッド System and method for local electrophysiological representation of cardiac matrix characteristics using a multi-electrode catheter
JP6507226B2 (en) 2014-03-20 2019-04-24 アトリカス エス.ピー.エー. Ablation catheter and ablation device
WO2015143327A1 (en) 2014-03-21 2015-09-24 Mayo Foundation For Medical Education And Research Multi-electrode epicardial pacing
US9956035B2 (en) 2014-03-27 2018-05-01 Biosense Webster (Israel) Ltd. Temperature measurement in catheter
US20150289923A1 (en) 2014-04-14 2015-10-15 Virginia Tech Intellectual Properties, Inc. Treatment planning for electrical-energy based therapies based on cell characteristics
US9717552B2 (en) * 2014-05-06 2017-08-01 Cosman Intruments, Llc Electrosurgical generator
EP3495018B1 (en) 2014-05-07 2023-09-06 Farapulse, Inc. Apparatus for selective tissue ablation
EP3142584A1 (en) 2014-05-16 2017-03-22 Iowa Approach Inc. Methods and apparatus for multi-catheter tissue ablation
US9848795B2 (en) 2014-06-04 2017-12-26 Boston Scientific Scimed Inc. Electrode assembly
EP3154464A4 (en) 2014-06-12 2018-01-24 Iowa Approach Inc. Method and apparatus for rapid and selective tissue ablation with cooling
EP3154463B1 (en) 2014-06-12 2019-03-27 Farapulse, Inc. Apparatus for rapid and selective transurethral tissue ablation
US12114911B2 (en) 2014-08-28 2024-10-15 Angiodynamics, Inc. System and method for ablating a tissue site by electroporation with real-time pulse monitoring
WO2016059027A1 (en) 2014-10-13 2016-04-21 Dr Philippe Debruyne Bvba Limited ablation for the treatment of sick sinus syndrome and other inappropriate sinus bradycardias
JP2017529169A (en) 2014-10-13 2017-10-05 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. Tissue diagnosis and treatment using mini-electrodes
EP3206613B1 (en) 2014-10-14 2019-07-03 Farapulse, Inc. Apparatus for rapid and safe pulmonary vein cardiac ablation
US10231778B2 (en) 2014-10-20 2019-03-19 Biosense Webster (Israel) Ltd. Methods for contemporaneous assessment of renal denervation
CN106604675B (en) 2014-10-24 2020-01-10 波士顿科学医学有限公司 Medical device having a flexible electrode assembly coupled to an ablation tip
EP3220843B1 (en) 2014-11-19 2020-01-01 EPiX Therapeutics, Inc. Ablation devices and methods of using a high-resolution electrode assembly
CA2969129A1 (en) 2014-12-03 2016-06-09 Metavention, Inc. Systems and methods for modulating nerves or other tissue
US10271893B2 (en) 2014-12-15 2019-04-30 Medtronic Ablation Frontiers Llc Timed energy delivery
CN106999080B (en) 2014-12-18 2020-08-18 波士顿科学医学有限公司 Real-time morphological analysis for lesion assessment
WO2016109207A1 (en) 2014-12-31 2016-07-07 St. Jude Medical, Cardiology Division, Inc. Filter circuit for electrophysiology system
US9782099B2 (en) 2014-12-31 2017-10-10 Biosense Webster (Israel) Ltd. Basket catheter with improved spine flexibility
JP6854015B2 (en) 2015-05-12 2021-04-07 ナショナル ユニバーシティ オブ アイルランド ゴールウェイ Devices and related methods and systems for therapeutic nasal nerve regulation
EP3294172B9 (en) 2015-05-12 2023-04-05 St. Jude Medical, Atrial Fibrillation Division, Inc. Asymmetric balanced waveform for ac cardiac irreversible electroporation
WO2016201264A1 (en) 2015-06-11 2016-12-15 Massachusetts Institute Of Technology Methods for inducing electroporation and tissue ablation
US9949656B2 (en) 2015-06-29 2018-04-24 Biosense Webster (Israel) Ltd. Catheter with stacked spine electrode assembly
US10583294B2 (en) 2015-07-02 2020-03-10 Dirk De Ridder Methods and apparatus for sensing cross-frequency coupling and neuromodulation
US9931487B2 (en) 2015-08-06 2018-04-03 Boston Scientific Scimed, Inc. Bidirectional steering control apparatus for a catheter
DE202016009215U1 (en) 2015-08-06 2024-04-29 Medtronic, Inc. Cardiac ablation using pulsed field
US20170071543A1 (en) 2015-09-14 2017-03-16 Biosense Webster (Israel) Ltd. Convertible basket catheter
US20170095291A1 (en) 2015-10-06 2017-04-06 Halcyon Medical, Inc. Aorticorenal Ganglion Detection
US20170105793A1 (en) 2015-10-15 2017-04-20 Boston Scientific Scimed, Inc. Energy delivery devices and related methods of use
US10675462B2 (en) 2015-11-04 2020-06-09 Boston Scientific Scimed, Inc. Medical device and related methods
CN108601616B (en) 2015-12-01 2022-04-12 苏州信迈医疗器械有限公司 System and method for mapping functional nerves innervating arterial wall, and 3D mapping method and catheter capable of realizing same
US10130423B1 (en) 2017-07-06 2018-11-20 Farapulse, Inc. Systems, devices, and methods for focal ablation
US10660702B2 (en) 2016-01-05 2020-05-26 Farapulse, Inc. Systems, devices, and methods for focal ablation
CN108778173A (en) 2016-01-05 2018-11-09 法拉普尔赛股份有限公司 Systems, devices and methods for impulse electric field ablation energy to be delivered to endocardial tissue
CN113813045A (en) 2016-01-05 2021-12-21 法拉普尔赛股份有限公司 Systems, devices, and methods for delivering ablation energy to tissue
US20170189097A1 (en) 2016-01-05 2017-07-06 Iowa Approach Inc. Systems, apparatuses and methods for delivery of ablative energy to tissue
US10172673B2 (en) 2016-01-05 2019-01-08 Farapulse, Inc. Systems devices, and methods for delivery of pulsed electric field ablative energy to endocardial tissue
US10512505B2 (en) 2018-05-07 2019-12-24 Farapulse, Inc. Systems, apparatuses and methods for delivery of ablative energy to tissue
US10548665B2 (en) 2016-02-29 2020-02-04 Pulse Biosciences, Inc. High-voltage analog circuit pulser with feedback control
US10874451B2 (en) 2016-02-29 2020-12-29 Pulse Biosciences, Inc. High-voltage analog circuit pulser and pulse generator discharge circuit
US11246656B2 (en) 2016-05-02 2022-02-15 Affera, Inc. Therapeutic catheter with imaging
EP3471631A4 (en) 2016-06-16 2020-03-04 Farapulse, Inc. Systems, apparatuses, and methods for guide wire delivery
EP4209190A1 (en) 2016-06-27 2023-07-12 Galvanize Therapeutics, Inc. System comprising a generator and a catheter with an electrode for treating a lung passageway
EP4039185B1 (en) 2016-11-11 2024-07-24 National University of Ireland Galway System for therapeutic nasal neuromodulation
CN110087572A (en) 2016-12-19 2019-08-02 波士顿科学医学有限公司 The electrod-array towards distal end with longitudinally mounted spline
US20180184982A1 (en) 2017-01-05 2018-07-05 Biosense Webster (Israel) Ltd. Hybrid balloon basket catheter
US10912609B2 (en) 2017-01-06 2021-02-09 St. Jude Medical, Cardiology Division, Inc. Pulmonary vein isolation balloon catheter
US11497550B2 (en) 2017-04-10 2022-11-15 St. Jude Medical, Cardiology Division, Inc. Electroporation system and method of energizing a catheter
WO2018191113A1 (en) 2017-04-10 2018-10-18 St. Jude Medical, Cardiology Division, Inc. Electroporation system and method of preconditioning tissue for electroporation therapy
EP4005500A1 (en) 2017-04-20 2022-06-01 Medtronic, Inc. Stabilization of a transseptal delivery device
US9987081B1 (en) 2017-04-27 2018-06-05 Iowa Approach, Inc. Systems, devices, and methods for signal generation
US10617867B2 (en) 2017-04-28 2020-04-14 Farapulse, Inc. Systems, devices, and methods for delivery of pulsed electric field ablative energy to esophageal tissue
US11426233B2 (en) 2017-06-06 2022-08-30 Cardiac Pacemakers, Inc. Ablation delivery using a catheter having a semipermeable inflatable balloon structure
US20180360534A1 (en) 2017-06-19 2018-12-20 St. Jude Medical, Cardiology Division, Inc. Apparatuses and methods for high-density sensing and ablation during a medical procedure
US11633121B2 (en) 2017-08-04 2023-04-25 Medtronic, Inc. Ablation check pulse routine and integration for electroporation
US10850095B2 (en) 2017-08-08 2020-12-01 Pulse Biosciences, Inc. Treatment of tissue by the application of energy
EP4279004A3 (en) 2017-10-26 2024-01-03 Boston Scientific Scimed, Inc. Use of electromagnetic fields in ire device delivery and therapy monitoring
EP3723845A4 (en) 2017-12-11 2021-01-13 Mayo Foundation for Medical Education and Research Methods and systems for electroporation
EP3668381A1 (en) 2017-12-19 2020-06-24 St. Jude Medical, Cardiology Division, Inc. Methods of assessing contact between an electrode and tissue using complex impedance measurements
EP4218640A1 (en) 2017-12-26 2023-08-02 Galvanize Therapeutics, Inc. Systems for the treatment of disease states and disorders
US20190336198A1 (en) 2018-05-03 2019-11-07 Farapulse, Inc. Systems, devices, and methods for ablation using surgical clamps
EP3578124A1 (en) 2018-06-05 2019-12-11 National University of Ireland Galway Electrophysiology apparatus

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060024359A1 (en) * 1995-06-07 2006-02-02 Walker Jeffrey P Drug delivery system and method
US20020077627A1 (en) * 2000-07-25 2002-06-20 Johnson Theodore C. Method for detecting and treating tumors using localized impedance measurement
US20060293730A1 (en) * 2005-06-24 2006-12-28 Boris Rubinsky Methods and systems for treating restenosis sites using electroporation
US20120095459A1 (en) * 2010-10-13 2012-04-19 Peter Callas System and Method for Electrically Ablating Tissue of a Patient
US20130030430A1 (en) * 2011-07-29 2013-01-31 Stewart Mark T Intracardiac tools and methods for delivery of electroporation therapies
WO2014025394A1 (en) * 2012-08-09 2014-02-13 University Of Iowa Research Foundation Catheters, catheter systems, and methods for puncturing through a tissue structure

Cited By (136)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10828093B2 (en) 2006-06-28 2020-11-10 Kardium Inc. Apparatus and method for intra-cardiac mapping and ablation
US11389231B2 (en) 2006-06-28 2022-07-19 Kardium Inc. Apparatus and method for intra-cardiac mapping and ablation
US11389232B2 (en) 2006-06-28 2022-07-19 Kardium Inc. Apparatus and method for intra-cardiac mapping and ablation
US11399890B2 (en) 2006-06-28 2022-08-02 Kardium Inc. Apparatus and method for intra-cardiac mapping and ablation
US10820941B2 (en) 2006-06-28 2020-11-03 Kardium Inc. Apparatus and method for intra-cardiac mapping and ablation
US10828094B2 (en) 2006-06-28 2020-11-10 Kardium Inc. Apparatus and method for intra-cardiac mapping and ablation
US10828098B2 (en) 2007-11-16 2020-11-10 Kardium Inc. Medical device for use in bodily lumens, for example an atrium
US10828096B2 (en) 2007-11-16 2020-11-10 Kardium Inc. Medical device for use in bodily lumens, for example an atrium
US11801091B2 (en) 2007-11-16 2023-10-31 Kardium Inc. Medical device for use in bodily lumens, for example an atrium
US11076913B2 (en) 2007-11-16 2021-08-03 Kardium Inc. Medical device for use in bodily lumens, for example an atrium
US11751940B2 (en) 2007-11-16 2023-09-12 Kardium Inc. Medical device for use in bodily lumens, for example an atrium
US10828095B2 (en) 2007-11-16 2020-11-10 Kardium Inc. Medical device for use in bodily lumens, for example an atrium
US11432874B2 (en) 2007-11-16 2022-09-06 Kardium Inc. Medical device for use in bodily lumens, for example an atrium
US11304751B2 (en) 2007-11-16 2022-04-19 Kardium Inc. Medical device for use in bodily lumens, for example an atrium
US11413091B2 (en) 2007-11-16 2022-08-16 Kardium Inc. Medical device for use in bodily lumens, for example an atrium
US10499986B2 (en) 2007-11-16 2019-12-10 Kardium Inc. Medical device for use in bodily lumens, for example an atrium
US11331141B2 (en) 2007-11-16 2022-05-17 Kardium Inc. Medical device for use in bodily lumens, for example an atrium
US11633231B2 (en) 2007-11-16 2023-04-25 Kardium Inc. Medical device for use in bodily lumens, for example an atrium
US10828097B2 (en) 2007-11-16 2020-11-10 Kardium Inc. Medical device for use in bodily lumens, for example an atrium
US20190083169A1 (en) * 2008-05-09 2019-03-21 Angiodynamics, Inc. Techniques for Controlling an Irreversible Electroporation System
US11707629B2 (en) 2009-05-28 2023-07-25 Angiodynamics, Inc. System and method for synchronizing energy delivery to the cardiac rhythm
US11931096B2 (en) 2010-10-13 2024-03-19 Angiodynamics, Inc. System and method for electrically ablating tissue of a patient
US11896295B2 (en) 2011-01-21 2024-02-13 Kardium Inc. High-density electrode-based medical device system
US11259867B2 (en) 2011-01-21 2022-03-01 Kardium Inc. High-density electrode-based medical device system
US11298173B2 (en) 2011-01-21 2022-04-12 Kardium Inc. Enhanced medical device for use in bodily cavities, for example an atrium
US11596463B2 (en) 2011-01-21 2023-03-07 Kardium Inc. Enhanced medical device for use in bodily cavities, for example an atrium
US11607261B2 (en) 2011-01-21 2023-03-21 Kardium Inc. Enhanced medical device for use in bodily cavities, for example an atrium
US10485608B2 (en) 2011-01-21 2019-11-26 Kardium Inc. Catheter system
US11399881B2 (en) 2011-01-21 2022-08-02 Kardium Inc. Enhanced medical device for use in bodily cavities, for example an atrium
US12059202B2 (en) 2011-01-21 2024-08-13 Kardium Inc. Catheter system
US11350989B2 (en) 2011-01-21 2022-06-07 Kardium Inc. Catheter system
US11779395B2 (en) 2011-09-28 2023-10-10 Angiodynamics, Inc. Multiple treatment zone ablation probe
US12102376B2 (en) 2012-02-08 2024-10-01 Angiodynamics, Inc. System and method for increasing a target zone for electrical ablation
US11589821B2 (en) 2012-05-21 2023-02-28 Kardium Inc. Systems and methods for activating transducers
US11633238B2 (en) 2012-05-21 2023-04-25 Kardium Inc. Systems and methods for selecting, activating, or selecting and activating transducers
US10918446B2 (en) 2012-05-21 2021-02-16 Kardium Inc. Systems and methods for selecting, activating, or selecting and activating transducers
US11154248B2 (en) 2012-05-21 2021-10-26 Kardium Inc. Systems and methods for activating transducers
US10568576B2 (en) 2012-05-21 2020-02-25 Kardium Inc. Systems and methods for activating transducers
US11805974B2 (en) 2012-05-21 2023-11-07 Kardium Inc. Systems and methods for selecting, activating, or selecting and activating transducers
US11690684B2 (en) 2012-05-21 2023-07-04 Kardium Inc. Systems and methods for selecting, activating, or selecting and activating transducers
US10470826B2 (en) 2012-05-21 2019-11-12 Kardium Inc. Systems and methods for selecting, activating, or selecting and activating transducers
US11672485B2 (en) 2012-05-21 2023-06-13 Kardium Inc. Systems and methods for activating transducers
US10827977B2 (en) 2012-05-21 2020-11-10 Kardium Inc. Systems and methods for activating transducers
US11426573B2 (en) 2012-08-09 2022-08-30 University Of Iowa Research Foundation Catheters, catheter systems, and methods for puncturing through a tissue structure and ablating a tissue region
US9861802B2 (en) 2012-08-09 2018-01-09 University Of Iowa Research Foundation Catheters, catheter systems, and methods for puncturing through a tissue structure
US11957405B2 (en) 2013-06-13 2024-04-16 Angiodynamics, Inc. Methods of sterilization and treating infection using irreversible electroporation
US11589919B2 (en) 2014-01-06 2023-02-28 Boston Scientific Scimed, Inc. Apparatus and methods for renal denervation ablation
US10517672B2 (en) 2014-01-06 2019-12-31 Farapulse, Inc. Apparatus and methods for renal denervation ablation
US11259869B2 (en) 2014-05-07 2022-03-01 Farapulse, Inc. Methods and apparatus for selective tissue ablation
US11241282B2 (en) 2014-06-12 2022-02-08 Boston Scientific Scimed, Inc. Method and apparatus for rapid and selective transurethral tissue ablation
US10433906B2 (en) 2014-06-12 2019-10-08 Farapulse, Inc. Method and apparatus for rapid and selective transurethral tissue ablation
US10624693B2 (en) 2014-06-12 2020-04-21 Farapulse, Inc. Method and apparatus for rapid and selective tissue ablation with cooling
US11622803B2 (en) 2014-06-12 2023-04-11 Boston Scientific Scimed, Inc. Method and apparatus for rapid and selective tissue ablation with cooling
US12114911B2 (en) 2014-08-28 2024-10-15 Angiodynamics, Inc. System and method for ablating a tissue site by electroporation with real-time pulse monitoring
US10835314B2 (en) 2014-10-14 2020-11-17 Farapulse, Inc. Method and apparatus for rapid and safe pulmonary vein cardiac ablation
US9999465B2 (en) 2014-10-14 2018-06-19 Iowa Approach, Inc. Method and apparatus for rapid and safe pulmonary vein cardiac ablation
US11026638B2 (en) 2014-11-17 2021-06-08 Kardium Inc. Systems and methods for selecting, activating, or selecting and activating transducers
US10758191B2 (en) 2014-11-17 2020-09-01 Kardium Inc. Systems and methods for selecting, activating, or selecting and activating transducers
US11026637B2 (en) 2014-11-17 2021-06-08 Kardium Inc. Systems and methods for selecting, activating, or selecting and activating transducers
US10722184B2 (en) 2014-11-17 2020-07-28 Kardium Inc. Systems and methods for selecting, activating, or selecting and activating transducers
US10368936B2 (en) 2014-11-17 2019-08-06 Kardium Inc. Systems and methods for selecting, activating, or selecting and activating transducers
US10751006B2 (en) 2014-11-17 2020-08-25 Kardium Inc. Systems and methods for selecting, activating, or selecting and activating transducers
US12133745B2 (en) 2014-11-17 2024-11-05 Kardium Inc. Systems and methods for selecting, activating, or selecting and activating transducers
US10433908B2 (en) 2016-01-05 2019-10-08 Farapulse, Inc. Systems, devices, and methods for delivery of pulsed electric field ablative energy to endocardial tissue
US10172673B2 (en) 2016-01-05 2019-01-08 Farapulse, Inc. Systems devices, and methods for delivery of pulsed electric field ablative energy to endocardial tissue
US11020179B2 (en) 2016-01-05 2021-06-01 Farapulse, Inc. Systems, devices, and methods for focal ablation
US10660702B2 (en) 2016-01-05 2020-05-26 Farapulse, Inc. Systems, devices, and methods for focal ablation
US10512779B2 (en) 2016-01-05 2019-12-24 Farapulse, Inc. Systems, apparatuses and methods for delivery of ablative energy to tissue
US10709891B2 (en) 2016-01-05 2020-07-14 Farapulse, Inc. Systems, apparatuses and methods for delivery of ablative energy to tissue
US11589921B2 (en) 2016-01-05 2023-02-28 Boston Scientific Scimed, Inc. Systems, apparatuses and methods for delivery of ablative energy to tissue
US10842561B2 (en) 2016-01-05 2020-11-24 Farapulse, Inc. Systems, devices, and methods for delivery of pulsed electric field ablative energy to endocardial tissue
US10322286B2 (en) 2016-01-05 2019-06-18 Farapulse, Inc. Systems, apparatuses and methods for delivery of ablative energy to tissue
US11376064B2 (en) * 2016-06-07 2022-07-05 Dot Medical Ltd. Apparatus and method for cardiac ablation
US10507302B2 (en) 2016-06-16 2019-12-17 Farapulse, Inc. Systems, apparatuses, and methods for guide wire delivery
US11369433B2 (en) 2016-06-27 2022-06-28 Galvanize Therapeutics, Inc. Methods, apparatuses, and systems for the treatment of pulmonary disorders
US10939958B2 (en) 2016-06-27 2021-03-09 Galary, Inc. Methods, apparatuses, and systems for the treatment of pulmonary disorders
US10702337B2 (en) 2016-06-27 2020-07-07 Galary, Inc. Methods, apparatuses, and systems for the treatment of pulmonary disorders
US11723710B2 (en) 2016-11-17 2023-08-15 Angiodynamics, Inc. Techniques for irreversible electroporation using a single-pole tine-style internal device communicating with an external surface electrode
US20230030152A1 (en) * 2017-04-10 2023-02-02 St. Jude Medical, Cardiology Division, Inc. Electroporation system and method of energizing a catheter
US20230404657A1 (en) * 2017-04-10 2023-12-21 St. Jude Medical, Cardiology Division, Inc. Electroporation system and method of energizing a catheter
US11786301B2 (en) * 2017-04-10 2023-10-17 St. Jude Medical, Cardiology Division, Inc. Electroporation system and method of energizing a catheter
US11497550B2 (en) * 2017-04-10 2022-11-15 St. Jude Medical, Cardiology Division, Inc. Electroporation system and method of energizing a catheter
US20210137587A1 (en) * 2017-04-10 2021-05-13 St. Jude Medical, Cardiology Division, Inc. Electroporation system and method of energizing a catheter
CN110573102A (en) * 2017-04-24 2019-12-13 美敦力 enhanced electroporation of cardiac tissue
US20220338925A1 (en) * 2017-04-24 2022-10-27 Medtronic Cryocath Lp Enhanced electroporation of cardiac tissue
US9987081B1 (en) 2017-04-27 2018-06-05 Iowa Approach, Inc. Systems, devices, and methods for signal generation
US10016232B1 (en) 2017-04-27 2018-07-10 Iowa Approach, Inc. Systems, devices, and methods for signal generation
US12121720B2 (en) 2017-04-27 2024-10-22 Boston Scientific Scimed, Inc. Systems, devices, and methods for signal generation
US11357978B2 (en) 2017-04-27 2022-06-14 Boston Scientific Scimed, Inc. Systems, devices, and methods for signal generation
US11833350B2 (en) 2017-04-28 2023-12-05 Boston Scientific Scimed, Inc. Systems, devices, and methods for delivery of pulsed electric field ablative energy to esophageal tissue
US10617867B2 (en) 2017-04-28 2020-04-14 Farapulse, Inc. Systems, devices, and methods for delivery of pulsed electric field ablative energy to esophageal tissue
US11690669B2 (en) 2017-05-12 2023-07-04 St. Jude Medical, Cardiology Division, Inc. Electroporation systems and catheters for electroporation systems
US10130423B1 (en) 2017-07-06 2018-11-20 Farapulse, Inc. Systems, devices, and methods for focal ablation
US10617467B2 (en) 2017-07-06 2020-04-14 Farapulse, Inc. Systems, devices, and methods for focal ablation
US10893905B2 (en) 2017-09-12 2021-01-19 Farapulse, Inc. Systems, apparatuses, and methods for ventricular focal ablation
US11969197B2 (en) 2017-10-13 2024-04-30 Mayo Foundation For Medical Education And Research Methods and devices for electroporation for treatment of ventricular fibrillation
US20190117970A1 (en) * 2017-10-23 2019-04-25 Cardiac Pacemakers, Inc. Electric field shaping leads for treatment of cancer
EP3723845A4 (en) * 2017-12-11 2021-01-13 Mayo Foundation for Medical Education and Research Methods and systems for electroporation
US11541241B2 (en) 2017-12-11 2023-01-03 Mayo Foundation For Medical Education And Research Methods and systems for electroporation
WO2019118436A1 (en) 2017-12-11 2019-06-20 Mayo Foundation For Medical Education And Research Methods and systems for electroporation
US12042208B2 (en) 2018-05-03 2024-07-23 Boston Scientific Scimed, Inc. Systems, devices, and methods for ablation using surgical clamps
US11033236B2 (en) 2018-05-07 2021-06-15 Farapulse, Inc. Systems, apparatuses, and methods for filtering high voltage noise induced by pulsed electric field ablation
US10512505B2 (en) 2018-05-07 2019-12-24 Farapulse, Inc. Systems, apparatuses and methods for delivery of ablative energy to tissue
US10709502B2 (en) 2018-05-07 2020-07-14 Farapulse, Inc. Systems, apparatuses and methods for delivery of ablative energy to tissue
US11020180B2 (en) 2018-05-07 2021-06-01 Farapulse, Inc. Epicardial ablation catheter
WO2019234133A1 (en) * 2018-06-05 2019-12-12 National University Of Ireland, Galway Electrophysiology apparatus
EP3578124A1 (en) * 2018-06-05 2019-12-11 National University of Ireland Galway Electrophysiology apparatus
US11813019B2 (en) 2018-08-22 2023-11-14 Healium Medical Ltd Catheter ultrasound transducer container
US10687892B2 (en) 2018-09-20 2020-06-23 Farapulse, Inc. Systems, apparatuses, and methods for delivery of pulsed electric field ablative energy to endocardial tissue
CN112969425A (en) * 2018-11-07 2021-06-15 美敦力公司 Methods of identifying and eliminating arcs and arc-induced plasmas during tissue energy delivery
US12082867B2 (en) 2018-11-16 2024-09-10 Applied Medical Resources Corporation Electrosurgical system
US11207123B2 (en) 2018-11-16 2021-12-28 Applied Medical Resources Corporation Electrosurgical system
US11691006B2 (en) 2019-04-22 2023-07-04 Boston Scientific Scimed, Inc. Electrical stimulation devices for cancer treatment
US12109412B2 (en) 2019-04-22 2024-10-08 Boston Scientific Scimed, Inc. Combination electrical and chemotherapeutic treatment of cancer
JP2020179169A (en) * 2019-04-24 2020-11-05 株式会社Mitテクノロジー Drug, etc. administration device, actuation method thereof, and supporter
US11738200B2 (en) 2019-09-17 2023-08-29 Boston Scientific Scimed, Inc. Systems, apparatuses, and methods for detecting ectopic electrocardiogram signals during pulsed electric field ablation
US10688305B1 (en) 2019-09-17 2020-06-23 Farapulse, Inc. Systems, apparatuses, and methods for detecting ectopic electrocardiogram signals during pulsed electric field ablation
US10625080B1 (en) 2019-09-17 2020-04-21 Farapulse, Inc. Systems, apparatuses, and methods for detecting ectopic electrocardiogram signals during pulsed electric field ablation
US11684408B2 (en) 2019-11-20 2023-06-27 Boston Scientific Scimed, Inc. Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses
US11065047B2 (en) 2019-11-20 2021-07-20 Farapulse, Inc. Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses
US11497541B2 (en) 2019-11-20 2022-11-15 Boston Scientific Scimed, Inc. Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses
US11931090B2 (en) 2019-11-20 2024-03-19 Boston Scientific Scimed, Inc. Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses
US10842572B1 (en) 2019-11-25 2020-11-24 Farapulse, Inc. Methods, systems, and apparatuses for tracking ablation devices and generating lesion lines
US11883655B2 (en) 2020-02-24 2024-01-30 Boston Scientific Scimed, Inc. Systems and methods for treatment of pancreatic cancer
US20210267672A1 (en) * 2020-02-28 2021-09-02 St. Jude Medical, Cardiology Division, Inc. Electrode assembly including expandable isolation member
CN112716599A (en) * 2020-02-28 2021-04-30 圣犹达医疗用品心脏病学部门有限公司 Electrode assembly including expandable spacer member
US12121290B2 (en) * 2020-02-28 2024-10-22 St. Jude Medical, Cardiology Division, Inc. Electrode assembly including expandable isolation member
US20220022953A1 (en) * 2020-07-24 2022-01-27 Boston Scientific Scimed, Inc. Esophagus catheter for irreversible electroporation
US20220022952A1 (en) * 2020-07-24 2022-01-27 Boston Scientific Scimed Inc Electric Field Application for Single Shot Cardiac Ablation by Irreversible Electroporation
US20220087736A1 (en) * 2020-09-23 2022-03-24 Biosense Webster (Israel) Ltd. Electrode shorting
EP4014870A1 (en) 2020-12-17 2022-06-22 Biosense Webster (Israel) Ltd Gui for highlighting signals prior, during, and post ablation using multi-electrode catheters
US12137968B2 (en) 2021-03-19 2024-11-12 Boston Scientific Scimed, Inc. Methods and apparatus for multi-catheter tissue ablation
CN114983557A (en) * 2022-04-29 2022-09-02 天津市鹰泰利安康医疗科技有限责任公司 Device and method for catheter-mediated irreversible electroporation ablation of tissue
WO2023250356A1 (en) * 2022-06-23 2023-12-28 Medtronic, Inc. Application of non-therapeutic waveforms with gradient sensing to predict pulsed field ablation (pfa) fields
WO2024081897A1 (en) * 2022-10-14 2024-04-18 Pulse Biosciences, Inc. Multi-strut ablation and sensing catheter devices and methods
US12144541B2 (en) 2023-02-01 2024-11-19 Boston Scientific Scimed, Inc. Systems, apparatuses and methods for delivery of ablative energy to tissue

Also Published As

Publication number Publication date
US20240299089A1 (en) 2024-09-12
US20240307117A1 (en) 2024-09-19
EP3495018B1 (en) 2023-09-06
US20220000548A1 (en) 2022-01-06
US20240307114A1 (en) 2024-09-19
US20240315769A1 (en) 2024-09-26
WO2015171921A3 (en) 2016-01-14
EP4238521A3 (en) 2023-11-29
US20240315770A1 (en) 2024-09-26
US20240299088A1 (en) 2024-09-12
EP3139997B1 (en) 2018-09-19
US20240307115A1 (en) 2024-09-19
US11259869B2 (en) 2022-03-01
US20240307116A1 (en) 2024-09-19
EP3495018A1 (en) 2019-06-12
EP4238521A2 (en) 2023-09-06
US20180042674A1 (en) 2018-02-15
WO2015171921A2 (en) 2015-11-12
EP3139997A2 (en) 2017-03-15

Similar Documents

Publication Publication Date Title
US20240299088A1 (en) Methods and apparatus for selective tissue ablation
JP7442076B2 (en) Systems, devices, and methods for delivering pulsed electric field ablation energy to endocardial tissue
US20180042675A1 (en) Methods and apparatus for multi-catheter tissue ablation
CN111065327B (en) Systems, devices, and methods for ventricular focal ablation
JP7153671B2 (en) Systems, devices and methods for signal generation
US9999465B2 (en) Method and apparatus for rapid and safe pulmonary vein cardiac ablation
EP4275738A2 (en) Apparatus for controlled delivery of pulsed electric field ablative energy to tissue
JP2023504069A (en) Electroporation system and method
KR20220001439A (en) Temperature control for ire
WO2023049954A1 (en) Method, systems, apparatuses and devices for cardiac tissue characterization and ablation using reversible electroporation and electrolysis
US12137968B2 (en) Methods and apparatus for multi-catheter tissue ablation
JP7586706B2 (en) Systems, devices and methods for focal ventricular ablation - Patents.com
JP7428816B2 (en) Electrode assembly including expandable isolation member
JP2024156696A (en) Systems, devices and methods for focal ventricular ablation - Patents.com

Legal Events

Date Code Title Description
AS Assignment

Owner name: IOWA APPROACH INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MICKELSEN, STEVEN R.;REEL/FRAME:041155/0525

Effective date: 20150904

STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

AS Assignment

Owner name: FARAPULSE, INC., CALIFORNIA

Free format text: CHANGE OF NAME;ASSIGNOR:IOWA APPROACH, INC.;REEL/FRAME:046844/0969

Effective date: 20180531

Owner name: IOWA APPROACH, INC., CALIFORNIA

Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE PERIOD AFTER APPROACH IN RECEIVING PARTY NAME. PREVIOUSLY RECORDED AT REEL: 041155 FRAME: 0525. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT;ASSIGNOR:MICKELSEN, STEVEN R.;REEL/FRAME:046845/0029

Effective date: 20150904

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION

AS Assignment

Owner name: BOSTON SCIENTIFIC SCIMED, INC., MASSACHUSETTS

Free format text: SECURITY INTEREST;ASSIGNOR:FARAPULSE, INC.;REEL/FRAME:053596/0364

Effective date: 20200821

AS Assignment

Owner name: BOSTON SCIENTIFIC SCIMED, INC., MINNESOTA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:FARAPULSE, INC.;REEL/FRAME:060802/0286

Effective date: 20210806